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Disrupted in Schizophrenia 1 (DISC1) is a well supported risk factor for 
schizophrenia, bipolar disorder and major recurrent depression. DISC1 is a 
multifunctional multicompartmentalised scaffold protein with essential roles in 
neuronal proliferation, differentiation, migration and integration. DISC1 also 
modulates pathways of vital importance for neuronal signalling and plasticity. One of 
the major hypotheses for the cause of psychiatric illness is N-methyl-D-aspartate 
(NMDA) receptor hypofunction. It was observed that NMDA receptor antagonists 
can induce symptoms of schizophrenia in unaffected individuals, and exacerbate 
symptoms in patients with schizophrenia. Recent work in our laboratory showed that 
DISC1 complexes with NMDA receptors within the cell body and at synapse of 
neurons. Here I studied whether DISC1, or DISC1 missense variants, affect the 
trafficking of NMDA receptors. This was done by quantifying surface NMDA 
receptor expression in the presence of DISC1 or variant DISC1. I found that one 
common variant, 607F, causes a significant reduction in surface expressed NMDA 
receptors. I went on to show that DISC1 reduces the number of internalised receptors 
associating with early RAB5-containing endosomes. This indicates that DISC1 may 
be involved in the trafficking and recycling of NMDA receptors, a process that may 
be affected by the missense DISC1 variant 607F. Further to this I studied the effects 
on NMDA receptor trafficking of DISC1 pathway partners Nuclear Distribution 
Element 1 (NDE1) and Trafficking-protein kinesin binding 1 (TRAK1), both 
regulators of neuronal intracellular trafficking. Phosphorylation of NDE1 at T131 has 
been shown to be modulated by DISC1. Using phospho-mimic and phospho-dead 
NDE1 expression constructs I observed a significant reduction in the surface-
expressed NMDA receptors in cells expressing the phospho-mimic form of NDE1. 
NDE1 may therefore be involved in the trafficking of NMDA receptors, and this role 
may be modulated by phosphorylation of NDE1. Finally, TRAK1 was shown to 
associate robustly with the GluN2B subunit, and to decrease the surface expression 
of NMDA receptors, most likely by sequestering them.  The TRAK1-induced 
GluN2B sequestration may be an artefact, but the association of the trafficking 
molecule TRAK1 with this subunit may point towards a role in NMDA receptor 
trafficking. These proteins have been shown to associate with each other and may 
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form a complex in order to traffic NMDA receptors. Disruption of this complex by 
defective DISC1 expression may affect NMDA receptor trafficking. In the brain this 
could conceivably contribute to NMDA receptor hypofunction and the development 
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1.1.1  t(1;11) family 
The disrupted in schizophrenia 1 (DISC1) locus was originally identified in a large 
Scottish family with a high incidence of mental illness, which co-segregated with a 
t(1:11) translocation (St Clair et al., 1990). 87 members of the family have been 
karyotyped 37 of which carry the t(1;11)translocation (Blackwood et al., 2001). 
Detailed assessment was only possible in 29 of the family members with the 
translocation, and of these, 7 members had schizophrenia, 10 had recurrent major 
depression and 1 had bipolar disorder (Millar et al., 2001). Therefore 18 of 29 had a 
major mental illness whereas 0 of the 38 non-translocation carriers had a diagnosis 
of major mental illness. High logarithm of odds ratio (LOD) scores confirmed close 
linkage of the translocation to schizophrenia (LOD score 3.6), thus providing 
evidence for a causal link between the t(1:11) translocation and schizophrenia in 
this family. Furthermore when the diagnostic criteria were extended to include 
schizophrenia, bipolar disorder and recurrent major depression a highly significant 
LOD score of 7.1 was obtained, indicating that inheritance of the translocation 
contributes to susceptibility to developing a major mental illness (Blackwood et al., 
2001). 
The breakpoint regions on chromosome 1 and 11 were fine mapped and cloned, no 
evidence of a gene was found at the breakpoint on chromosome 11 (Devon et al., 
1997, Millar et al., 1998) however two genes were discovered to be disrupted by 
the breakpoint on chromosome 1, DISC1 and DISC2 (Millar et al., 2001, Millar et al., 
2000). Broadly speaking DISC1 has been found to be a multi-functional, multi-
compartmentalised protein linked to pathways which regulate neuronal outgrowth 
(Millar et al., 2000) and intracellular trafficking (Atkin et al., 2010, Millar et al., 2001, 
Ogawa et al., 2013). Furthermore alterations in DISC1 levels affect neuronal 
precursor proliferation (Mao et al., 2009) neuronal migration (Young-Pearse et al., 
2010, Kamiya et al., 2005, Duan et al., 2007) and neuronal integration (Duan et al., 
2007). DISC1 therefore plays many important roles in brain development. DISC2 is 
thought to be a natural anti-sense transcript (NAT) of DISC1, which may negatively 
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regulate DISC1, however the function of DISC2 has yet to be determined (Chubb et 
al., 2007).  
Subsequently a novel gene on chromosome 11 was found to be disrupted by the 
translocation named “Boymaw”. Two fusion proteins between Boymaw and DISC1 
have been proposed by Zhou et al, one is a protein containing exons 1-8 of DISC1 
fused to exons 4-6 of Boymaw (DB7) and the other is exons 1 and 2 from Boymaw 
fused to 9-13 of the DISC1 gene (DB13). DB7 when overexpressed in HEK 293 cells 
was found to be insoluble as western blot analysis showed their presence in the 
pellet, whereas the DB13 fusion proteins were found in the supernatant. To analyse 
the subcellular localisation of these fusion proteins rat hippocampal neurons were 
transfected with HA-tagged DB7 or DB13. DB7 appeared punctate in appearance 
whereas DB13 appeared diffuse throughout the cytoplasm, generation of these 
fusion transcripts could contribute to the pathogenesis of mental illness as the 
insoluble proteins could disrupt normal function of neuronal cells. Therefore the 
translocation event at t1:11 disrupts DISC1 and lead to the formation of fusion 
proteins which could in turn contribute to an increase in susceptibility of mental 
illness.  
The wider significance of the DISC1 translocation in the cause of mental illness has 
been called into question. There has been a lack of GWAS data highlighting DISC1 as 
a risk factor for mental illness which some have interpreted to mean that DISC1 is 
not a risk factor for mental illness. An alternative view is that there are no common 
ancient variants in DISC1 and is therefore less likely to appear by GWAS, but there 
may well be population-specific variants which are detectable by smaller 
population-based family studies. For example family based studies have shown 
linkage between DISC1 and schizophrenia (Hennah et al., 2007) with additional loci 
which link to mental illness being identified once conditioned on the DISC1 risk 
haplotype e.g. nuclear distribution protein-E 1 (NDE1). Through a direct interaction 
DISC1 regulates NDE1 and is essential for several fundamental processes during 
brain development and its function is regulated by DISC1 (Bradshaw et al., 2009) 
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thereby providing  evidence of a shared risk pathway disruption of which leads to an 
increase in susceptibility in schizophrenia. 
1.1.2 Protein structure 
The DISC1 gene consists of 13 exons which encodes a protein of 854 amino acids. The 
human DISC1 gene produces a number of alternatively spliced transcripts of which there 
are four major transcripts; Long, exons 1-13; Long variant, this transcript excludes 66 
amino acids from the distal end of exon 11; Short, this transcript has an alternative 
3’-UTR in exon 9; and Extremely short, which has an alternatively spliced exon 1a 
causing termination of transcription two intronic codons after exon 3. (Millar et al., 
2001, Taylor et al., 2003). In the human brain DISC1 is predominantly expressed as 
the long transcript with low levels of the alternatively spliced DISC1 transcripts 
being expressed (Lipska et al., 2006). Due to the fusion of chromosomes 1 and 11 
after the translocation event a number of fusion transcripts with protein coding 
potential have been found. A study into the potential function of these fusion 
transcripts showed the exogenous expression can induce abnormal mitochondrial 
morphology and membrane potential (Eykelenboom et al., 2012). The fusion 
transcripts also formed large stable protein aggregates which could be linked to 
those observed post mortem in patients with mental illness (Leliveld et al., 2008, 
Korth, 2009). However, these transcripts are very scarcely detected in patient 
lymphoblastoid cell lines and therefore any data should be interpreted with caution.   
There is no experimentally determined 3D structure for DISC1 and therefore the 
field has relied on bioinformatic predictions and biophysical studies (using 
fragments of DISC1) to gain information about the structure of DISC1. The structure 
of DISC1 is predicted to form a largely unstructured N-terminus (~1-350aa) with the 
C-terminus adopting a helical structure with the potential to form a coiled-coil 




Figure 1.1 Predicted structure of DISC1 – adapted from Soraes et al 2011 
Predicted DISC1 structure grey oval represents the disordered N-terminal head domain 
with the yellow lines representing regions of disorder. The green and pink boxes represent 
the helical nature of the C-terminal of DISC1 with the chromosomal translocation 
breakpoint shown in black. Stars represent the location of different variants. Also a heat 
map showing the conservation of regions of DISC1 with Red being highly conserved and 
blue not conserved. 
 
It has been recently shown that DISC1 can assemble into octomers using a self-
association domain located within the C-terminus of DISC1 to form dimers. These 
dimers are then used to form octomers. The authors of this study proposed a model 
where the octomers of DISC1 interact with nuclear distribution protein-E like 
(NDEL1) to create DISC1/NDEL1 complexes (discussed in 1.1.5). In addition a 
common variant identified as a risk factor for schizophrenia S704C-DISC1 has been 
shown to affect the oligomeric status of DISC1 (discussed in 1.1.5). Previous studies 
reported 704C-DISC1 having increased NDEL1 binding when compared to WT-DISC1. 
The authors of this study determined that the NDEL1 binding site was located in the 
C-terminus of DISC1 and predicted the 704C variant caused the formation of higher 
order oligomers rather than increasing the binding affinity to NDEL1 (Leliveld et al., 
2008). Further to this Leliveld et al characterised the multimerisation of DISC1 
fragment 598-854 and found it existed as dimeric, octameric and miltimeric species 
(Leliveld et al., 2008). Under physiologically relevant conditions the authors found 
the fragment reduces aggregation but only the octomeric species interacted with 
NDEL1, indicating that oligomerisation was necessary for interaction between the 
two proteins. Finally the authors found NDEL1 did not bind aggregates of FL-DISC1 
(Leliveld et al., 2008). Whilst bioinformatic predictions have been useful in 
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determining a general structure, without an experimentally determined structural 
model for DISC1 there are limits to what can be determined about structure-
function relationships with other proteins and how single nucleotide 
polymorphisms (SNP) may affect the structural integrity of DISC1 (Soares et al., 
2011) 
1.1.3 Expression in tissue 
DISC1 has been found to be expressed in a number of different locations in human 
adult and foetal tissue at both the protein and RNA level, which include the brain, 
the heart and the placenta (Millar et al., 2000, James et al., 2004). Within the 
human brain DISC1 is expressed in many brain regions with its highest expression 
within the dentate gyrus of the hippocampus (James et al., 2004, Lipska et al., 
2006). This was also observed in mouse brain samples where the highest DISC1 
expression was found in the dentate gyrus and lower expression in the cerebellum, 
cerebral cortex, ammons horn and the olfactory bulbs (Ma et al., 2002). In mice 
DISC1 is expressed throughout the brains development, but there are expression 
peaks at both embryonic day 18 (E18 (active neurogenesis)) and P35 (onset of 
puberty) (Brandon et al., 2004).The studies cited here were carried out using in situ 
hybridisation of RNA and therefore the findings are quite robust, with the exception 
of James et al where the authors used several DISC1 antibodies to determine 
localisation of DISC1 (James et al., 2004) (and therefore the findings are quite 
robust) and Schurov et al where the authors only used one DISC1 antibody and 
therefore the results should be interpreted with caution. 
At the subcellular level DISC1 has a broad expression pattern where it is located 
within multiple cellular compartments (Ozeki et al., 2003, James et al., 2004, Kamiya 
et al., 2005, Morris et al., 2003, Ogawa et al., 2005, Kamiya et al., 2006, Miyoshi et 
al., 2003, Brandon et al., 2004, Brandon et al., 2005, Miyoshi et al., 2004, Shinoda et 
al., 2007, Taya et al., 2007). Endogenous DISC1 has been shown to co-localise with 
markers for the mitochondria (Ozeki et al., 2003, Millar et al., 2000, Millar et al., 
2005b, Brandon et al., 2005), the golgi apparatus (Kuroda et al., 2011, Lepagnol-
Bestel et al., 2013) and the centrosome (Kamiya et al., 2006, Kamiya et al., 2005) as 
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well as markers for the cytoskeleton (Brandon et al., 2004, Brandon et al., 2005, 
Atkin et al., 2012) and the nucleus (Millar et al., 2005a). In neurons DISC1 is also 
been shown to localise to a number of different subcellular locations including post-
synaptic density (PSD), the cell body, neurites and the nucleus (Taya et al., 2007, 
Shinoda et al., 2007, James et al., 2004, Ozeki et al., 2003, Ogawa et al., 2005, 
Brandon et al., 2005, Miyoshi et al., 2003, Bradshaw et al., 2008). Furthermore 
DISC1 has been implicated in membrane targeting and vesicle tethering via its 
interaction with dynein and the exocyst complexes (Mead et al., 2010) therefore 
opening up a potential role of DISC1 in neuronal signalling (discussed in 1.1.4). 
One study used electron microscopy of human samples to visualise DISC1 
expression (Kirkpatrick et al., 2006). Kirkpatrick et al discovered DISC1 expression 
within axon terminals, the PSD and dendritic spines. Furthermore the authors 
showed an association between DISC1 with the cell body, with ribosomes within 
dendritic shafts and with the endoplasmic reticulum (ER) (Kirkpatrick et al., 2006). 
These studies have determined that DISC1 is widely expressed throughout the cell 
and throughout neurons which, coupled with the many known interactors of DISC1, 
indicate DISC1 may have (and be essential for) multiple functions within the cell. 
Although DISC1 has been shown to localise to many subcellular compartments 
these studies must be interpreted with caution. This is due to a large number of 
different DISC1 antibodies being used by different groups (15-33) many of which are 
made “in-house” by the labs and the data has not been replicated by independent 
groups. This has lead to a debate over suitable antibodies which can detect full 
length DISC1. It was found that 129s6/SvEv carry a 25bp deletion in exon 6 of DISC1 
which leads to a premature stop codon in exon 7 (Clapcote and Roder, 2006) The 
predicted protein which would be produced because of this stop codon was not 
detected, indicating that it may form an unstable protein which is degraded and 
therefore no full-length DISC1 is detected in this mouse.  A study in 2007 compared 
antibody detection of full length DISC1 using antibodies that were generated from 
eight independent groups and generated against more than 10 different epitopes 
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within DISC1. The authors found that all the antibodies they tested detected full 
length DISC1 at similar levels in 129s6/SvEv strain of mice with the exception of one 
antibody generated by Dr J. A. Gogos. The 129s6/SvEv mouse does not express full-
length DISC1 and therefore with the exception of the Gogos antibody the antibodies 
tested may not detect DISC1. 
Since then it has been suggested that a consensus was agreed that studies of DISC1 
should use two different DISC1 antibodies and yield consistent western blot and IP 
results. Many of the studies referenced here were published before this consensus 
but the localisation of DISC1 to some subcellular compartments has been confirmed 
by multiple groups using overexpressed protein as well as endogenous protein and 
therefore there is strong evidence for DISC1 expression at the; centrosome (Morris 
et al., 2003, Miyoshi et al., 2004, Bradshaw et al., 2008, Kamiya et al., 2008), PSD 
(Kirkpatrick et al., 2006), mitochondria (Ramsey et al., 2011, Paspalas et al., 2012, 
Ogawa et al., 2013), cytoskeleton (James et al., 2004, Miyoshi et al., 2003, Brandon 
et al., 2004, Brandon et al., 2005, Atkin et al., 2012), nucleus (Sawamura et al., 
2008, Malavasi et al., 2013) and golgi (Kuroda et al., 2011, Lepagnol-Bestel et al., 
2013). DISC1 localisations which have been suggested but need more evidence are 
the ER and ribosomes, (Kirkpatrick et al., 2006). 
1.1.4 DISC1 function 
1.1.4.1 DISC1 in brain development 
DISC1 has been described as a multifunctional, multicompartmentalised “hub” 
protein due to its many interactors and functions. A yeast 2-hybrid screen using 
DISC1, and DISC1 fragments, as bait revealed over 200 potential interactors, many 
of which have now been confirmed biochemically in neuronal or mammalian cell 
lines (Morris et al., 2003, Millar et al., 2003, Ozeki et al., 2003, Camargo et al., 
2006). Additional yeast 2-hybrid studies found DISC1 interactors linking DISC1 to the 
centrosome, neurotransmission and neuronal plasticity (Hattori et al., 1994, 
Miyoshi et al., 2004). Disruption of the DISC1 gene in the t(1;11) family could not 
only disrupt the formation and function of DISC1 but also a number of interacting 
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proteins leading to the disruption of signalling pathways and intracellular processes 
(Millar et al., 2003, Hennah et al., 2007).  
The hippocampus is a major site of neuronal precursor proliferation whereby new 
neurons are constantly being created throughout the life of the mammalian brain. 
DISC1 has been found to play a critical role in this process (Mao et al., 2009). 
Knockdown of DISC1 using electroporation of shDISC1 at E13, caused a significant 
reduction in cells within the sub and ventricular zone of the hippocampus (Mao et 
al., 2009). Whereas, the overexpression of full length DISC1 caused a significant 
increase in proliferation of newborn cells within sub ventricular and ventricular 
zones. Further to this the same authors showed in adult brain knockdown of DISC1 
also caused a significant reduction in the proliferation of newborn cells (Mao et al., 
2009). 
Several studies have shown that the knockdown of DISC1 in the developing mouse 
brain can cause deficits in neuronal migration. One study showed knockdown of 
DISC1 in utero inhibits the migration of neurons from the ventricular zone to the 
cortex. The authors electroporated embryos at E14.5 with RNAi to knockdown 
DISC1 and analysed the brains at postnatal day 2 (P2) where they observed a 
significant reduction in neuronal migration as there were few labelled neurons 
within the upper layers of the cortex, but still detected neurons within the 
ventricular zone. Additionally the authors noticed (in the neurons which had 
migrated) abnormalities in the branching structure at P14 when branching and the 
formation of circuits is usually quite extensive (Kamiya et al., 2005). Conversely 
DISC1 knockdown in adult mice leads to overextended migration of new-born 
neurons in the hippocampus  and neurons which had DISC1 expression knocked 
down exhibited a much more complex branching structure indicating DISC1 may be 
involved in dendritic branching development in new-born adult neurons (Duan et 
al., 2007). Although these are contrasting findings Duan et al offered a potential 
explanation into why this may be as the authors speculated that the differences 
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between these studies may suggest that DISC1 regulates the detection of cues that 
aid the migration of neurons in the developing and adult brain (Duan et al., 2007). 
DISC1 also plays a critical role in neuronal integration (Duan et al., 2007, Faulkner et 
al., 2008, Kvajo et al., 2008). Knockdown of DISC1 in the adult dentate gyrus leads to 
the accelerated formation of functional GABAergic and glutamergic synaptic inputs 
to new neurons, as increased numbers of dendritic spines were observed in new 
neurons after 2 weeks post knockdown of DISC1 whereas in control cells an 
increase in the number of dendritic spines was only observed after 4 weeks (Duan 
et al., 2007). Further evidence for DISC1s role in neuronal integration was provided 
by Fulkner et al who showed DISC1 knockdown in the dentate gyrus of adult mice 
lead to an increase in axonal growth of newborn neurons which projected outwith 
the CA3 region of the hippocampus (Faulkner et al., 2008). In control cells axons did 
not grow beyond the CA3 region indicating DISC1 regulates the correct integration 
of newborn neurons (Faulkner et al., 2008).  DISC1 therefore plays a critical role in 
the integration of newborn neurons into the dentate gyrus of adult mice. 
DISC1 is present at the synapse where it interacts with the synaptic protein PSD95. 
Additional studies have showed exogenous expression of DISC1 localises to 
dendritic spines (Bradshaw et al., 2008, Hayashi-Takagi et al., 2010). Functional 
studies have yet to be performed therefore the exact role of DISC1 at the synapse 
has yet to be elucidated. However one study has determined that DISC1 modulates 
size and density of dendritic spines via an interaction with Kal-7. Kal-7 is a GTP/GDP 
exchange factor for RAC1 and regulates spine morphology and plasticity. DISC1 
anchors KAL-7 in a protein complex and controls access of Kal-7 to RAC1 thereby 
regulating dendritic spine size and density (Hayashi-Takagi et al., 2010). 
Furthermore DISC1 knockdown results in a decrease mobility of synaptic vesicles 
and an accumulation of vesicles along neuronal processes indicating DISC1 has a 
role in vesicle trafficking within neurons (Flores Iii et al., 2011). Pre-synaptically 
DISC1 may play a role in the regulation of glutamate release since the targeted 
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expression of a C-terminal truncated DISC1 disrupts glutamate vesicle fusion at the 
synapse (Maher and LoTurco, 2012). 
Therefore DISC1 plays a critical role in the development and DISC1 can affect a 
number of different processes within the brain; neuronal migration, integration, 
neuronal precursor proliferation and neuronal signalling. Defective expression of 
DISC1 or any of its interactors that are also involved in these processes are likely to 
have a detrimental effect on brain development and function. 
 
Figure 1.2 Potential DISC1 function at the synapse adapted from Brandon and 
Sawa 2011 
This figure shows DISC1 potential interaction with AMPA receptors via TNIK where DISC1 
via TNIK photphorylates AMPA receptors which are then endocytosed and either recycled 
or degraded. DISC1 may also have function with NMDA receptors via PSD95. 
DISC1/PDE4/GSK3β complex may provide additional function via phosphorylation. 
 
1.1.4.2 DISC1 in intracellular trafficking 
Within the cell DISC1 has a number of functions, that could influence its role in 
neurogenesis and neurosignalling, but this introduction will specifically examine the 
role of DISC1 in intracellular trafficking. Other DISC1 functions at the subcellular 
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level have been reviewed previously (Chubb et al., 2007, Thomson et al., Soares et 
al., 2011). Knockdown of DISC1 causes inhibition of axonal transport of various 
cargoes, which suggests a general role in microtubule based intracellular trafficking. 
More specifically DISC1 has been shown to interact with the microtubule motor 
proteins kinesin (Taya et al., 2007) and dynein (Kamiya et al., 2005) and interacts 
with a number of known trafficking molecules; LIS1, NDEL1, NDE1, 14-3-3α and 
TRAK1 (Ogawa et al., 2005, Ozeki et al., 2003, Morris et al., 2003, Brandon et al., 
2004).  
Dynein is a minus-end retrograde motor protein which has three main functions 
within the cell; to carry various cargoes away from the cell periphery (Roberts et al., 
2013); assist in assembling microtubules into the spindle during cell division (Heald 
et al., 1996, Merdes et al., 1996); and exert tension on microtubules in order to pull 
the cytoskeleton in various directions. For example in migrating neurons, to aid 
movement dynein pulls the cytoskeleton towards the leading edge of the neuron 
(Tsai et al., 2007). Cytoplasmic dynein interacts with the proteins NDE1/NDEL1, LIS1 
and dynactin, which are key regulators of its function (Roberts et al., 2013). 
Endogenous DISC1 was shown to coimmuniprecipicate with dynein intermediate 
chain in PC12 cells (Kamiya et al., 2005). Furthermore knockdown of DISC1 using 
RNAi in PC12 cells caused a reduction in neurite outgrowth an effect which was 
rescued by overexpression of WT-DSIC1. Expression of a C-terminally truncated 
form of DISC1 consisting of amino-acids 1-597 which mimics the translocation, 
caused the displacement of DISC1, LIS1 and dynactin from the centrosome and 
ultimately inhibits the anchoring of dynein to the centrosome leading to a 
disorganised microtubule network and a reduction in neurite outgrowth (Kamiya et 
al., 2005). Kamiya et al suggested that the failure of DISC1 mediated recruitment of 
the motor complex to the centrosome underlies the reduced neurite outgrowth and 
cortical migration deficits observed in neurons after DISC1 knockdown or 
overexpression of 1-597 (Kamiya et al., 2008). This could be due to a reduction of 
nucleokinesis (movement of the nucleus after the extension of the leading edge of 
the cell during cell migration) for which both the DISC1 interactors dynein and 
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kinesin are essential. Therefore a reduction in DISC1 levels would be predicted to 
result in a reduction in neuronal migration and outgrowth. DISC1 therefore 
associates with dynein and is critical for dynein function in relation to neuronal 
outgrowth and microtubule organisation and therefore is well placed to also play a 
role in dynein mediated intracellular transport, however this has yet to be studied. 
Kinesin is a plus end molecular motor, which moves various cargoes such as 
synaptic vesicle precursors, mitochondria, NMDA receptor vesicles, AMPA receptor 
vesicles and mRNAs. In most cases kinesin motors recognise and bind their cargoes 
through scaffold proteins or adaptor protein complexes (Hirokawa et al., 2010). 
DISC1 interacts with kinesin-1 and can therefore potentially link several proteins 
and protein complexes to kinesin, and regulate their movement and localisation 
within the cell. DISC1 links the LIS1/NDE1/14-3-3ε complex with kinesin and 
regulates the transport of the complex in neurons, which leads to axon elongation 
(Taya et al., 2007). Further to this, DISC1 can regulate the transport of the growth 
factor receptor bound protein 2 (Grb2) (Shinoda et al., 2007). Grb2 links cell surface 
receptors to intracellular signalling pathways (Lowenstein et al., 1992) and forms a 
ternary complex with DISC1 and kinesin-1. In growth cones of rat hippocampi DISC1 
and Grb2 are associated with the microtubules (Shinoda et al., 2007). Furthermore 
knockdown of kinesin caused a reduction in Grb2 motility and accumulation in 
growth cones similarly DISC1 KD also leads to an accumulation of GRB2 in growth 
cones and therefore they may be related in function (DISC1 and Kinesin), thus DISC1 
is required for the kinesin-dependent movement of Grb2 along microtubules 
(Shinoda et al., 2007). 
DISC1 expression levels have been shown to influence the number of motile 
mitochondria within neurons (Atkin et al., 2010) and DISC1 has been found to 
promote anterograde axonal mitochondrial trafficking within neurons (Ogawa et al., 
2013). However the latter study failed to replicate the influence of DISC1 upon the 
number of motile mitochondria, therefore additional work is required to further 
elucidate the precise function of DISC1 in mitochondrial trafficking. However recent 
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studies showed DISC1 also associates with TRAK1 and Miro1 which link 
mitochondria to kinesin (Ogawa et al., 2013, Brickley et al., 2005, MacAskill et al., 
2009), And therefore it is likely, through a direct interaction with TRAK1, that DISC1 
influences mitochondrial trafficking within neurons. 
Through Yeast 2-hybrid studies an interaction between DISC1 and EXOC1 (a 
component of the exocyst complex, which is essential for targeting exocytic vesicles 
to specific docking sites on the plasma membrane) has been found (Camargo et al., 
2006). Mead et al further characterised the interaction by showing co-
immunoprecipitation of endogenous DISC1 and exogenous EXOC3 in HEK-293 cells 
(Mead et al., 2010). DISC1 was also shown to be critical in vesicle transport in 
neurons as DISC1 knockdown resulted in a reduction of vesicle movement in 
neurons leading to an accumulation of vesicles along processes (Mead et al., 2010). 
This indicates DISC1 plays a central role in vesicle movement in neurons (Flores Iii et 
al., 2011). 
The literature shows that DISC1 can act as a scaffold to link various proteins to 
dynein and kinesin motors to regulate their transport and localisation within the 
cell. DISC1 therefore plays an essential role in intracellular trafficking but due to its 
large number of protein interactors its full role in trafficking is still to be 
determined.  
Within the developing brain disruption to DISC1 function or expression could lead to 
a reduction in; axonal elongation via its interaction with LIS1/NDE1/14-3-3ε and 
kinesin, a reduction in anterograde cargo movement via its interaction with kinesin 
which could lead to deficits in neuronal signalling and synaptic activity. Via DISC1s 
interaction with dynein, neuronal migration and intracellular trafficking would be 
affected which could lead to brain development and removal of synaptic protein. 
Therefore DISC1 likely plays an essential role in brain development and neuronal 
transport with further complexity still to be discovered. 
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1.1.5 DISC1 variants and mutants 
Within the DISC1 gene three common amino acid variants have been identified 
which associate with mental illness: S704C, L607F and R264Q (reviewed in (Chubb 
et al., 2007, Bradshaw and Porteous, 2012)). Studies of R264Q have R264Q has 
been shown to affect cortical thickness within the lateral occipital gyrus (Brauns et 
al., 2011). DISC1 has been shown to regulate the activity of GSK3β through direct 
interaction, thereby regulating Wnt signalling (Mao et al., 2009). The same authors 
showed in a later study that the DISC1-264Q cannot rescue the decrease in 
neuronal progenitor proliferation observed after DISC1 knockdown (electroporation 
of shRNA and either DISC1 or DISC1-264Q was carried out at E13 and analysis was at 
E16). Finally the authors showed that DISC1-264Q also significantly reduced Wnt 
signalling in human lymphoblast cells (Singh et al., 2011). There is also a growing 
body of biological evidence for causative effects of the S704C and L607F variants.  
There is genetic evidence linking S704C variant to mental illness. Callicot et al found 
evidence for variation at 704C in one of 3 independent cohorts and co-segragation 
of schizophrenia (Callicott et al., 2005). Subsequently other groups also observed a 
co-seragation with 704C and mental illness in Han-Chineese populations (Qu et al., 
2007) and in Japanese populations a co-segragation of 704C and major depression 
(Hashimoto et al., 2006). Interestingly the 704C allele also co-segregated with 
cognitive defects in both healthy and patients with schizophrenia and 704C allele 
carriers performed worse in cognitive flexibility tests (Wisconsin card sorting 
test)(Di Giorgio et al., 2008). 
Variation at position 704 was identified as a risk factor for mental illness by Ekelund 
et al (Ekelund et al., 2004). Since then this polymorphism has been associated with 
altered grey matter volume in the hippocampus and prefrontal cortex (Callicott et 
al., 2005, Cannon et al., 2005). Functional imaging studies confirmed that the 
polymorphism S704C lead to functional differences within the brain. First of all 
although patients performed similarly during testing, S704 homozygotes showed an 
increase in hippocampal-DLPFC functional coupling during memory encoding which 
indicates higher activity in this region (Di Giorgio et al., 2008). Additional studies 
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also showed differences between S704 homozygotes and patients with 
schizophrenia or bipolar disorder in the synaptic activity within a number of regions 
within the brain (Prata et al., 2008) therefore providing further evidence for a 
causative effect of this polymorphism. 
At the molecular level  the C704 variant is associated with reduced activity of the 
kinases extracellular signal-regulated kinase 1 (ERK1) and RAC-alpha 
serine/threonine-protein kinase (AKT) when compared to S704 (Hashimoto et al., 
2006). The ERK signalling pathway controls a number of processes within the cell 
including proliferation and motility (Kolch, 2005), therefore disruptions to the 
homeostatis of this signalling pathway could be detrimental the health of the cell. 
Analysis of brain tissue from C704 carriers showed a trend towards reduced PCM1 
immunoreactivity in glial cells when compared to S704 homozygotes (Eastwood et 
al., 2010). PCM1 is essential for microtubule assembly, and DISC1 (along with 
Bardet-Biedl Syndrome 4 protein (BBS4), which is localised to the centrosome and 
contributes to the maintenance of microtubular dynamics, as well as intracellular 
transport and ciliary function (Kamiya et al., 2008), recruit PCM1 to the centrosome. 
Disruption of this process leads to neuronal migration deficits during cortical 
development (Kamiya et al., 2008), therefore DISC1-704C carriers may suffer from 
neuronal migration deficits. Finally the S704C polymorphism was found to have an 
effect on NDEL1 binding, with the 704C-DISC1 having slightly increased affinity for 
NDEL1. As discussed in 1.1.2 DISC1-704C oligomerises more extensively than DISC1-
704S, and DISC1 octomers associate with NDEL1 therefore the 704C vaiant has a 
stronger association with NDEL1 (Leliveld et al., 2008). The 704C variant is more 
strongly associated with abnormal behavioural phenotypes(Leliveld et al., 2009). It 
is, therefore, possible that aberrant oligomerisation of DISC1 could affect 
behaviour, however more work is needed to draw any firm conclusions (Leliveld et 
al., 2009). 
Another common variant is L607F (Cannon et al., 2005, Hodgkinson et al., 2004). 
Variation in DISC1 at 607 was first identified as potential risk factor in mental illness 
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by Hodgkinson et al (Hodgkinson et al., 2004). Using a case-control data set of 
individuals the authors found an undertransmission of a common haplotype and 
evidence of association of schizophrenia, schizo affective disorder and bipolar 
disorder with multiple haplotypes which included a strong association of 607F 
carriers and schizoaffective disorder (Hodgkinson et al., 2004). A second group 
looked at family trios in French and Algerian populations where they found the L-
allele of L607F was over transmitted in both populations and assessing for 
schizophrenia the authors found patients with the F scored significantly higher on 
the scale for the assessment of negative symptoms (which is a scaling system used 
to determine the severity of negative symptoms of mental illness), thus providing 
further evidence for a lack of 607F and increasing influence of schizophrenia 
(Lepagnol-Bestel et al., 2013). Callicot used a family based association and looked at 
the functional impact of DISC1 variation on phenotypes linked to hippocampal 
formulation but only found evidence for an effect with the 704C risk allele (Callicott 
et al., 2005). 
Functionally variation at position 607 has been associated with a greater severity of 
the positive symptoms of schizophrenia and volume reduction in the 
superiorfrontal, anterior cingulate gyri (Szeszko et al., 2008). Similar to the findings 
with S704C, this variant influences cortical thickness and DLPFC activation, with the 
Phe variant having a detrimental effect when compared to Leu homozygotes 
(Brauns et al., 2011). However the biological mechanisms underlying these traits 
have yet to be determined. 
Within the cell DISC1-607F is associated with reduced PCM1 immunoreactivity and 
reduced noradrenaline release (Eastwood et al., 2009). This could be due to the 
location of the polymorphism, which is located within a predicted leucine zipper, 
changes in this region have been shown (in other models) to disrupt stability, 
oligomeric state and orientation of the coiled-coil helices, and the change from Leu 
to Phe would be predicted to disrupt coiled-coil formation (Soares et al., 2011). 
DISC1-607F has also been shown to be influence mitochondrial trafficking, with 
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DISC1 carrying the Phe allele unable to rescue mitochondrial trafficking deficits 
induced by DISC1 knockdown (Atkin et al., 2010). Finally , the Phe variant impairs 
nuclear targeting of DISC1, which leads to a decreased ability of DISC1 to regulate 
ATF4-dependent transcription (Malavasi et al., 2013). DISC1 interacts with the stress 
response factor ATF4, which has a number of functions within the cell including 
activation of gene transcription (Ameri and Harris, 2008), regulation of synaptic 
plasticity (Green et al., 2008, Costa-Mattioli et al., 2007) and promote cell survival 
or cell death pathways (Fawcett et al., 1999, Ohoka et al., 2005). Through decreased 
association the 607F carriers may have altered ATF4 signalling which could lead to 
abnormalities in synaptic communication.   
Rare amino acid sequence variants have also been identified within DISC1. R37W is 
an ultra-rare polymorphism which was first identified in a large study performed by 
Song et al (Song et al., 2008). The group originally identified 5 novel mutations; 
G14A, R37W, S90L, R418H and T603I, in 6 patients out of 288 diagnosed with 
schizophrenia but not in 288 matched controls or a subsequent sample of 5000 
unaffected individuals (Song et al., 2008). Additionally this variant was identified in 
a single individual diagnosed with depression in a separate study of 653 patients 
with a major mental illness (schizophrenia, bipolar disorder or major depressive 
disorder) and 889 matched controls (Thomson et al., 2013b). Within this family 
there were two carriers of the R37W mutation, one of whom has been diagnosed 
with major depressive disorder and the other with anxiety (Song et al., 2008, 
Thomson et al., 2013b) and another member of the family who did not carry the 
mutation but has been diagnosed with bipolar disorder. 
To date there have been few studies of the effect of 37W at the subcellular level. 
One recent study demonstrated that 37W alters the mitochondrial localisation of 
DISC1 from punctate to tubular, while blocking DISC1’s ability to promote 
anterograde mitochondrial movement (Ogawa et al., 2013). This study also showed 
that 37W increases DISC1/TRAK1 association in COS7 cells (Ogawa et al., 2013). 
Furthermore DISC1-37W overexpression in COS7 cells results in decreased nuclear 
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abundance and, similar to the variant form of DISC1 carrying 607F, has a decreased 
ability to inhibit ATF4 mediated transcription (Malavasi et al., 2013).  
The R37W polymorphism is located within a tetra-Arginine stretch that is a known 
nuclear localisation sequence (Sawamura et al., 2008). Therefore disruptions to this 
region may affect the nuclear targeting of DISC1 and thereby may explain the 
reduction in nuclear abundance observed for DISC1-37W (Malavasi et al., 2013). 
Furthermore it has been hypothesised that the 37W alteration could affect the 
positive charge created by the tetra-arginine region and thereby affecting formation 
of ionic bonds with other proteins (Ogawa et al., 2013). In addition, the authors 
speculated that the presence of an aromatic ring introduced by the tryptophan may 
alter the conformation of the protein in this region making binding more favourable 
in the case of TRAK1 (Ogawa et al., 2013). 
Taken together studies have shown that DISC1 sequence variants can dramatically 
alter its function, leading to deficits in several processes. Mitochondrial trafficking is 
one of the processes now know to be affected by at least two of the variants, 37W 
and 607F. While these studies have focused upon mitochondrial trafficking, DISC1 is 
also known to modulate synaptic vesicle transport (Flores Iii et al., 2011). Moreover 
DISC1 interactors also regulate motility of other cargoes e.g. in addition to its 
involvement in mitochondrial transport, TRAK1 also directs endosome to lysosome 
trafficking, and modulates GABAA receptor trafficking. There is potential, therefore, 





1.2 The NMDA receptor  
1.2.1 NMDA receptors in psychiatric illness 
NMDA receptor hypofunction has long been implicated in psychosis. Since the 
1970’s, post mortem studies of patients with schizophrenia have shown abnormal 
glutamate receptor binding levels and abnormal glutamate levels in the 
cerebrospinal fluid in patients with schizophrenia. More recently it has been shown 
that the NMDA receptor antagonists PCP and ketamine can model both the positive 
and negative symptoms of the disease in unaffected individuals (Moghaddam and 
Krystal, 2012, Krystal et al., 1994). What’s more these drugs exacerbate the 
symptoms in patients with schizophrenia indicating a link between NMDA receptor 
hypofunction and schizophrenia (Malhotra et al., 1997, Krystal et al., 1994). 
Furthermore patients with schizophrenia can present with hypofrontality where 
they show decreased activity in the prefrontal cortex, further implicating 
hypofunction of NMDA receptors. Although there is a strong case for NMDA 
receptor hypofunction contributing to mental illness, the mechanisms of how this 
occurs have yet to be elucidated. There has been extensive testing for variation in 
the genes encoding receptor subunits and an association with mental illness, with 
no significant data being published. Using independent cohorts a weak association 
in some genes has been found but any genetic evidence linking NMDA receptors or 
other receptor subunits (GABAA, AMPA, kinate ect) has been very limited 
(O'Donovan and Owen, 1999). 
There is some genetic evidence linking the NDMA receptor to schizophrenia via 
NRG1. NRG1 is a pleiotropic growth factor which has a multitude of different roles 
including but not limited to synaptogenesis, neurotransmission and neuronal 
migration. NRG1 can act via the ErbB family of transmembrane tryrosine kinases 
where it activates a signalling cascade which can modulate a number of receptors 
(NMDA, Dopamine, and GABAA, for a detailed review see Deng et al 13 (Deng et al., 
2013)). Several linkage studies have shown chromosome 8p to link to schizophrenia 
(for detailed review see Harrison and Law (Harrison and Law, 2006)). Therefore in 
part linking NMDA receptor signalling to mental illness however this is a tentative 
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link as NRG1 acts on several different signalling pathways. As DISC1 is a known risk 
factor for schizophrenia and potentially binds to NMDA receptors (peptide S. 
Mackie and Murdoch unpublished) this further implicates the NMDA receptor in 
mental illness 
The NMDA receptor is one of the major excitatory receptors in the mammalian 
brain. The NMDA receptor is an ionotropic coincidence detector (as it is regulated 
simultaneously by voltage and two ligands, glutamate and glycine) and is part of the 
glutamate receptor family which also encompasses AMPA and Kainate receptors. 
Whereas AMPA receptors are the primary mediators of fast excitatory transmission 
under basal signalling conditions, NMDA receptors are responsible for slow 
excitatory transmission and are highly permeable to Ca2+ ions. The influx of Ca2+ into 
the cell activates signal transduction cascades, which in turn regulate a number of 
cellular processes including synaptogenesis, synaptic modification, elimination and 
long term potentiation (LTP), a synaptic paradigm which is the current 
understanding for learning and memory (Constantine-Paton, 1990, Malenka and 
Nicoll, 1999, Mori and Mishina, 1995). 
NMDA receptors exist as tetramers containing two GluN1 subunits and at least one 
GluN2 (A-D) subunit (Lau and Zukin, 2007). The GluN2 subunits are developmentally 
regulated with GluN2B-containing NMDA receptors primarily expressed during 
development, and GluN2A-containing receptors being primarily expressed in 
adulthood (Hardingham and Bading, 2010). The GluN2 subunit also determines the 
biophysical and pharmacological properties of the receptor with GluN2A subunits 
having a lower affinity for glutamate, faster channel kinetics and greater open 
channel probability (Cull-Candy and Leszkiewicz, 2004). GluN3 (A+B) containing 
NMDA receptors form excitatory glycine receptors which are impermeable to Ca2+ 
and unresponsive to glutamate however their physiological role has yet to be 
determined. As NMDA receptors are permeable to Ca2+ there is a need for tight 
regulation of expression of the receptor as too much activation can lead to 
excitotoxicity (where pro-death pathways are activated due to a large influx of 
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Ca2+), or too little stimulation can lead to signalling deficits and hyposignalling (For 
detailed review see Lau and Zukin (Lau and Zukin, 2007)). 
1.2.2 NMDA receptor trafficking to the cell surface 
1.2.2.1 ER Retention 
Like many proteins, the GluN1 subunit of the NMDA receptor contains ER retention 
signals which act to either modulate the export of misfolded (or otherwise 
imperfect) NMDA receptor subunits, or to ensure GluN1 is not exported until it has 
assembled with the GluN2 subunit. The NMDA receptor is wholly formed within the 
ER thus preventing export of monomers or incompletely assembled receptor 
complexes. ER retention of the GluN1 subunit is dependent on alternative splicing in 
the C-terminus (Standley et al., 2000, Scott et al., 2001, Xia et al., 2001). The major 
splice variant GluN1-1 is retained within the ER because of an RRR and KKK 
retention motif in its C1 cassette. GluN1-2,3, are not retained because they lack this 
cassette. GluN1-4 is not retained because it contains a C2’ cassette which contains a 
PDZ binding domain which has been shown to initiate premature exit from the ER 
through the regulation of the RRR motif (Petralia et al., 2009). Mutation of the 
either the KKK or RRR site to AAA results in ER retention of the GluN1 subunit and 
surface expression of individual GluN1 subunits is only achieved when both sites are 
mutated to AAA (Horak and Wenthold, 2009). 
The GluN2B subunit contains only one retention motif, HLFY, which immediately 
follows TM4 and is required for the export of receptors from the ER (Hawkins et al., 
2004). Subunits which have the HLFY motif mutated to AAAA can still form 
receptors with GluN1, but are retained within the ER (Hawkins et al., 2004). This 
indicates that forward trafficking of the receptor only occurs when the HLFY motif is 
accessible i.e. unmasked and if masked then there is ER retention of the NMDA 
receptor. Thus the motif functions as an indicator that the assembly process is 
complete, unlike the KKK and RRR motifs in the GluN1 subunit which are masked 
when correctly formed receptors are assembled. The HLFY motif is absent from the 
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GluN1 subunit but is present in GluN2A and GluN2B and has the sequence HLVY in 
GluN2C and GluN2D subunits (Hawkins et al., 2004).  
Other factors can also affect the release of the GluN1 subunits from the ER. PKC 
phosphorylation of a serine at S896, which is next to the RXR ER retention, was 
reported to override the ER retention motif and elicits robust surface expression of 
GluN1 (Scott et al., 2001, Scott et al., 2003). This also may involve phosphorylation 
of an adjacent PKA site (S897) or the co-ordinated action of both PKA and PKC (Scott 
et al., 2001, Scott et al., 2003). These studies found; first, brain macrosomes are 
largely dually phosphorylated at S896 and S897 (by PKC and PKA respectively), 
whereas in synaptosomes the subunits are largely de-phosphorylated; Second, 
S896, S897 and dual SS896,897 phosphorylation can occur in early secretory 
compartments suggesting that PKC and PKA can phosphorylate GluN1 in the ER and 
/or Golgi; Thirdly, phosphomimic mutants of S897 are sufficient to override ER 
retention, while phosphomimic mutants of S896 sites are not. However a later 
study by Horak and Wenthold disputed these findings as they found mutation of the 
phosphosites did not result in surface expression of the GluN1 subunit (Horak and 
Wenthold, 2009). This could have been due to Scott et al using tac-GluN1 C-terminal 
tails and Horak and Wenthold using full length receptor subunits. 
1.2.2.2 Trafficking to the cell surface 
The mechanism of transport of the NMDA receptor from the ER to the surface 
membrane is still largely unknown. It is generally believed that, once released from 
the ER, NMDA receptors are transported to the surface of the cell where they are 
either inserted directly into the plasma membrane or maintained within an 
intracellular pool. Holding receptors within this pool allows for, upon activation of 
surface receptors, their rapid insertion into the plasma membrane (Perez-Otano 
and Ehlers, 2005). 
After receptor formation, the sub-cellular localisation of the GluN2B subunit is 
regulated by its protein-protein interactions in the C-terminal tail. Via its PDZ 
domain, GluN2B binds to the adaptor proteins AP1, AP3 and AP4. These adaptor 
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protein facilitate cargo transport by both clathrin dependent and clathrin 
independent mechanisms indicating that the NMDA receptor can be trafficked from 
the trans-golgi network by both clathrin and non-clathrin mechanisms (Sans et al., 
2000). GluN2B has also been shown to interact, between the ER and trans-golgi 
network, with the synaptic membrane associated guanylate kinase (MAGUK) 
protein SAP102 (Muller et al., 1996, Sans et al., 2005, Lau and Zukin, 2007). SAP102 
is an early resident of synapses and is prevalent in the cytoplasm, suggesting that it 
may be involved in trafficking of membrane cargo. mPins, a ubiquitously expressed 
protein critical for the regulation of mitotic spindle organisation in developing cells, 
interacts with SAP102. Disrupting the interaction between these regulatory 
proteins, results in a decrease in trafficking of NMDA receptors (Sans et al., 2005). 
Successful interaction between mPins and SAP102 is therefore thought to be 
required for NMDA receptor trafficking (Sans et al., 2005). 
Another protein thought to be involved in NMDA receptor trafficking is the exocyst 
complex component, sec8 (Prybylowski and Wenthold, 2004, Sans et al., 2003, Groc 
et al., 2006). Sec8 facilitates vesicle fusion to the plasma membrane although the 
exact mechanism of how this occurs is unknown. inhibition of the ER, Golgi and 
trans-golgi networks resulted in the mistargeting of  Sec8 indicating Sec8 is 
associated with these organelles (Hsu et al., 1999, Yeaman et al., 2001, Vega and 
Hsu, 2001, Shin et al., 2000). Sec8 exerts its function by binding directly to the PDZ 
domain of SAP102 forming a complex containing the NMDA receptor (Sans et al., 
2003). Use of a dominant negative form of Sec8 that lacks a PDZ binding domain has 
been shown to block the interaction of Sec8 with SAP102 thus preventing delivery 
of the NMDA receptors to the cell surface (Sans et al., 2003). Therefore NMDA 
receptors require both for surface expression; however GluN2B subunits lacking the 
PDZ binding domain have been shown to still be delivered to the cell surface and 
therefore can be inserted into the plasma membrane via a mechanism independent 
of sec8 and MAGUK (a class of scaffold proteins present in the PSD which control a 
number of signalling pathways), thus there is clearly further complexity waiting to 
be uncovered (Sans et al., 2003, Chung et al., 2004, Prybylowski et al., 2005). 
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Trafficking of the complex containing; GluN1, GluN2B, SAP102, Sec8 and mPins is 
likely to be via kinesin motors due to GluN2B being able to bind to KIF17 accessory 
proteins mLin 2, mLin7 and mLin10 (Guillaud et al., 2003, Setou et al., 2000, Wang 
et al., 2010a). Knockdown of KIF17 impairs expression and synaptic localisation of 
GluN2B, which is followed by an increase in GluN2A at the synapse (Guillaud et al., 
2003). Therefore the complex of SAP102, sec8 and mPins modulates the transport 
of the NMDA receptor bound in the membrane of the carrier vesicle or 
tubulovesicular organelle along the dendrite. 
Taken together this indicates NMDA receptors are trafficked via clathrin or non-
clathrin coated vesicles from the trans-golgi network via a complex of Sec8, SAP102 
and mPins which attach to kinesin motors and traffic the complex to the surface of 
the cell. However this may not be the only mechanism of receptor trafficking as 
disruption of the PDZ domain on the GluN2B subunit did not lead to total loss of 
NMDA receptor surface expression. These receptors must therefore be trafficked to 




Figure 1.3 NMDA receptor trafficking from the soma and at the synapse adapted 
from Lau and Zukin 2007 
GluN1 and GluN2 subunits are assembled into the NMDA receptor in the ER at the soma 
and are trafficked along microtubules via kinesin motors to a dendritic spine (top image). 
Receptors are inserted into the synapse via a large number of interacting proteins at either 
the PSD or extra synaptic sites (enlarged box). 
 
1.2.2.3 NMDA receptor recycling and degradation 
NMDA receptor recycling is a fundamental process by which neurons regulate 
intracellular signalling, synapse maturation and synaptic strength and 
involvesendocytosing receptors and either recycling them for re-insertion to the 
surface membrane or degrading the receptor. NMDA receptor endocytosis is a 
tightly regulated process and is governed by a subunit-specific set of rules. Under 
basal conditions NMDA receptor internalisation occurs via the clathrin-coated pit 
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pathway and is mediated by interactions between tyrosine-based internalisation 
motifs contained within the GluN2 C-terminus and the adaptor protein 2 (AP2). 
GluN2A and GluN2B contain different internalisation motifs in their distal C-termini, 
which regulate internalisation at different rates (Lavezzari et al., 2004). GluN2B 
endocytosis is more rapid than that of GluN2A and is mediated by the interaction 
between the YEKL motif and AP2 (Roche et al., 2001), whereas GluN2A is mediated 
by a dileucine motif (LL) (Lavezzari et al., 2004). NMDA receptor subunits also 
contain proximal endocytic motifs; GluN1 subunits contain two independent signals 
(YKRH and VWRK); GLuN2B contains one (YWQF); and GluN2A also contains one 
(YWKL) all of which are necessary and sufficient to drive the internalisation of 
NMDA receptors (Scott et al., 2004). While the proximal and distal signals 
contribute in an additive manner to endocytosis they exert distinct effects on post-
endocytic trafficking. Proximal C-terminal motifs in GluN2B direct receptors to 
recycling endosomes whereas GluN2A and GluN1 proximal signals direct 
internalised receptors to degradative endosomes (Scott et al., 2004). By coding for 
degradation or recycling, endocytic motifs provide a powerful means to control 
NMDA receptor synaptic abundance by co-ordinating intracellular trafficking. 
Due to the nature of the NMDA receptor there is tight regulation at key steps during 
its surface expression in order to ensure it is expressed correctly and in the required 
amount. ER retention ensures misfolded and incorrectly assembled receptors do 
not get expressed at the surface. Internalisation motifs ensure regulation of 
signalling, maturation and cell death. Although there is a general understanding of 
the mechanism behind these processes the full mechanism has yet to be elucidated, 
as knockdown studies of key trafficking components of the NMDA receptor do not 
inhibit surface expression indicating there is another way of trafficking of NMDA 
receptors. 
1.3 DISC1 and NMDA receptors 
Studies in the Millar lab have revealed a direct interaction between the GluN1 
subunit and DISC1 (S. Mackie & K. Millar, unpublished). This was originally found via 
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a peptide array and was later confirmed via co-immunoprecipitation. Furthermore 
DISC1 plays a critical role in regulating excitatory synaptic function through TNIK 
and kalirin (Hayashi-Takagi et al., 2010, Wang et al., 2010b) and loss of DISC1 in 
vitro leads to increased NMDA receptor current densities in cortical cultures, 
resulting in an increase in GluN2A containing NMDA receptors (Wang et al., 2010b). 
Overexpression of GluN2A in the forebrain leads to deficits in certain-forms of long 
term memory and long term depression, which could link DISC1 dependent 
increases in GluN2A to dysfunction of synaptic and cognitive processes (Cui et al., 
2013).  
DISC1 has also been shown to regulate glutamate release from presynaptic 
terminals (Maher and LoTurco, 2012). Studies showed that, when a truncated form 
of DISC1 is transfected into cells, it enhances the frequency of mEPSC and disrupts 
the synchronous nature of evoked glutamate release. Also the expression level of 
DISC1 in presynaptic neurons correlates with the probability of glutamate release, 
which is interesting as certain splice variants of DISC1 have been found to have 
higher expression in some patients with schizophrenia  (Nakata et al., 2009), which 
could then lead to the misregulation of glutamate firing. Taken together there is an 
emerging and interesting link between DISC1 and NMDA receptors, coupled with 
DISC1s role in subcellular trafficking DISC1 could play an important role in NMDA 
function. 
As DISC1 is known to interact with many trafficking molecules and has been 
implicated in trafficking via dynein and kinesin, while NMDA receptors are known to 
be trafficked from the Golgi to the surface via kinesin, I hypothesised that DISC1 
may be involved in NMDA receptor trafficking. This thesis describes my 
investigation of this hypothesis.  
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1.4 NDE1 function and in mental illness 
1.4.1 NDE1 in mental illness 
Nuclear distribution element 1 (NDE1) and its orthologue NDE-like1 (NDEL1) are a 
pair of highly similar coiled-coil proteins which have been shown to play significant 
roles in a variety of vital cellular functions including mitosis, neuronal migration as 
well as microtubule organisation during brain development (Toyo-Oka et al., 2005, 
Hirohashi et al., 2006b, Shu et al., 2004, Hirohashi et al., 2006a). Both NDE1 and 
NDEL1 were identified in mammals through their interaction with lissencephaly 1 
(LIS1), a gene which, when mutated, results in human lissencephaly (Feng et al., 
2000, Feng and Walsh, 2004, Niethammer et al., 2000, Feng and Walsh, 2001). 
Lissencephaly is a rare but severe brain malformation which results in the 
appearance of a smooth surface of the brain rather than the characteristic “folds”. 
Mutations of the LIS1 gene cause a disruption in binding between LIS1 and NDEL1 
which results in an abnormal pattern of cortical development and the subsequent 
appearance of a ‘smooth brain’ on MRI or post-mortem (Feng and Walsh, 2001).  
NDE1 and NDEL1 are thought to have evolved from a common ancestral gene and 
are homologous proteins as ~60% of the amino acid sequence identity of these 
protein are the same. Due to these similarities it has previously been presumed that 
they both undertake identical functions. Whilst this can be the case in some 
instances e.g. maintaining the correct position of the Golgi, for other functions their 
parity has often been presumed without full investigation of the role of the other 
protein.  (Efimov and Morris, 2000, Feng et al., 2000). Although the two proteins 
have overlapping functions and can to some extent compensate for the loss of one 
another, there is evidence suggesting that they also have different functions within 
the cell. In particular, they undertake distinct roles in the dynein-related regulation 
of mitotic checkpoints (Vergnolle and Taylor, 2007), and also have different binding 
sites on the dynein protein complex, although these do overlap. Furthermore, 
NDEL1 knockout mice are embryonically lethal whereas NDE1 knockout mice 
maintain viability to birth (Sasaki et al., 2005).     
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NDE1 and NDEL1 have not been highlighted in genome-wide association studies 
using samples from psychiatric patients, thus there are no common ancient causal 
variants in these genes. However both NDE1 and NDEL1 have been implicated in a 
number of mental health disorders (such as schizophrenia, bipolar affective 
disorder, ADHD) by genetic association (Hennah et al., 2007, Tomppo et al., 2009). 
There was initially little evidence linking disruptions in NDE1 with schizophrenia. 
However, subsequently NDE1 was implicated in the development of schizophrenia 
in a study of the Finnish population (Hennah et al., 2007). To begin with the authors 
didn’t find any direct link between NDE1 and schizophrenia, but once the dataset 
was conditioned on the presence of a previously identified risk haplotype in DISC1, 
a significant link between NDE1 and the development of schizophrenia was 
detected (Hennah et al., 2007).  
In a separate study, a Caucasian-American schizophrenia cohort found no direct 
association of NDE1 with schizophrenia but did find evidence for an interaction 
between NDE1 and DISC1 on schizophrenia susceptibility, which, interestingly 
depended on the status of a common variant in DISC1 (C704) (Kamiya et al., 2006). 
These studies further strengthen the link between mutations within NDE1 and 
mental illness. 
Tentative associations between NDEL1 and schizophrenia have been proposed via 
an interaction between an independently significant mutation to the CIT gene, 
which encodes a protein kinase involved in cell division. However an association 
between NDEL1 and CIT have not been widely replicated and therefore this 
evidence should be interpreted with caution. (Nicodemus et al., 2010, Ikeda et al., 
2008, Kahler et al., 2008, Numata et al., 2008, Rastogi et al., 2009).  
A number of mental illnesses have been associated with ‘relatively frequent’ copy 
number variations (CNVs) (both duplication and deletions) at the locus of the NDE1 
gene (16p13.11) including autism (duplication) (Ullmann et al., 2007), ADHD 
(duplication) (Williams et al., 2010) and schizophrenia (deletion and duplication) 
which had a penetrance of 2 and 7.4 (Need et al., 2009, Sahoo et al., 2011). There 
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are a number of other genes located at the locus 16p13.11 but NDE1 is the most 
likely candidate for disruption of normal function causing the aforementioned 
mental illnesses due to the role of NDE1 within the cell and due to its interaction 
with DISC1 (Bradshaw et al., 2013). Taken together these observations highlight 
NDE1 as a possible risk factor for mental illness. This, coupled with its interaction 
with DISC1, indicates the importance of studying the potential role of NDE1 in 
influencing disease risk. There is less evidence for a link between NDEL1 and mental 
illness, therefore this introduction will focus mainly on NDE1 function and its link to 
DISC1. 
 
Figure 1.4 Structure, Binding, phosphorylation and palmitoylation sites of NDE1 
and NDEL1 adapted from Bradshaw et al 2013 
The structure of NDE1 and NDEL1 is similar as both contain a coiled-coil domain and an α-
helix. They have largely different phosphorylation sites (locations shown as stars) and 




1.4.2 NDE1 function 
Via its interaction with cytoplasmic dynein, NDE1 is known to play a role in a wide 
variety of cellular processes. Along with its binding partners LIS1 and NDEL1, NDE1 
regulates cytoskeletal organisation, intracellular transport, membrane trafficking, 
and cell signalling. As described in 1.1.4.2 cytoplasmic dynein is a multisubunit 
complex that functions as a minus end-directed microtubule motor and plays critical 
roles in a variety of eukaryotic cellular functions, including retrograde axonal 
transport (Stehman et al., 2007, Paschal and Vallee, 1987), directed cell migration 
(Dujardin et al., 2003) and numerous aspects of mitosis. Dynein function is 
regulated by several protein complexes e.g. LIS1/NDE1/NDEL1, dynactin (Lam et al., 
2009, Allan, 2011). NDE1 binds directly to the intermediate chain of dynein 
(Stehman et al., 2007, Lam et al., 2009) where it competes with dynactin for binding 
to dynein. Once bound NDE1 recruits LIS1 which results in increased transport along 
microtubules (McKenney et al., 2010). The NDE1/LIS1/Dynein complex is essential 
for the correct organisation and function of the microtubule network during neurite 
outgrowth and neuronal migration (Wynshaw-Boris and Gambello, 2001, Wynshaw-
Boris, 2007) showing NDE1 plays a critical role in cellular functions via regulation of 
dynein function. 
The intracellular positioning of organelles is dependent on correct dynein function. 
Using siRNA to reduce the levels of NDE1, Lam et al showed that the Golgi complex 
became fragmented and mispositioned (Lam et al., 2009). This NDE1 depletion also 
had an effect on the positioning of lysosomes and early endosomes, as LAMP1 (a 
marker for lysosomes) and EEA1 (early endosome marker) distribution was also 
altered (Guo et al., 2006, Lam et al., 2009). The effect of NDE1 knockdown on Golgi 
scattering and on the positioning of the lysosomes was reversed when NDE1 was 
reintroduced into the cell (Lam et al., 2009), thus indicating that NDE1 plays an 
important role in dynein-dependent positioning of cellular components. 
Studies into NDE1 using knockout mice uncovered several roles for NDE1 within 
neurons. NDE1 knockout mice displayed large reductions in several regions of the 
brain (neocortex, cerebellum, thalamus) indicating NDE1 is essential for the correct 
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development of the brain (Feng and Walsh, 2004). The knockout mice also display a 
thinning of cortical neurons in the superficial layers but no change in the deeper 
cortical layers. BrdU birthdating was used to determine if the observed cortical 
layering abnormalities were due to impaired neurogenesis, rather than abnormal 
neuronal migration. The authors found no changes in BrdU staining of the deeper 
layers of the cortex at E13, however BrdU-positive neurons stained at E15 or E17 
show a reduced distance of migration and a more scattered distribution within the 
cortical layers in NDE1 knockout mice. Furthermore there was a decrease in the 
overall number of neurons, indicating a reduced neuronal proliferation rate  in 
cortical progenitor cells (Feng and Walsh, 2004). The authors also found NDE1 to 
play a role in mitosis after observing an increase number of cortical progenitors in 
metaphase or anaphase in NDE1 knockout mice (Feng and Walsh, 2004). This was 
replicated by another group who observed mistargeted spindles after antibody 
disruption of NDE1. Additionally the authors observed the cells did not progress 
from metaphase, due a lack of dynein function as this relies on correct NDE1 
function (Stehman et al., 2007). Furthermore NDE1 knockdown by siRNA in HeLa 
cells causes an increase in duration of mitosis of 197% indicating a role for NDE1 in 
mitotic progression in HeLa cells (Lam et al., 2009). 
Mutations within NDE1 have been shown to cause (co-segregate) with 
microlissencephely. Alkuraya et al showed that two mutations within NDE1 caused 
a frameshift mutation resulting in a truncated protein lacking the dynein interaction 
site (Alkuraya et al., 2011). The authors found a lack of expressed NDE1 in patient 
lymphoblastoid cells which indicated the proteins are degraded and therefore there 
is a large reduction in mitotic spindle organisation, interkinetic nuclear migration 
and neuronal migration resulting in the aforementioned microlissencephaly 
(Alkuraya et al., 2011).  
1.4.3 Posttranslational modifications 
Posttranslational modifications are essential modifications which regulate the 
activity of proteins thereby controlling their function. Phosphorylation is a well 
studied form of posttranslational modification where a phosphate group is added to 
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a protein which “activates” or “deactivates” the protein. NDE1 has a number of 
experimentally determined phosphorylation sites which modulate its subcellular 
localisation and protein interactions (Yan et al., 2003, Hirohashi et al., 2006b, 
Hirohashi et al., 2006a, Bradshaw et al., 2011). Hirohashi et al identified several 
phosphosites which were found to modulate the interaction of the centrosomal 
protein Su48 and NDE1 (Hirohashi et al., 2006b). Using bioinformatics the group 
identified 6 potential phosphosites (T191, T215, T228, T243, T246 and S282), all 
within the C terminal flexible linker region, and created phosphomimic and 
phosphomutant versions of these sites to test whether the interaction between of 
NDE1 and Su48 is altered. The phosphomimic NDE1 had significantly reduced 
interaction with Su48 (a centrosomal protein essential for cell division (Wang et al., 
2006) and the phosphomimic version of NDE1 had altered subcellular localisation 
when analysed by florescence microscopy. The T246 site was later shown to be 
phosphorylated at G2/M phase in cell division by Cdk1 and, using T246A mutant 
NDE1 cells, arrest at the G2 phase suggested phosphorylation of T246 is essential 
for G2/M transition, thus providing an explanation for how knockdown of NDE1 
results in neuronal proliferation deficits (Hirohashi et al., 2006b)(Hirohashi et al., 
2006a)(Alkuraya et al., 2011) NDE1 is also a known target of the cAMP-dependent 
kinase PKA (Bradshaw et al., 2008, Bradshaw et al., 2011) as will be discussed in the 
next section.  
Taken together the literature shows that NDE1, through its interaction with dynein 
plays a vital role in mitosis and cell division, correctly positions organelles, regulates 
intracellular trafficking, neuronal migration and neurogenesis. Post-translational 
modifications have been shown to provide a way in which NDE1 function can be 
regulated. However the full function of this protein has yet to be determined. 
1.4.4 Interaction with DISC1 
NDE1 is a known DISC1 interactor (Millar et al., 2003, Brandon et al., 2004, Burdick 
et al., 2008, Bradshaw et al., 2008, Bradshaw et al., 2009). Together they regulate 
neurite outgrowth and may, as NDE1 and DISC1 are both known trafficking 
molecules, interact to regulate aspects of intracellular trafficking. NDE1 and DISC1 
35 
 
were first identified as potential interacting partners through yeast 2 hybrid screens 
of DISC1 (Millar et al., 2003, Brandon et al., 2004). Direct interaction between these 
proteins was shown by Burdick et al where the authors co-immunoprecipitated 
both exogenous NDE1 and DISC1, and endogenous NDE1 and DISC1 from SH-SY5Y 
(Burdick et al., 2008). This interaction was later confirmed as a direct interaction by 
co-immunoprecipitation of in vitro transcribed and translated DISC1 and NDE1 
(Bradshaw et al., 2009). Together these data show that there is a robust interaction 
between DISC1 and NDE1. 
DISC1 also interacts with the cAMP phospodiesterase PDE4, which complexes with 
DISC1, NDE1, LIS1 and NDEL1 at the centrosome, suggesting a potential role for 
cAMP dependent regulation of NDE1/LIS1/NDEL1 by DISC1/PDE4. In addition PDE4 
co-precipitates with dynein intermediate chains (Bradshaw et al., 2008) which 
indicates a potential involvement in regulating aspects of intracellular trafficking. 
Indeed, bioinformatic analysis of NDE1 identified two potential phosphosites, at 
positions T131 and S306, which may be regulated by PKA. Bradshaw et al used an 
antibody raised against phosphorylated PKA motifs in conjunction with IBMX and 
forskolin, to increase intracellular cAMP levels and stimulate PKA activity. This 
analysis determined that NDE1 can be phosphorylated by PKA in a DISC1/PDE4-
dependent manner (Bradshaw et al., 2008). Phosphorylation of T131 modulates 
NDE1 binding to LIS1, as there is a significant reduction in NDE1/LIS1 binding when 
a phosphomimic form of NDE1, T131E-NDE1, is used for co-immunoprecipitation 
experiments. Consistent with this, after IBMX/forskolin treatment there is a 
significantly reduced binding between endogenous NDE1 and LIS1. However, under 
these conditions there is increased NDE1/NDEL1 binding, indicating that 
phosphorylation/dephosphorylation at T131 may act as a switch to determine 
whether NDE1 binds to LIS1 or NDEL1 and DISC1/PDE4 may regulate this process via 
local cAMP gradients (Bradshaw et al., 2011). It could be speculated that this 
mechanism also regulates dynein activity: As described earlier (1.4.2) NDE1/LIS1 
interaction activates dynein and this interaction is needed for several key 
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intracellular processes. The modulation of NDE1/LIS1 binding by cAMP could 
therefore regulate dynein activity. 
Finally NDE1 has been shown to be present at the synapse where it co-localises with 
PDE4B. Mouse hippocampal neurons were transfected with NDE1 and PDE4B and 
NDE1 was found to accumulate in proximal axons suggesting a potential role in 
determining axon polarity. Further to this, co-localisation between NDE1 and PBE4B 
was observed in dendritic spines. Coupled with evidence of DISC1 co-localisation 
with PSD95 (Bradshaw et al., 2011) and studies showing DISC1 localisation in the 
PSD via electron microscopy (Kirkpatrick et al., 2006) DISC1/NDE1/PDE4 may 
function together at the post-synapse. 
Altogether then, NDE1 is critical for a number of intracellular processes and via its 
interaction with LIS1 and Dynein can regulate many trafficking processes. Further to 
this NDE1 has been implicated as a risk factor for psychiatric illness and binds 




1.5 TRAK1 function and interaction with DISC1 
1.5.1 TRAK1 Discovery and function 
Trafficking-protein-Kinesin-binding-1 (TRAK1) in a trafficking protein involved in the 
transport of a range of different cargoes such as mitochondria, early endosomes 
and GABAA receptors (Gilbert et al., 2006, Webber et al., 2008, Brickley et al., 2005, 
Brickley and Stephenson, 2011). Genetic screens in Drosophilla identified two 
proteins critical for mitochondrial transport in neurons, named Milton and Miro 
(Mitochondrial Rho GTPase)(Stowers et al., 2002, Guo et al., 2005). In mammals 
there are two orthologes of Milton named TRAK1 and TRAK2 (Brickley et al., 2005, 
Smith et al., 2006). The TRAKs act as motor adaptor proteins which connect kinesin 
motors to the mitochondria anchored protein Miro, thereby linking motors to 
mitochondria for movement within the cell (MacAskill et al., 2009, Wang and 
Schwarz, 2009). The TRAKs interact with miro via their C-terminal domain, with the 
N-terminal forming a coiled-coil region which is also found in several kinesin and 
dynein interacting proteins (Glater et al., 2006, Stowers et al., 2002). 
TRAK1 and TRAK2 associate with kinesin both in vitro and in vivo. This indicates a 
strong association between these two proteins and kinesin, and provides evidence 
that TRAK1 and TRAK2 are species orthologues of Milton (Brickley et al., 2005). The 
use of a dominant negative TRAK2 (DN-TRAK2) species resulted in the inhibition of 
both TRAK1 and TRAK2. Brickley and Stephenson used this to inhibit both TRAK1 
and TRAK2 association with the mitochondrial motor KIF5C, which resulted in a 
significant decrease in mobile axonal mitochondria in hippocampal neurons 
(Brickley and Stephenson, 2011). To determine any differences in TRAK1 and TRAK2 
function the authors also used shRNAi to individually knock down TRAK1 or TRAK2 
protein expression. TRAK1 knockdown resulted in a significant decrease in the 
number of mobile mitochondria in both the anterograde and retrograde direction, 
similar to what was observed in the DN-TRAK2 study, which was rescued by 
exogenous expression of either TRAK1 or TRAK2. Interestingly TRAK2 knockdown by 
shRNAi caused no significant effects on axonal mitochondrial trafficking, indicating 
that TRAK2 might be predominantly localised in a different neuronal location e.g. 
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soma or dendrites, or that the two TRAK proteins may have different functions 
within the cell (Brickley and Stephenson, 2011). The difference in effect of 
mitochondria mobility after knockdown was subsequently shown to be due to 
occupation of different in cellular locations. Van Spronsen et al showed that TRAK1 
is predominantly localised to the axon whereas TRAK2 is predominantly localised to 
the dendrites, explaining the differences in KD between TRAK1 and TRAK2 
(van Spronsen et al., 2013). 
 
Figure 1.5 TRAK1 and TRAK2 interaction with kinesin for cargo transport, adapted 
from MacKaskill and Kittler 200 
In mitochondrial trafficking TRAK1 binds to Miro1 which is bound to the mitochondria. 
TRAK1 links this with kinesin to move the mitochondria through the cell via microtubules, 
calcium is used to inhibit the movement possibly by altering the kinesin structure leading to 
the de-coupling from TRAK1. TRAK1 can also bind other proteins and transport the cargo to 
different locations within the cell via kinesin motors. 
 
TRAK1 and TRAK2 have also been shown to bind to the dynein motor complex. 
Mass spectrometry and subsequent western blotting showed an interaction 
between the TRAK proteins and a number of components of the dynein complex 
(van Spronsen et al., 2013). Co-IP experiments determined binding between the 
p150Glued domain of dynactin and both TRAK1 and TRAK2, providing further 
evidence for the interaction between these proteins (van Spronsen et al., 2013). 
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Not only can TRAK1 and TRAK2 bind to the dynein complex, van Spronsen et al 
showed, using an inducible cargo-trafficking assay which labels static cargoes which 
can then be linked to trafficking molecules via administration of rapalog (a small 
molecule used to trigger binding of motor proteins of interest to mitochondria), 
that TRAKs mediate dynein-dependent motility. When KIF5 is overexpressed there 
is an accumulation of cargoes at the cell periphery and if dynein is overexpressed 
there is an accumulation of cargoes in more central regions. TRAK1 or TRAK2 
overexpression induced a significant redistribution of static cargoes to both the cell 
periphery and to central regions, indicating TRAK proteins mediate both dynein and 
kinesin motor activity. This was further confirmed when knockdown of KIF5B 
resulted in a large accumulation of cargoes in central regions, similar to that 
observed when dynein is overexpressed. This indicates that, in the absence of 
kinesin, dynein actively transports TRAKs. Similarly, blocking dynein binding to 
TRAK1 or TRAK2 using HA-p50 resulted in a random distribution of cargoes, and co-
expression with KIF5B re-distributed the cargoes to the cell periphery (van Spronsen 
et al., 2013). This demonstrates that TRAK1 and TRAK2 not only bind to dynein but 
they are also able to modulate its motor activity. 
1.5.2 TRAK1 in receptor trafficking 
TRAK1 was recently identified as the mutated gene in hyrt mice, an animal model of 
hypertonia (Gilbert et al., 2006). The authors showed that the hypertonia observed 
in the hyrt mice was alleviated by both the administration of GABAA or GABAB 
agonists indicating that a dysfunction of GABA receptors is responsible for the 
hypertonia. TRAK1 immunoprecipitated with the α1 subunit of the GABAA receptor 
indicating an association of these proteins. The mutation in TRAK1 results in a 
frameshift in the C-terminus, leading to the formation of a truncated protein, TRAK1 
1-824 which immunoprecipitated with the α1 subunit of the GABAA receptor in 
similar amounts, indicating that mutant TRAK1 has no apparent affect on the 
association of GABAA and TRAK1 (Gilbert et al., 2006). Based on the administration 
of GABA agonists reliving the observed hypertonia in the mouse model the authors 
hypothesised that TRAK1 plays an essential role in the trafficking of GABA receptors. 
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TRAK1 interaction with the GABAA receptor was further supported by yeast-2-
hybrid interaction assays (Beck et al., 2002, Stephenson, 2013). The location of the 
interaction between TRAK1 and the GABAa receptor has yet to be determined. 
However Anne Stephenson showed TRAK1 to interact with the β3 subunit of GABAA 
(Stephenson, 2013) receptors whereas Gilbert et al (Gilbert et al., 2006) observed 
an interaction between the α1 subunit and TRAK1. However the disparity between 
these results could be explained by the antibodies used in the experiments. Gilbert 
et al used an anti-α1 subunit antibody, which given that the GABAA receptor 
contains both α1 and β3 subunits does not necessarily mean that TRAK1 associated 
with the α1 subunit. In any case, these studies provide evidence for additional 
functions of TRAK1 other than mitochondrial trafficking via kinesin and dynein.  
1.5.3 TRAK1 in endocytosis 
TRAK1 however has been shown to regulate the transport of other cargoes 
including early endosomes (Kirk et al., 2006, Webber et al., 2008). Although 
originally thought to predominantly traffic and localise to mitochondria Webber et 
al showed endogenous TRAK1 was not primarily localised to the mitochondria as 
the group found only a 39.4% overlap with the inner mitochondrial membrane 
marker, TIM23 in HeLa cells (Webber et al., 2008). They went on to show a 64.3% 
overlap with the early endosome marker EEA1, a 21.8% overlap with the late 
endosome marker LAMP2, and a 21.2% overlap with the ER marker KEDL (Webber 
et al., 2008). Indicating that TRAK1 is predominantly localised to early endosomes 
and therefore may have additional roles within the cell other than linking 
mitochondria to kinesin motors.  
This indicates that TRAK1 may play a role in endosome trafficking. Using epidermal 
growth factor-induced (EGF) degradation of the EGF receptor (EGFR) (a widely used 
model for studying endocytic trafficking) Webber et al (Webber et al., 2008) showed 
overexpression or KD of TRAK1 inhibits EGF induced EGFR degradation but not EGFR 
endocytosis. Using [I125]EGF they showed that cells expressing TRAK1 had similar 
amounts of internalised  [I125]EGF compared to control cells, indicating that TRAK1 
has no significant effect on endocytosis. Using a degradation assay, the cells were 
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incubated with [I125]EGF for 10 minutes and chased for 1,2, or 3 hours to allow for 
degradation. It was shown that 69.7% of internalised EGF was degraded in control, 
and 39.9% of internalised EGF was degraded in TRAK1 expressing cells. Similarly 
TRAK1 KD resulted in no change in EGF internalisation but there was a statistically 
significant decrease in degradation. Using a “pulse-chase” trafficking assay they 
went on to show that TRAK1 impedes endosome to lysosome trafficking, so taken 
together this supports a functional role for TRAK1 in regulating the trafficking of 
internalised EGF-EGFR complexes to the lysosome (Webber et al., 2008). 
1.5.4 TRAK1 mental illness and DISC1 interaction 
 
There is little evidence linking disruptions in TRAK1 to mental illness . One study 
found a non-synonomys mutation of TRKA1 (via poly-phen2 analysis) in a patient 
with schizophrenia TRAK1 H678R. Analysis of the mutated region predicted that the 
observed mutation could cause a damaging alteration of protein function. Although 
the authors did not specifically discuss the mutation in TRAK1 and how it may cause 
schizophrenia they did draw attention to TRAK1 mutant mice and GABAA 
dysfunction. Additionally the authors found a correlation between de novo 
mutations and disruptive amino acid changes therefore there is a high likelihood for 
pathogeneity (Xu et al., 2011). As TRAK1 plays a critical role in mitochondrial 
trafficking any disruption to its function could cause interference to mitochondrial 
movement and therefore upset the homeostasis within cells. This could in turn lead 
to altered synaptic transmission as energy demands at the synapse are great (Harris 
et al., 2012). However although there is only tentative evidence likening TRAK1 to 
mental illness as TRAK1 has only relatively recently been found to interact with 
DISC1 and its function is still being analysed more evidence is needed before any 
firm conclusions can be made about its role in mental illness 
Recently an association between TRAK1 and DISC1 has been identified. Co-IP of 
both exogenous and endogenous DISC1 and TRAK1 in mammalian cell lines 
indicates a robust association, but not necessarily a direct interaction, between 
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these two proteins, however the association between these two proteins was not 
confirmed in brain at that time due to lack of a suitable antibody for TRAK1 (Ogawa 
et al., 2013). TRAK1/DISC1 association has since been confirmed in mouse brain (F. 
Ogawa & K. Millar, unpublished). Overexpression of TRAK1 causes mitochondrial 
clustering in the majority of cells (Brickley et al., 2005). When DISC1 is co-expressed 
with TRAK1, DISC1 expression at the mitochondria becomes more pronounced and 
isolation of mitochondria from transfected COS7 cells showed that TRAK1 recruits 
DISC1 to the mitochondria (Ogawa et al., 2013). Therefore DISC1 and TRAK1 clearly 
associate, with the function of this association, and consequences of disrupting this 
function still to be fully investigated. 
Sequence variants in DISC1 have been shown to alter its protein-protein 
interactions and its function. DISC1-37W overexpression results in mitochondrial 
clustering in approximately 50% of transfected cells in a pattern very similar to that 
induced by TRAK1 overexpression (Ogawa et al., 2013). The location of 37W lies 
within the TRAK1 association site on DISC1 and co-immunoprecipitation studies 
revealed a 50% increase in TRAK1 association with DISC1-37W when compared to 
WT-DISC1 (Ogawa et al., 2013). This indicates that mutations within DISC1 may alter 
its interaction with TRAK1 and could conceivably alter overall function of the 
DISC1/TRAK1 complex. Furthermore DISC1 has been shown to increase anterograde 
mitochondrial movement when overexpressed in mouse hippocampal neurons. 
However, DISC1-37W did not promote anterograde movement, nor did it increase 
total mitochondrial density (Ogawa et al., 2013). Thus the 37W variant impairs the 
ability of DISC1 to stimulate anterograde mitochondrial transport. This may be due 
to the effect of DISC1-37W at the mitochondria where it induces altered 










2.1.1 DNA sequence analysis 
The sequences for all the expression plasmids used in this study were validated by 
direct sequencing. Plasmid DNA sequences were obtained using the method 





2.2 Cell Culture 
2.2.1 Maintenance of cell lines  
All cell culture work was carried out in an Envair Bio2+ class II safety cabinet, under 
contamination level 1. 
Cell lines were grown in T75 or T175 Cell Star (Grenier Bio-one) flasks and 
maintained in an incubator at 37  °C and 5 % CO2. All the media and buffers, unless 
otherwise stated, were obtained from Gibco, Invitrogen. 
Cells were grown in DMEM (Dulbecco’s Modified Eagle Medium) supplemented 
with 10% Foetal Bovine Serum (FBS) and split when they reached 90-95% 
confluency. To split the cells, old media was aspirated and the cells were washed 
twice with DPBS. Tryple-express was diluted in a 1:1 ratio with Versene and 15 mL 
was added to the cells. After incubation for 2-5 minutes the cells were aided in 
detachment by gently tapping the flask and 3 volumes of DMEM/FBS were added, 
then the cells were transferred to a falcon tube and spun at 1000rpm for 5minutes. 
The cells were resuspended in 10 mL of fresh DMEM/FBS, if necessary the cell 
concentration was determined as described in 2.2.2. If the cells were needed for 
future use they were passaged by dilution of the cell suspension in a 1:25 ratio in a 
new flask containing fresh DMEM/FBS. 
2.2.2 Cell Counting  
To determine the cell concentration of cell suspensions the cells were harvested as 
described in 2.2.1 and counted using an Improved Neubauer Heamocytometer. First 
the haemocytometer and coverslip were washed in 70 % ethanol and dried. The 
coverslip was then humidified and applied to the haemocytometer. The cell 
suspension was gently mixed and a small volume was applied to the two chambers 
of the haemocytometer. The cells were counted in a 0.1mm3 area of each chamber, 
and then an average cell count was calculated and multiplied by 104 to obtain the 
cell concentration expressed in cells/mL. 
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2.2.3 Cell Plating 
For cells to be transfected for immunocytochemistry they were seeded on dry heat 
sterilized glass cover slips (VWR) in sterile 12-well plates (Corning). The cells were 
first harvested and counted as described in 2.2.1 and 2.2.2, then diluted to the final 
concentration of 3x105 cells/mL before equal volumes of cell suspension were 
added to each well. Cells were placed in an incubator and transfected 16-18 hours 
after plating. 
2.2.4 Transfection 
Transfection of COS-7 cells was carried out using the liposome-based reagent 
Lipofectamine-2000 (Invitrogen). For transfection of COS-7 cells; on the afternoon 
of the day before, cells were plated in multi-well plates as described in 2.2.3. Cells 
were transfected as according to the manufacturer’s protocol, although the DNA 




2.3 Primary Culture 
2.3.1 Dissection and preparation of neurons 
All buffers, media and supplements used for the preparation and maintenance of 
the primary cultures were obtained from Gibco, Invitrogen. Two days before 
dissection glass coverslips were sterilized in 100 % ethanol overnight with end-over-
end agitation at 4  °C. Then the coverslips were washed in fresh 100 % ethanol 
twice, dried and heat sterilized. To allow the neurons to adhere, the day before the 
neuron preparation the coverslips were coated in Poly-D-Lysine by applying the 
Poly-D-Lysine solution to individual coverslips in a 12 well plate, and left overnight 
at 37 °C. The coverslips were then washed twice in distilled water and left to dry 
before seeding neurons on them as described below. 
Eighteen days post-fertilization pregnant C57 mice were sacrificed by an 
experienced animal facility technician then handed to me for dissection. Embryonic 
day 18 (E18) foetuses were extracted using sterile surgical tools from the mother’s 
uterus and immediately placed in ice cold dissection buffer (DB – 3:2 ratio of triple 
express:versine to make a 0.1 % tripsin containing solution). The brains were 
removed from the embryos and placed in fresh DB and dissected under a Leica M26 
microscope with a Fiber-Lite MI-150 high intensity illuminator. After removal of the 
meninges, the cortices were separated and the hippocampus was removed and 
stored in ice cold DB until all the brains had been dissected.  
Once all of the hippocampi had been dissected they were placed in 10 mL of 0.01% 
trypsin (diluted with DB) for 45minutes at 37 °C and were manually inverted every 
10-15minutes. After trypsinisation the trypsin solution was removed using a plastic 
pasteur and the neurons were re-suspended in 2 mL DMEM supplemented with 
10%FBS, the volume was made up to 10 mL and the neurons were passed through a 
40 µm cell strainer (BD bioscience) and spun at 1000rpm for 5 minutes. The medium 
was removed and the neurons were re-suspended in 10 mL of Neurobasal medium 
supplemented with B27 and Glutamax and counted as described in 2.2.2. The 
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neurons were seeded at a concentration of 3x106 cell/mL in 1 mL on Poly-D-Lysine 
treated coverslips and maintained at 37 °C with 5% CO2.  
2.3.2 Maintenance 
The neurons were fed with fresh Neurobasal medium every 7 days. As the neurons 
were seeded at 1 mL an additional 1 mL was added the following day. Every 7 days 
after that 1 mL was removed and 1 mL of fresh medium was added. Cells were 
transfected between days in vitro (DIV) 18-20 and stained the following day. 
2.3.3 Transfection of primary cultures 
Transfection of primary neurons were carried out using the liposome-based reagent 
Lipofectamine-2000 (Invitrogen). Primary neurons were obtained and maintained as 
described in 2.3.1 and 2.3.2 and transfected at DIV 18, and the DNA lipofectamine 
complexes were assembled in 200 µl of warm neurobasal media supplemented with 
glutaMAX only, 4 µl of Lipofectamine 2000 and 2-3 µg of DNA. 1 hour before the 
DNA lipofactamine complexes were added the media was removed from the wells 
and kept in a 50 mL falcon tube and replaced with fresh neurobasal media without 
B27 serum. The DNA lipofectamine 2000 complexes were added and left for 3-4 




2.4 Drug and cell treatments 
2.4.1 Mitotracker RED 
MitotrackerRED is a cell permeant red fluorescent protein which diffuses across the 
plasma membrane and accumulates in active mitochondria, where it is retained 
after fixation and permeabilisation, allowing the visualisation of mitochondria. 
MitotrackerRED was added to the cells approximately 24 hours after transfection 
where the MitotrackerRED was diluted to 50 mM in DMSO and added to the media 
for 20-30 minutes. Cells were washed twice in warm PBS before being processed as 
described in 2.5. 
 
2.4.2 NMDA antagonists 
DL-AP5 is a selective NMDA receptor antagonist. It acts as a competitive inhibitor of 
the glutamate binding site of the NMDA receptor and therefore inhibits receptor 
opening. 
MK-801 is a collective non-competitive antagonist of the NMDA receptor. It acts by 
binding inside the ion channel and preventing the influx of ions (similar to the Mg2+ 
block seen at resting membrane potentials). 
In order to stop excitotoxicity in COS-7-cells transfected with GluN1 and GluN2B 
subunits DL-AP5 and MK801 were diluted to 10 mM and 100 nM respectively in H2O 





Immunocytochemistry is used for; the detection of endogenous or exogenously 
expressed proteins and analysis of the subcellular localisation of endogenous and 
exogenous proteins in structurally intact cells. Adherent cells are grown on glass 
coverslips, fixed and permeabilised then incubated with protein specific antibodies 
and fluorescently labelled secondary antibodies. A fluorescent or confocal 
microscope can be used to visualise the cells and a number of imaging software can 
be used to analyse the cells. 
 
2.5.1 Cell fixation and permeabilization 
Cell fixation is used to preserve cells in a “life-like” state by stopping the activity of 
the cell and inhibiting autolysis. Cell membranes can be permeabilised by using 
detergents or solvents and is necessary for the detection of proteins which are not 
present at the cell surface. 
For this study 4% paraformaldehyde (PFA – 2 g PFA in 50 mL PBS) was used. Cell 
medium was aspirated and 500µl of PFA was added to each well for 10minutes at 
room temperature. After which the cells were washed quickly 3x and permeabilized 
using 500 µl 0.2% triton-X for 10minutes. Cells were again washed 3x to remove 






Antibody Species Raised In Source Dilution 
NR1 Rat Rabbit Sigma 1/500 
HA 16B12 
Monoclonal 
Mouse Covance 1/2000 
HA Polyclonal Goat ABcam 1/500 
FLAG M2 Monoclonal Mouse Sigma 1/20000 
V5 V5-10 
Monoclonal 
Mouse Sigma 1/1000 
ER Calreticulin Mouse BD 1/500 
ER Calreticulin Rabbit ABCam 1/1000 
Secondary Antibodies 
Alexa Fluour conjugated antibodies Source Dilution 
Donkey anti-Mouse 350 Molecular probes 1/1000 
Donkey anti-Mouse 488 Molecular probes 1/1000 
Donkey anti-Rabbit 488 Molecular probes 1/1000 
Donkey anti-Goat 594 Molecular probes 1/1000 
Donkey anti-Mouse 594 Molecular probes 1/1000 
Donkey anti-Rabbit 594 Molecular probes 1/1000 
Chicken anti-Mouse 647 Molecular probes 1/1000 
Chicken anti-Rabbit 647 Molecular probes 1/1000 
Table 1  









2.5.2.1 Total staining 
All immunostaining was performed at room temperature (unless otherwise stated). 
After fixation cells were blocked with 3% BSA/PBS for at least 30 minutes to block 
any non-specific binding sites. Both the primary and secondary antibodies were 
made up in 3 % BSA/PBS as detailed in Table 1. When 2 or more antibodies were 
used they had to be from different species (to avoid any cross reactivity of the 
secondary antibodies), and diluted together in blocking buffer. After blocking, the 
primary antibodies were added and the cells were left to incubate for 1 hour with 
gentle rocking. The cells were then washed 3x in PBS and an appropriate secondary 
antibody was added for 1 hour with gentle rocking. After the addition of the 
secondary antibody the dish was wrapped in tin-foil to avoid any photobleaching of 
the secondary antibodies. Cells were again washed 3x in PBS and mounted on glass 
microscope slides using mowiol mounting medium supplemented with 2 mg/mL 
DAPI when appropriate. The slides were wrapped in tin-foil and kept at 4 °C for at 
least 16 hours to allow the mowiol to set. 
2.5.2.2 Surface labelling and receptor endocytosis 
For some experiments it was necessary to label surface proteins before fixation. Cell 
media was aspirated and the cells were quickly washed with warm 3 % BSA/PBS. 
The appropriate primary antibodies were added and the cells were incubated with 
gentle agitation at 4 °C (to stop constitutive activity of the cell) for 1 hour. The cells 
were washed in PBS and incubated with the appropriate secondary antibody for 1 
hour at 4 °C with gentle agitation and wrapped in tin-foil. Cells were then washed 
and fixed (as described in 2.5.1) or, for receptor internalization, fresh DMEM/FBS 
was added to the cells which were then returned to the incubator for 15 or 30 
minutes before fixation. 
2.5.3 Confocal microscopy 
Laser scanning confocal microscopy allows the generation of highly detailed images 
from a single (or multiple) plane of focus of a sample. This is achieved by using a 
specific high-intensity monochromatic laser beam precisely focused to excite a 
53 
 
specific focal plane. Monochromatic mirrors and a pinhole aperture attached to a 
PMT exclude peripheral and out of focus light. Coupled to this florescent bleed 
through (when the emission spectrum of two fluorophores overlap) is reduced by 
sequential scanning of the sample. Individual lasers are used to excite individual 
fluorophores and the PMT aperture of the detector is finely set so only light emitted 
by one fluorophore is detected. 
All images were captured using a Nikon A1R confocal microscope using its own 
software NIS elements 4.0.0. 
2.5.4 Cell Surface Quantification 
2.5.4.1 Surface expression quantification (no-internalisation) 
For the quantification of surface expressed GluN2B when co-expressed with DISC1 
or a DISC1 variant, COS-7 cells were transfected and stained as described in 2.2.4, 
2.5.2.1, 2.5.2.2. Until completion of the analysis the operator was blinded to which 
DISC1 variant has been transfected to which set of cells. To ensure comparability of 
the images all images from a single experiment were taken on a Nikon A1R confocal 
microscope and all the images were taken at the same time using the same confocal 
settings. 
Image analysis was performed using an I-Vision script developed in collaboration 
with Paul Perry, IGMM University of Edinburgh. For each image the four colour 
image was split into its individual channels, removing one and merging them into a 
3 colour image and converting the image into TIFF format. These 3 colour images 
are loaded into I-Vision where the channel with the surface expressed GluN2B was 
loaded and the user is prompted to encircle the cell of interest creating a region of 
interest (ROI). The script then assigns a mask around the cell and measures the 
mean pixel intensity under this mask. A second line is drawn around the mask and 
imposed onto the image showing the DISC1 signal. Using the third image a mask is 
drawn around the nucleus and is also imposed onto the image with the DISC1 
signal. The mean pixel intensity between the two masks is taken, thus generating 
the DISC1 expression level. The nucleus is omitted as some of the DISC1 variants are 
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not expressed in the nucleus and would therefore give an overall lower signal value. 
A table is produced recording this measurement which is saved for statistical 
analysis. 
2.5.4.2 Incubated surface labelled quantification 
To quantify internalised protein, the image was opened in ImageJ and a region of 
interest was drawn around the cell. The Pearsons co-efficient was generated using 
the co-localisation threshold plugin which determines the Pearsons coefficient of 
two specified channels. Pearsons coefficient is a measure of the overlap between 
two separate objects, in cell biology this usually requires two objects to be lablled 
(in this case with fluorophores) and if the two objects overlap sufficiently then they 
are deemed to be close enough to interact. The Pearsons coefficient measures the 
amount the signal from each protein and calculates how much of the signal 
overlaps with the other signal and generates a value from -1 to +1, with -1 = total 
negative correlation, 0 = no correlation and +1 is total positive correlation. So the 
closer the Pearsons coefficient is to +1 then the more chance of the two proteins of 
interest have of being close enough to interact.(Adler and Parmryd, Dunn et al.). 





2.6 Molecular biology methods 
2.6.1 Plasmids 
Plasmids used during the course of this PhD are described in Table 2. All were gifts 
from the specified person and were transformed and purified as appropriate as 
described in 2.6.2 and 2.6.3. 
Plasmid Name Encoded protein Tag Source 
pCB6/NR1 Rat GluN1 None William Green1 
pCB6/HA-GluN2B Rat GluN2B HA N-term William Green1 
pcDNA/TO-FLAG 
DISC1 
Human DISC1 FLAG N-term Elise Malavasi2 
pcDNA/TO-FLAG 
DISC1-607F 
Human DISC1 FLAG N-term Elise Malavasi2 
pcDNA/TO-FLAG 
DISC1-37W 
Human DISC1 FLAG N-term Elise Malavasi2 
pcDNA/TO-FLAG 
DISC1-704C 
Human DISC1 FLAG N-term Elise Malavasi2 
pcDNA/TO FLAG-
TRAK1 
Human TRAK1 FLAG N-term Fumiaki Ogawa2 
pcDNA/TO FLAG-
TRAK1-H678R 
Human TRAK1 FLAG N-term Fumiaki Ogawa2 
pDEST40NDE1 Human NDE1 V5 C-term Kirsty Millar2 
pDEST40NDE1-
T131A 
Human NDE1 V5 C-term Nick Bradshaw2 
pDEST40NDE1-
T131E 
Human NDE1 V5 C-term Nick Bradshaw2 
pmCherry-C1/RAB5 RAB5 mCherry N-term Vilma Martins3 
pmCherry-C1/RAB7 RAB7 mCherry N-term Vilma Martins3 
pMAX-GFP GFP None Fumiaki Ogawa2 
PCMV/Globin Human Globin None Giles Hardingam2 
FLAG-pcDNA 4TO Empty Vector HA N-term Elise Malavasi2 
pDEST40 Empty Vector V5 C-term Kirsty Millar2 
Table 2 
A list of all plasmids used in this thesis, their source and any tag the protein will possess. 1 
University of Chicago. 2University of Edinburgh. 3National Institute for Translational 





2.6.2 Transformation  
Transformation of E. coli allows for the amplification of existing plasmids. DH5α-
competent cells (Invitrogen) were used to amplify existing plasmids. 
An aliquot of cells were thawed on ice and the cell suspension was transferred to a 
sterile tube. 1-5 µl of 10mg DNA was added to the cell suspension and was gently 
mixed by swirling the pipette tip and incubated on ice for 30minutes. The cells were 
then heat shocked at 42 °C followed by an incubation on ice for 2 minutes. 200 µl of 
pre-warmed S.O.C (Invitrogen) was added and the cells were incubated at 37 °C 
shaking at 220 rpm for 1-2 hours. 100 µl of the suspension was then evenly spread 
over an agar plate inoculated with the appropriate antibiotic. The plates were left at 
37 °C for 16-22 hours or when bacterial colonies could be seen. 
2.6.3 Purification of plasmids from E.Coli 
In order to purify DNA from transformed cultures commercial kits from Qiagen were 
used. Individual colonies were picked from the agar plate using a sterile pipette tip 
which was placed into 5 mL lysogeny broth (LB) inoculated with the appropriate 
antibiotic for 4-8 hours while shaking at 250rpm. 1.5 mL of the culture was spin at 
13,000rpm for 1 minute, the supernatant removed and another 1.5 mL was added 
and spun again. The supernatant was removed and the pellet was left for 1-2 
minutes to dry. Plasmid DNA was purified from the pellet using a Qiagen spin mini-
prep kit according to the manufacturers’ directions. To make larger volume  and 
concentration of plasmid DNA, colonies were grown in 5 mL LB supplemented with 
the appropriate antibiotic for 6-8 hours shaking at 220rpm at 37 °C and 1 mL was 
added to 400 mL LB supplemented with the relevant antibiotic and left shaking at 
37 °C overnight. The culture was spun at 6000 g for 15minutes at 4 °C. The 
supernatant was discarded and plasmid DNA was extracted using a Qiagen Maxi-
prep kit using the manufacturers’ guidelines. 
2.6.4 Measuring DNA concentration 
To measure the concentration of newly purified plasmid DNA a spectrophotometer 
was used. Purified plasmid was diluted to 1 in 20 and after calibrating the machine 
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with water, 1 mL of sample was analysed and the wavelength noted down. The 
concentration of DNA was calculated using the following equation: 
                                       
 
2.6.5 DNA sequencing 
Sequencing was used to verify protein expression plasmids, specifically the DISC1, 
DISC1 variants, NDE1 and phosphomutant NDE1 constructs. To do this Big Dye 
terminator (ABI) kit was used. In brief the plasmid DNA was diluted to 300 ng and a 
reaction mix was assembled: 
1.5  µl 5x Big Dye Buffer 
1.0  µl 3.2pMol/  µl sequence primer 
1.0  µl Big Dye enzyme 
300 ng DNA 
H2O to 10  µl 
This was assembled in a 500 µl eppendorf tube and ran on a PTC-225 deltimhouse 
cycle using the following programme: 
1. 96 °C 1min 
2.  96 °C 10sec 
3. 50 °C 5sec 
4. 60 °C 4min 
5. Repeat 2-4 24 times 
6. 4 °C holding temp 
After the sample had cooled to 4 °C the samples were removed and 2.5 µl 125mM 
EDTA, and 30 µl 100 % ethanol added. The samples were briefly vortexed to mix and 
left for 15 minutes at room temperature. The samples were spun at 1300 rpm for 
20 minutes at 4 °C and supernatant was removed. 30 µl 70 % ethanol was added 
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and the samples were spun for 5 minutes at 13,000 rpm at 4 °C. The supernatant 
was removes and the samples were left to dry for 5 minutes and stored at -20 °C. 
The nucleic acid sequence was determined by the sequencing service at the IGMM. 






Dissection and culturing of neurons used for electrophysiology were kindly 
performed by the Hardingham lab (McKay et al., 2012). Neurons were cultured on 
coverslips and transfected with PMAX GFP + DISC1 L607F-DISC1 or globin as 
described in 2.2.3 at DIV 7 or 8 and recorded from on DIV 9 or 10. 
Coverslips were transferred to a recoding chamber perfused with the following 
external recording solution: 
NaCl : 150 mM 
KCL: 2.8 mM 
HEPES: 10 mM 
CaCl2: 2 mM 
MgCl2: 1 mM 
Glucose: 10 mM 
Glycine: 100  µm 
Tetrodotoxin: 100 nM 
pH to 7.3 – 7.35 with NaOH  
osmolarity between 300 – 350 osm 
Patch pipettes were made from thick walled borosilicate glass (Harvard) and filled 
with internal solution consisting of: 
K-Gluconate: 141 mM 
NaCl: 2.5 mM 
HEPES: 10 mM 
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EGTA: 11 mM 
Adjust to pH 7.3 with KOH 
Electrode tips were fire polished for a final resistance ranging between 3 and 7 MΩ. 
Currents were recorded at room temperature (21±2 °C) and all recordings were 
digitally stored on MATLAB. Neurons were voltage clamped at -65 mV and 
recordings were repeated if the holding current changed by more than ±100 pA 






3 Selection of proteins and 






To identify proteins in the DISC1 complex that have potential to participate in 
NMDA receptor trafficking for testing in the surface expression assay described in 
chapter 4. 
3.2 Introduction 
DISC1 is known to play a role in trafficking events within the cell, through an 
involvement in mitochondrial trafficking and synaptic vesicle trafficking, as 
discussed in chapter 1. These observations point towards trafficking disruptions as 
potentially important in searching for the disease mechanisms that underlie mental 
illness. Because DISC1 is already known to be involved in trafficking of mitochondria 
and synaptic vesicles (Atkin et al., 2010, Ogawa et al., 2013, Flores Iii et al., 2011, 
Maher and LoTurco, 2012), I hypothesised that it has a general role in trafficking 
that extends to NMDA receptors. I therefore set out to investigate the role of DISC1 
in NMDA receptor trafficking from the endoplasmic reticulum onwards, and to 
determine whether DISC1 sequence variants have any effect upon this process.  
A number of DISC1 sequence variants have been found to cause changes in DISC1 
function, and I chose to investigate three of these; R37W, L607F and S704C. The 
minor allele of the common variant L607F has been shown to cause a number of 
deficiencies when compared to wild-type DISC1 function (Brauns et al., 2011, 
Malavasi et al., 2013, Soares et al., 2011). Of particular relevance to this thesis, 
unlike wild-type DISC1, DISC1-607F fails to rescue mitochondrial trafficking deficits 
caused by DISC1 knock down (Atkin et al., 2010), thus it adversely influences the 
role of DISC1 in trafficking.  
The ultra-rare DISC1 variant 37W has also been shown to influence mitochondrial 
trafficking, by inhibiting DISC1’s ability to promote anterograde mitochondrial 
movement (Ogawa et al., 2013). This effect may be related to increased DISC1 
association with the trafficking molecule TRAK1 due to the 37W variant (Ogawa et 
al., 2013). Preliminary evidence indicates that it may also impact upon DISC1 
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association with the NMDA receptor subunit GluN1 and upon GluN1 
phosphorylation (K. Millar, unpublished).  
In contrast there is currently no evidence that the S704C variant influences 
intracellular trafficking. The minor allele does, however, influence DISC1 interaction 
with the trafficking molecules NDE1 and NDEL1 (Leliveld et al., 2008, Leliveld et al., 
2009), suggesting that it may affect dynein-mediated transport. 
In addition to investigating a potential role for DISC1 in NMDA receptor trafficking, 
and any effects of the DISC1 sequence variants 37W, 607F and 704C, I also set out 
to investigate whether any DISC1-associated proteins may also be involved in the 
process. Because of their known involvement in trafficking events, I selected NDE1 
and TRAK1 for study. Moreover, endogenous NDE1 has been shown to associate 
with TRAK1 independently of DISC1 in HEK293 cells, SH-SY5Y cells and in mouse 
brain (F. Ogawa & K. Millar, unpublished), indicating that they likely function 
together in regulating intracellular transport. In addition, a TRAK1 sequence variant, 
678R, has been identified in a single schizophrenic patient so I chose to test 
whether this putatively causal variant affects any potential role of TRAK1 in NMDA 
receptor trafficking. 
In this chapter I describe preliminary investigation of these proteins and sequence 





3.3 DISC1 localises to the endoplasmic reticulum in 
the presence of NMDA receptors 
Although DISC1 is known to localise to multiple subcellular compartments including 
the nucleus, centrosome, mitochondria and Golgi apparatus, it has not been shown 
to be targeted to the endoplasmic reticulum, the site of NMDA receptor synthesis 
and assembly. I wanted to determine which stages of NMDA receptor trafficking 
might be influenced by DISC1, therefore I first determined whether DISC1 is ER-
associated. COS7 cells were transfected with FLAG-DISC1 and co-stained with anti-
calreticulin to stain the ER (Figure 3.1 A-C). There was no obvious co-localisation 
between DISC1 and the ER marker, indicating that DISC1 is likely not present there 
in significant quantities when overexpressed in COS7 cells. However, because DISC1 
complexes with NMDA receptors (S.Mackie unpublished), I wanted to determine 
whether the presence of the receptor affects DISC1 subcellular distribution. DISC1, 
GluN1 and GluN2B were co-expressed in COS7 cells, the cells were fixed and stained 
for GluN1, GluN2B DISC1 and the ER. Under these circumstances DISC1 apparently 
co-localises with the ER marker calreticulin to approximately the same extent as 
GluN1 or GluN2B, thus all three proteins may associate at the ER (Figure 3.1 D-K). 
There is potential therefore, for DISC1 to associate with NMDA receptors from the 
ER onwards during the forward trafficking process.  
GluN1 KKK RRR Surface 
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Figure 3.1 DISC1 co-localises with GluN1 and GluN2B within the ER and at the 
surface of COS7 cells.  
COS7 cells transfected with FLAG-DISC1 (A) and co-stained with anti-calreticulin to stain the 
ER (B) show no DISC1/ER co-localisation (C). Cells co-transfected with FLAG-DISC1 (E), HA-
GluN2B (F) and GluN1 (G) and co-stained with anti-calreticulin (D) show co-localisation 
between DISC1/ER (H) GluN2B/ER (I) and GluN1/ER (K) indicating that the presence of 
GluN1 and GluN2B may redistribute DISC1 to the ER. n = 3 Scale bar 20 µm, white boxes are 




3.4 TRAK1 co-localises robustly with NMDA 
receptors 
 
Overexpression of TRAK1 in COS7 cells leads to its accumulation at mitochondria 
and causes mitochondrial clustering (Ogawa et al., 2013) Figure 3.2 A-C). I could find 
no evidence of TRAK1 ER-localisation in COS7 cells transfected with FLAG-TRAK1 
and co-stained with anti-FLAG and anti-calreticulin antibodies (Figure 3.2 D-F). 
FLAG-TRAK1 carrying the 678R mutation identified in a schizophrenia patient 






Figure 3.2 TRAK1 and TRAK1-678R do not co-localise with the ER. 
COS7 cells transfected with TRAK1 (A) and co-stained with MitoTracker (B) show significant 
co-localisation (C). TRAK1 (D) does not co-localise with calreticulin (ER marker E and F) 
indicating little or no ER localisation. COS7 cells transfected with TRAK1-678R (G) co-localise 
with MitoTracker (H and I). Like TRAK1, TRAK1-678R (J) does not co-localise with the ER 







Next, although TRAK1 is exclusively mitochondrial when expressed in COS7 cells, 
and mitochondria are not known to be a site of NMDA receptor expression, I 
examined co-localisation between TRAK1 and GluN1 or GluN2B in COS7 cells. 
Co-expression of HA-GluN1 and FLAG-TRAK1 did not result in any change in 
subcellular localisation for either protein. As expected, HA-GluN1 localises to the ER 
in the presence or absence of FLAG-TRAK1 (Figure 3.3 A-D). Similarly, FLAG-TRAK1 
localises to mitochondria irrespective of GluN1 (Figure 3.3 A-D). I could therefore 
find no evidence of an association between TRAK1 and GluN1, as expected. 
Interestingly, however, this was not the case for TRAK1 and GluN2B. FLAG-TRAK1 
and HA-GluN2B co-expression in COS7 cells substantially altered the distribution of 
GluN2B and resulted in significant co-localisation of the two proteins (Figure 3.3 E-
H). This dramatic co-localisation suggested a strong association between the two 
proteins which was confirmed by co-immunoprecipitation of overexpressed TRAK1 
and GluN2B (S. Mackie & K. Millar, unpublished) and by co-immunoprecipitation of 
endogenous TRAK1 and GluN2B from mouse brain synaptosomes (F. Ogawa & K. 
Millar, unpublished). Unexpectedly therefore, there is a robust association between 
TRAK1 and the NMDA receptor GluN2B subunit. 
Having established that TRAK1 co-localises robustly with GluN2B, but not GluN1, I 
next determined whether assembled GluN1/GluN2B-containing NMDA receptors 
can associate with TRAK1. Importantly, co-expression of HA-GluN2B, GluN1 and 
FLAG-TRAK1 in COS7 cells resulted in co-localisation of all three proteins with the 
mitochondrial marker MitoTracker (Figure 3.3 I-M).  The TRAK1/GluN2B association 
is therefore maintained when GluN2B is assembled with GluN1, and GluN1 appears 
to be recruited to mitochondria via the association of its binding partner GluN2B 
with TRAK1. It is likely that the mitochondrial NMDA receptor association in COS7 
cells is an artefact of protein overexpression because these receptors are not 
known to localise to mitochondria, but that said, my data, and the data from other 
members of the group, do indicate that TRAK1 may associate with assembled 




Figure 3.3. TRAK1 co-localises with GluN2B and assembled NMDA receptors in 
COS7 cells. 
COS7 cells overexpressing GluN1 (A) and TRAK1 (B) were co-stained with MitoTracker (C). 
There is co-localisation between TRAK1 and MitoTracker but not  between GluN1 and 
TRAK1 or MitoTracker (D). COS7 cells overexpressing GluN2B (E) and TRAK1 (F) were co-
stained with MitoTracker (G) which leads to co-localisation between all three signals (H). 
Co-expression of GluN2B (I), GluN1 (J) and TRAK1 (K) leads to co-localisation (M) of all three 
signals with MitoTracker (L) indicating recruitment to the mitochondria. White boxes are 
enlarged beside (A-H) and below (I-M). n = 3, Scale 20 µm. GluN1 image in bottom panel (J) 




To confirm the TRAK1/GluN2B co-immunoprecipitation data, I then examined the 
association between TRAK1 and NMDA receptor subunits in neurons. FLAG-TRAK1, 
GluN1 and HA-GluN2B were transfected into hippocampal neurons at DIV 17 and 
processed at DIV18. Overexpression of these proteins leads to expression in both 
the axons and the dendrites (Figure 3.4 A-C). TRAK1 and GluN2B co-localise in 
dendritic spines and along dendritic shafts, with similar co-localisation detectable 
between GluN1 and TRAK1 (Figure 3.4 E). This provides further support for an 
association between NMDA receptors and the trafficking molecule TRAK1, and 










Figure 3.4 TRAK1 co-localises with GluN1 and GluN2B in neurons.  
DIV17 C57 hippocampal neurons were transfected with GluN1, HA-GluN2B and FLAG-
TRAK1. At DIV18 the neurons were stained for TRAK1 (A) which is present throughout the 
dendrites and axon. GluN2B shows a largely similar staining pattern (B) as does GluN1 (C). A 
merge of TRAK1 and GluN2B (D) shows significant co-localisation of the two signals, White 
boxes are enlarged below and white arrows indicate spines expressing both proteins. 
Similarly, merging TRAK1 and the GluN1 channels results in significant co-localisation of the 
two signals. This indicates a possible association of TRAK1 and NMDA receptors in spines in 
hippocampal neurons. n = 3,  Scale bar 20 µm. 
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3.5 NDE1 may associate with NMDA receptors 
I set out to examine whether NDE1 may associate with NMDA receptors by 
transfecting COS7 cells with GluN1 and V5-NDE1 (Figure 3.5 A-C). Both proteins 
were expressed in a similar pattern, but it was difficult to distinguish clear co-
localisation. Cells were also transfected with HA-GluN2B plus V5-NDE1, with similar 
results (Figure 3.5 D-F). Next, COS7 cells were co-transfected with GluN1, HA-
GluN2B and V5-NDE1, and stained for all three proteins (Figure 3.5 G-I). Under 
these conditions there was clear co-localisation between NDE1 and a subset of the 
GluN2B and GluN1 (Figure 3.5 J), indicating a possible association between NDE1 





Figure 3.5 NDE1 may associate with assembled NMDA receptors. 
COS7 cells transfected with V5-NDE1 (A) and GluN1 (B) show little obvious NDE1/GluN1 co-
localisation (C). Similarly cells expressing V5-NDE1 (D) and HA-GluN2B (E) show little 
obvious co-localisation (F). Cells expressing NDE1 (G), GluN2B (H) and GluN1 (I) show co-
localisation between within the cytoplasm and at the surface of the cell, as indicated by 




I also examined NDE1 co-localisation with NMDA receptor subunits in primary 
cultured mouse hippocampal neurons. Mouse hippocampal neurons were 
transfected at DIV17 with GluN1, HA-GluN2B and V5-NDE1, and stained at DIV 18 
for GluN1, HA and V5 (Figure 3.6). All three proteins were expressed throughout the 
soma, dendrites and axon, with clear co-localisation within dendrites and dendritic 
spines. 
Taken together these data indicate that NDE1 and NMDA receptors may associate 








Figure 3.6 NDE1 co-localises with GluN1 and GluN2B in neurons 
DIV18 C57BL/6 hippocampal neurons were transfected with GluN1, HA-GLuN2B and V5-
NDE1. The neurons were stained for NDE1 (A) which is and is present throughout the 
dendrites and axon, GluN2B (B) and GluN1 (C). A merge of NDE1 and GluN2B signal (D) 
shows clear co-localisation. White boxes are enlarged below, and white arrows indicate 
spines where both proteins co-localise. Similarly, merging NDE1 and GluN1 signals revealed 






In this chapter I have provided suggestive evidence that DISC1 may associate with 
both GluN1 and GluN2B subunits of the NDMA receptor within the ER when co-
expressed in COS7 cells. Moreover, DISC1 has also been shown to localise to the 
Golgi (Kuroda et al., 2011, Lepagnol-Bestel et al., 2013). Coupled with the data 
showing that DISC1 binds to GluN1 subunits of the NMDA receptor (S. Mackie & K. 
Millar, unpublished) and the fact that DISC1 is known to be involved in intracellular 
trafficking (Shinoda et al., 2007, Ozeki et al., 2003, Morris et al., 2003, Ogawa et al., 
2005, Brandon et al., 2004), there is clearly potential for involvement of DISC1 in 
trafficking of the NMDA receptor. DISC1 could act at many levels. 1) DISC1 regulates 
PKA signalling via modulation of PDE4 cAMP hydrolysis activity (Millar et al., 2005b, 
Bradshaw et al., 2008) and could therefore potentially regulate phosphorylation of 
sites that influence receptor ER-retention and forward trafficking from the ER (Scott 
et al., 2001, Scott et al., 2003). 2) DISC1 could directly participate in receptor 
trafficking via association with TRAK1 and NDE1, and its reported association with 
the molecular motors dynein and kinesin (Taya et al., 2007, Kamiya et al., 2005). 3) 
DISC1 may be involved in NMDA receptor recycling at the cell surface as it is has 
been reported to co-localise with RAB11, a marker of the recycling endosome 
(Lepagnol-Bestel et al., 2013).  
I also identified a novel robust association between GluN2B and TRAK1. The strong 
association between these two proteins in mouse brain, and my data indicating that 
TRAK1 also associates with assembled NMDA receptors, is indicative of a role for 
TRAK1 in NMDA receptor trafficking. Consistent with this, in neurons TRAK1 is 
known to traffick GABAA receptors and endosomes, as well as mitochondria 
(Webber et al., 2008, Brickley et al., 2005, Ogawa et al., 2013, Brickley et al., 
Brickley and Stephenson, 2011), therefore it is possible that NMDA receptors could 
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be an additional cargo. Indeed in neurons I observed co-localisation between TRAK1 
and NMDA receptors. 
In COS7 cells endogenous TRAK1 has been shown to co-localise with an ER marker 
(Webber et al., 2008). Because TRAK1 is a kinesin adaptor molecule it could 
therefore potentially be involved in NMDA receptor forward trafficking from the ER 
to the surface of the cell. Furthermore endogenous TRAK1 has been shown to 
associate with the early endosome (Webber et al., 2008), and with dynein 
(van Spronsen et al., 2013). Consequently, because the NMDA receptor is a highly 
dynamic receptor which is constantly endocytosed, TRAK1 could conceivably be 
involved with this process as well.  
In COS7 cells the TRAK1/NMDA receptor association apparently occurs exclusively 
at mitochondria. It is likely that this is an artefact due to the strong targeting of 
TRAK1 to mitochondria in COS7 cells, and it is improbable that NMDA receptors are 
genuinely targeted to mitochondria via TRAK1 association in vivo. Indeed, as already 
discussed, TRAK1 is not exclusively mitochondrial in neurons. It is an interesting 
possibility however, that NMDA receptors and mitochondria could be co-
transported within neurons, but this is not something I was able to investigate in 
this thesis.  
I additionally obtained evidence that the dynein regulator NDE1 may associate with 
GluN1 and GluN2B subunits, although further work, such as co-
immunoprecipitation experiments, is required to confirm this possibility. Previous 
studies showed that NDE1 localises to the glutamergic synapse (Bradshaw et al., 
2008). Here I showed co-localisation of NDE1 and GluN1 and GluN2B within the 
spines of dendrites, which is consistent with a role for NDE1 in trafficking NMDA 
receptors to the synapse. Given what is known about NDE1 function within the cell, 
it could regulate NMDA receptor trafficking at two stages. 1) NDE1 is known to be 
present at the ER (Lam et al., 2009) where the NMDA receptor is retained until 
correctly assembled, before being trafficked to the surface of the cell. As NDE1 
plays a critical role in intracellular trafficking it could be involved in trafficking of the 
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receptor from the surface 2) At the cell surface, NDE1 could regulate NMDA 
receptor endocytosis via its role in modulation of dynein and of endosomes (Lam et 
al., 2009).  
To summarise, we now know that DISC1, and TRAK1 associate with NMDA 
receptors, and that NDE1 associates robustly with DISC1 and NDE1, and may 
associate with NMDA receptors. All three molecules regulate intracellular trafficking 
events and the role of DISC1 in trafficking is influenced by DISC1 amino acid 
variants. In the next chapters I will describe my investigation into the role of DISC1, 




4 Development and optimisation 
of the surface expression 






The GluN1 and GluN2 subunits of the NMDA receptor co-translationally assemble in 
the ER to form functional channels (McIlhinney et al., 1998, Monyer et al., 1992, 
Ozawa et al., 1998). When expressed individually, GluN1 and GluN2B subunits are 
retained in the ER (McIlhinney et al., 1998, McIlhinney et al., 1996). A number of 
studies of mammalian cell lines transfected (either transiently or permanently) with 
GluN1 subunits indicate that, when expressed alone GluN1 does not give rise to a 
glycine-glutamate responsive channel but instead requires the presence of the 
GluN2 subunit in order to form such a channel. (Cik et al., 1993, Varney et al., 1996, 
Grimwood et al., 1995). Co-precipitation of in vitro synthesised GluN1 and GluN2B 
can be achieved when both subunits are expressed together, indicating that these 
subunits bind to one another (Mcilhinney et al 98). Interestingly, transfecting COS7 
cells with GluN1 and GluN2B separately (with subsequent mixing) does not result in 
co-precipitation, suggesting that their association relies on co-synthesis (Mcilhinney 
et al 98). Fukaya et al (Fukaya et al., 2003) showed that GluN2B subunits are 
retained in the ER in GluN1 knock-out mice (targeted knock-out to the CA1 
pyramidal cells of the hippocampus) further demonstrating that both subunits are 
required to form a functional channel. 
As described in the introductory chapter studies of NMDA receptor trafficking 
indicate tight regulation of GluN1 and GluN2B subunit expression. ER retention 
occurs until the full NMDA receptor is formed, it is then forward trafficked to the 
surface. In this chapter I will describe optimisation of an assay for specifically 
detecting the surface expression of NMDA receptors, and use of this assay to 
compare how different proteins of interest may affect the surface expression of 
NMDA receptors. I will then describe generation of a script using image analysis 
software which allows me to quantify the signal from the surface NMDA receptors, 
thus generating a robust way of analysing the data.  
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4.2 Methods optimisation 
 
4.2.1 GluN1 and GluN2B localise to the ER as expected 
As described previously, GluN1 and GluN2B subunits of the NMDA receptor are 
retained in the ER until co-expressed. To ensure the GluN1 and HA-GluN2B 
constructs I will be using express the protein correctly, a number of co-localisation 
studies were carried out. COS7 cells were transfected separately with the GluN1 
and HA-GluN2B subunits and co-stained with an antibody specific for the ER 
(calreticulin). From the literature the localisation of these proteins should be 
exclusively within the ER. Figure 3.1 shows clear and extensive co-localisation 
between GluN1 and the ER (Figure 3.1A-C). Similarly this was observed for cells 
expressing GluN2B and co-stained with the calreticulin (Figure 3.1D-F). This was 
observed in 100% of the cells transfected. When the subunits are co-expressed 
there is a much more even expression throughout the cell than compared to 
individually expressed subunits. Also there is a much stronger presence at the 
surface of the cell which is very apparent in the enlarged images (Figure 3.1G-I). 
These observations follow the published literature, thus the plasmids I will be using 
express GluN1 and GluN2B subunits that are retained within the ER and expressed 




Figure 4.1 Individually expressed GluN1 and GluN2B subunits co-localise with the 
ER. Co-expression leads to additional expression at the surface. 
Representative images of COS7 cells overexpressing GluN1 or HA-GluN2B and co-stained 
with calreticulin (ER). GluN1 shows significant co-localisation with the ER (A, B, merged in 
C). HA-GluN2B also shows significant overlap with the ER (D, E, merged in F). Co-expression 
of GluN1 and GluN2B leads to surface expression (G, H, merged in I). Boxed areas are 





4.2.2 Optimisation of the surface expression assay 
In order to determine the effect of DISC1 and its binding partners on NMDA 
receptor trafficking I optimised a trafficking assay in COS7 cells. A study by Horack 
et al showed specific surface staining of NMDA receptors in COS7 cells. The group 
co-transfected the cells with GluN1 and GFP-GluN2B. As the GFP- tag is located on 
the extracellular N-terminus they could specifically label the surface NMDA 
receptors using an anti-GFP antibody. This incubation was carried out before 
fixation, so there is no labelling of intracellular protein, and at 4 °C to inhibit any 
constitutive internalization of the NMDA receptor (Horak et al., 2008). 
As I am interested in determining the effects of DISC1 on NMDA receptor surface 
expression I transfected COS7 cells with; GluN1 and HA-GluN2B or GluN1, HA-
GluN2B plus FLAG-DISC1. To examine surface NMDA receptors via visualisation of 
GluN2B, transfected cells were labelled live with anti-HA at 4 °C, followed by an 
appropriate secondary antibody to specifically detect GluN2B expressed at the cell 
surface. The cells were next fixed, permeabilized and stained with anti–HA and anti-
GluN1 to detect the total GluN2B and GluN1 populations, respectively. Figure 4.2 (A-
D) shows the resulting staining pattern, the surface GluN2B staining shows a 
punctate staining pattern, which is in line with that published in the literature. Also 
the total staining for GluN1 and HA-GluN2B gives a clear signal and clearly shows 
adequate amounts of subunit are present within the cell. Similarly, using an 
antibody specific for the N-terminus of the GluN1 subunit, surface staining was 
carried out on live cells in the same way as for HA-GluN2B. This produced a similar 
pattern of expression as the HA surface labelling (Figure 4.2 E-H). In cells expressing 
HA-GluN2B, GluN1 and FLAG-DISC1 the HA-GluN2B surface staining is again 
punctate in appearance, and the total staining patterns of GluN1 and HA-GluN2B 
indicate they are present at adequate concentrations (Figure 1.2 I-K). Finally the 
staining for DISC1 (Figure 1.2 L) appears punctate as has been described in several 
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publications, and exhibits extensive overlap with surface-expressed and intracellular 
NMDA receptor subunits. 
This assay clearly gives specific staining for; surface expressed NMDA receptors, the 
whole population of GluN subunits and of an additional protein, in this case DISC1. 
Therefore the assay is suitable for determining whether DISC1, or another protein, 




Figure 4.2 Optimisation of the surface expression assay in COS7 cells. 
COS7 cells transfected with GluN1 and HA-GluN2B were stained live at 4 °C with anti-HA (A, 
I) or anti-GluN1 (E) to label surface NMDA receptors, then fixed, permeabilized and stained 
again for GluN1 (B, F, J) and GluN2B (C, G, K). When cells were also transfected with FLAG-




4.2.3 Confirmation of surface expression 
In order to confirm the specificity of the staining of the surface-expressed NMDA 
receptors, COS7 cells were co-stained with VLA-2α. VLA-2α is a transmembrane 
receptor for collagen and other associated proteins, and is often used to indicate 
surface labelling (Harburger and Calderwood, 2009). COS7 cells were transfected 
with GluN1 and HA-GluN2B subunits and labelled live at 4 °C with an anti-HA 
antibody to label the surface expressed receptors. The cells were then fixed and 
stained for VLA-2α, GLuN1 and HA-GluN2B. Figure 4.3 A-F shows a cell with staining 
for endogenous VLA-2α staining (Figure 4.3 B). The surface HA-GluN2B (Figure 4.3 
B) clearly co-localises with the surface marker VLA-2a (Figure 4.3 A-C).  
These data confirm that the surface staining protocol for labelling GluN2B subunits 
gives a specific surface signal and can therefore be used to quantify the amount of 
signal at the surface of the cell. Furthermore total staining for GluN1, GluN2B and 
another protein of interest (e.g. DISC1) can also be stained for and quantified to 




Figure 4.3. Co-localisation of surface NMDA receptors with the membrane marker 
VLA-2α.  
COS7 cells transfected with GluN1 and HA-GluN2B were stained for surface NMDA 
receptors (A) and the surface membrane marker VLA-2α (B) which show strong co-
localisation (C). Total HA-GluN2B (D) and GluN1 (E) show cytoplasmic and perinuclear 






4.2.4 Surface quantification 
In order to quantify the surface-expressed NMDA receptors I worked with Paul 
Perry (HGU, IGMM) to develop a script in I-vision. First the four colour images 
(Surface GluNB, Total GluN2B, GluN1 and DISC1) are manually converted to three 
colour images by removing the total GluN2B channel. This is due to I-vision only 
being able to analyse images of three colours and not four colours. 
An image is opened in I-vision and is split into the three individual colour channels. 
A cell of interest is then selected using the surface HA-GluN2B channel by drawing a 
rough mask around it (Figure 4.4 A). The script crops the image to the mask and 
assigns a new mask around the edge of the cell, shown in green in Figure 4.4 B. This 
can be manually erased and drawn back in by hand if the mask is not perfect (Figure 
4.4 C). The script then measures the mean pixel intensity under the green mask, 
thus generating a value for surface expressed NMDA receptors.  
Next the script imposes the green mask over the total GluN1 image and assigns a 
red line around the edge of the green mask to create an outline of the cell (Figure 
4.4 D). It then generates a mask around the nucleus, shown in red in Figure 4.4 D, 
again this can be erased and drawn back in if it is not perfect. The script then 
measures the mean pixel intensity between the red line and the red mask thereby 
generating a value for non-nuclear GluN1 expression, which can be used to 
determine that GluN1 levels are unaffected by the presence of DISC1. The 
programme then assigns the surface outline mask and the nuclear mask to the 
DISC1 channel (Figure 4.4 E) and measures the mean pixel intensity between the 
red line and the red mask thereby generating a value for non-nuclear DISC1 
expression. The nucleus is omitted due to some of the DISC1 variants to be tested, 
DISC1-37W and DISC1-607F, not being expressed in the nucleus (Malavasi et al., 
2013).  
As I am interested in determining the effect of DISC1 on the surface expression of 
the NMDA receptor I only measured the surface NMDA receptor intensity from cells 
which had similar DISC1 expression levels. To ensure this, within the script a 
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threshold for DISC1 pixel intensity was set. Any cell expressing DISC1 below the 
threshold was discounted. The threshold was set by taking the average DISC1 pixel 
intensity from three randomly selected cells which were expressing GluN1, HA-
GluN2B and had moderate DISC1 expression (i.e. no aggregation of DISC1 and 
moderate florescent signal) from three separate experiments. Therefore if a cell had 
a low DISC1 expression level the surface expression data generated from it would 
not be included in the analysis. 
To allow direct comparison all the images within an experiment were taken within a 
single session and all the images were captured using the same confocal settings 
(laser power, gain, offset and pinhole size). 
As the pixel intensity is very important in this protocol, so it is paramount there are 
no saturating pixels in any of the cells used for analysis as this would affect the final 
quantification. Before any images were taken the cells were examined, and the 
microscope settings were set using a random cell from one of the cover slips used in 
that data set. Then using the saturation indicator in NIS elements confocal imaging 
software, I was able to determine if any of the pixels in subsequent images had 
saturating pixels and if so they were discounted.  
This analysis script will be used to determine if there is any effect of DISC1 or DISC1 
sequence variants, NDE1 or NDE1 phosphosite mutants, or TRAK1 or a TRAK1 
sequence variant on surface-expressed NMDA receptors. The script is able to 
quantify both the surface-expressed NMDA receptors and total DISC1 expression 




Figure 4.4. Screen shots of the surface quantification method.  
A cell is selected for analysis by drawing a rough mask (dotted line) around the cell (A). A 
surface mask is generated by the programme and assigned around the edge of the cell of 
interest in green (B). This mask can be edited manually if it is not perfect (C) then the 
programme measures the mean pixel intensity from underneath the mask. A red line is 
drawn around the green mask and superimposed onto the GluN1 channel and a nuclear 
mask is generated in red (D). The red surface mask and the red nuclear mask are 
superimposed onto the DISC1 channel and the mean pixel intensity within these two masks 








The expression and localisation of proteins is a precise and highly regulated process 
as mistargeting, over- or under-expression can lead to disruption of signalling 
cascades, intracellular trafficking, cell to cell communication and a multitude of 
other processes. In this chapter I set out to optimise an assay for the specific 
detection of surface-expressed NMDA receptors, as well as total expression levels of 
GluN subunits, and another protein of interest (e.g. DISC1), and to generate a script 
which allows for the quantification of the signal of the surface-expressed NMDA 
receptors and the total DISC1 expression. 
COS 7 cells were chosen as a cell line to use for several reasons; they have a large 
size in comparison to other cell lines and therefore the subcellular structures can be 
better identified and analysed. Unlike other cells, COS 7 cells do not grow in a 
monolayer sheet but as individual cells this allows the surface of the cells to be 
studied as the cells will not be in close proximity to each other and the surface of 
the cell more accessible for antibody attachment. In cells which grow as a 
monolayer sheet the surface of each cell touches each other therefore knowing 
which surface belongs to which cell is difficult and is surface labelling is performed, 
there may be an accumulation of signal from two cells so measuring the surface 
expression via microscopy would not be possible. Finally the transfection efficiency 
of COS 7 cells is very high (≈ 95 %) as I will be expressing 3 or 4 constructs this gave 
a large number of cells which express all constructs. 
The surface expression assay I described in this chapter generates a clear signal for 
the surface-expressed NMDA receptors. The staining protocol for GluN2B subunits 
at the cell surface generates a clear punctate staining pattern which is similar to 
that which has been published in the literature (Horak et al., 2008, Jeyifous et al., 
2009). The specificity of this signal was confirmed by co-staining with a surface 
marker (VLA-2α). Furthermore the assay allows for the visualisation of total 
expressed GluN1, GluN2B and another protein (in this chapter DISC1). This ensures 
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only cells expressing similar amounts of exogenous protein are used for analysis as 
variations in surface expressed NMDA receptors could be due to varying amounts of 
intracellular protein. This assay gives rise to clear images of each cell and therefore 
allows for the analysis of each cell via a script using the imaging software I-Vision. 
COS 7 cells do not endogenously express NMDA receptors but when over expressed 
they do form functional channels (Kaniakova et al., 2012) so NMDA receptor 
antagonists are used when transfecting the cells to inhibit NMDA receptor mediated 
excitotoxicity. DISC1, TRAK1 and NDE1 are all endogenously expressed in COS 7 cells 
where they may have some function within the cell. These constructs were 
overexpressed so to evaluate their effect on the NDMA surface expression and 
trafficking and evaluate more specifically their influence on NMDA receptor 
trafficking. There could be additional effects of the endogenous protein e.g. 
endogenous NDE1 expression may influence the NDE1 131A as there may be an 
accumulation of the effect of the over-expressed NDE1 131A and the endogenous 
NDE1. To determine if this happens the knockout of NDE1 and subsequent over-
expression of NDE1 131A could be carried out. However as a decrease in the surface 
expression on NMDA receptors was observed for both NDE1 131E and DISC1 607F 
expressing cells there is likely to be minimal accumulation effect from endogenous 
protein 
The translation of findings in COS7 cells into effects observed in neurons is not 
always the same. There is a greater degree of complexity in neurons with a larger 
number of interacting proteins and cell to cell interactions governing trafficking and 
expression of proteins. As NMDA receptors are not endogenously expressed in COS 
7 cells and could be trafficked to the surface via a different mechanism than they 
are in neurons and may not be as constitutively active as in neurons. Conclusions 
made based on data generated from COS 7 cells is not always going to be the same 
as conclusions based on data generated using neuronal cells. However little is 
known about the interaction of DISC1 and the NMDA receptor or even NDE1 or 
TRAK1 therefore a simple cell system which can generate well controlled data is the 
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ideal starting point for the investigation of the effect of an interaction. Once data 
has been obtained from the simple system, a more complex or physiologically 
relevant system can be employed to further evaluate any relationship between the 
two interacting proteins.  
Despite these caveats COS 7 cells will be suitable for the investigation of DISC1 , 
NDE1 and TRAK1 on NMDA receptor trafficking as they can be easily analysed as 
individual cells, can exogenously express numerous proteins and with further 
investigation of any observed effect to be confirmed in a more complex system e.g. 
neurons. 
As I was investigating overexpressed protein the majority of the proteins I 
transfected in contained an epitope tag this increased the specificity of the antibody 
for the proteins and allowed for the easier detection of multiple proteins. Although 
not exactly representative of the physiological protein the FLAG-, HA-, and V5- tags 
are small additions to the proteins (6, 9 and 14 amino acids long respectively) and 
are unlikely to significantly impact on the protein function. F. Ogawa et al showed 
endogenous DISC1 expression and FLAG- tagged DISC1 overexpression to be very 
similar (Ogawa et al., 2013). Larger fluorescent tags such as GFP were not used due 
to their size and the causation of aggregation of proteins which made it difficult to 
assess the impact of DISC1 on NMDA receptor localisation and surface expression. 
Further to this there has been a lot of controversy regarding DISC1 antibodies 
(discussed in 1.1.3) and their specificity so the use of tagged constructs negated the 
use of any of these antibodies. 
Any effect upon surface expressed NMDA receptors may be quite subtle and 
therefore it is important to generate a large enough data set to be able to measure 
these effects. Therefore three independent experiments will be carried out and 20 
images for each condition (e.g. EV, DISC1) will be taken from each experiment 
generating 60 images per condition. The images will be taken at the same time 
using the same confocal settings and analysed at the same time. This will allow for 
the direct comparison of all the images and statistical analysis will be carried out.  
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The experimental n number was important as the effect of the variants could be 
quite subtle so a large enough sample had to be taken. 20 images were taken in 
each experiment and the experiment was repeated 3 times giving a total of 60 
images per condition and a large enough data set for any effect to be observes. Also 
all images were taken at the same time which gave more consistency to the images 
as if they were taken over a number of days or weeks the lasers within the 
microscope may have deteriorated slightly or they may have been colder which 
could impact on their functionality and ultimately provide two images which may 
have the same settings on the software but are of different pixel intensity which 
may lead to false negative or false positive data. A larger sample size and larger 
independent replicates would have generated a more robust data set however, as 
all the images were taken at the same time and the time taken to capture all the 
images increasing the number of images taken would have been unfeasible. 
Overexpression of trafficking proteins may be controversial as some of the proteins 
studied here are not endogenous to the COS-7 cell (e.g. NMDA receptors) and 
therefore may not follow their normal trafficking pathway. Also overexpression of 
endogenous proteins may overload the endogenous pathway leading the protein to 
behave differently and may utilise alternative pathways. On the other hand as we 
know that DISC1 and the NMDA receptor are likely to bind to each other it is 
reasonable to think the NMDA receptors use DISC1 in some capacity. As this was a 
novel finding there is little known about the interaction they have or what affect 
DSIC1 may have on the NMDA receptor so this was a first look at any potential 
affect that DISC1 may have or any of the variants of DISC1 may have so a simple 
system was used in order to determine if any interaction or effect could be seen. 
This could then be replicated looking at endogenous proteins to determine if the 
same effect is observed. As this is a novel discovery little is known about any 
potential impact sequence variants might have on surface expression of NMDA 
receptors so a “simple” system was used here. 
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The surface expression assay described in this chapter is a viable way to determine 
the effect, if any, of DISC1 and DISC1 variants, or other proteins of interest, upon 
NMDA receptor surface expression. The assay generates images with specific signals 
for surface and total expression of proteins and the script created in I-Vision allows 
for the quantification of these signals. This assay will therefore be used to test 
whether DISC1, DISC1 variants or any of DISC1 pathway partners influence the 
surface expression of NMDA receptors. 
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5 Effects of DISC1 and its 
pathway partners on NMDA 





To determine if 1) DISC1, or DISC1 carrying the variants 607F, 704C or 37W, 2) 
NDE1, or NDE1 phosphosite mutants, or 3) TRAK1 or a variant, putatively causal 
disease form, TRAK1-678R, have any effect on the surface expression of NMDA 
receptors in COS7 cells. 
5.2 Introduction 
Once released from the ER, NMDA receptors are transported to the surface of the 
cell at which point they are either inserted directly into the plasma membrane or 
maintained within an intracellular pool. Holding receptors within this pool allows 
for, upon activation of surface receptors, their rapid insertion into the plasma 
membrane (Perez-Otano and Ehlers, 2005).  The exact mechanism of transport of 
the NMDA receptor from the ER to the surface membrane is still unknown, despite 
being extensively studied. 
The current understanding of NMDA receptor trafficking was discussed in chapter 1. 
In brief NMDA receptors are trafficked via a complex of Sec8, SAP102 and mPins 
which attach to kinesin motors to bring the complex to the surface of the cell, 
however studies have shown that this is not the only mechanism of transport to the 
cell surface (Sans et al., 2003, Chung et al., 2004, Prybylowski et al., 2005). DISC1 
could be involved in NMDA receptor trafficking due to its 1) binding directly to the 
GluN1 subunit of the NMDA receptor (S. Mackie unpublished),  2)  direct 
involvement in intracellular trafficking (Shinoda et al., 2007, Taya et al., 2007, Atkin 
et al., 2010, Flores Iii et al., 2011, Ogawa et al., 2013) or 3) robust association with 
the trafficking molecules NDE1, NDEL1, LIS1, kinesin1, dynein and TRAK1 (Brandon 
et al., 2004, Burdick et al., 2008, Bradshaw et al., 2009, Shinoda et al., 2007, Taya et 
al., 2007, Kamiya et al., 2005, Ogawa et al., 2013). I therefore set out to determine 
whether DISC1 and some of its partners may influence NMDA receptor surface 
expression in COS7 cells. 
To investigate this I used the trafficking assay described in chapter 4 to specifically 
label surface-expressed NMDA receptors, and used the computer programme 
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described in chapter 4 to quantify the intensity of the surface labelling, thereby 
allowing me to directly compare the effect of DISC1, NDE1 and TRAK1 and their 






5.3.1 DISC1 overexpression does not influence surface 
NMDA receptor expression in COS7 cells 
 
DISC1 is known to associate with the NMDA receptor as it binds directly to the 
GluN1 subunit (S. Mackie, unpublished) and is known to be involved in trafficking 
through binding to both dynein and kinesin, binding to the NDE1/LIS1/NDEL1 
complex as well as an association with the trafficking molecule TRAK1 
(Higginbotham and Gleeson, 2007, Shinoda et al., 2007, Ogawa et al., 2013, Taya et 
al., 2007, Brandon et al., 2004). To determine the effect of overexpression of DISC1 
on surface expression of NMDA receptors I used the surface expression assay and 
the surface quantification script described earlier in chapter 3. I found that empty 
vector (EV)-transfected cells produce robust surface NMDA receptor expression 
(Figure 5.1 A) and strong total GluN2B (Figure 5.1 B) and GluN1 (Figure 5.1 C) 
staining. Cells co-transfected with DISC1 also gave robust surface NMDA receptor 
expression (Figure 5.1 E), with strong GluN1, GluN2B and DISC1 expression (Figure 
5.1 F-I). Quantification of surface NMDA receptor expression revealed no significant 
difference in the cells expressing DISC1 compared to the EV control (as shown in 
Figure 5.1 J), indicating that DISC1 does not affect the amount of surface expression 
of the NMDA receptor in this system. Additionally the images show clear co-
localisation between DISC1 and total GluN1 and GluN2B both at the surface of the 
cell and within the cytoplasm. This is consistent with co-IP and peptide array studies 





Figure 5.1 DISC1 overexpression has no effect on the quantity of surface 
expressed NMDA receptors.  
Co-transfection with GluN1, GluN2B and either EV or DISC1 resulted in a similar mean pixel 
intensity after surface quantification. EV-transfected cells gave robust surface expression 
(A) and robust total GluN2B (B) and GluN1 expression (C), shown merged (D). Cells 
expressing GluN1, HA-GluN2B and FLAG-DISC1 also gave robust surface staining (E) and 
robust total Glun2B (F), GluN1 (G) and DISC1 (H) staining patterns, shown merged (I). J 
shows quantification of surface expression, n=3 independent experiments, 20 images per 
experiment, total=60 cells. No significant difference was observed between cells 
transfected with EV or DISC1. Error bars represent SEM, Scale 20 µm. C and G were 






5.3.2 DISC1 variant 607F causes a reduction in surface 
expression of NMDA receptors 
As DISC1 had no effect on surface expression of NMDA receptors, I next 
investigated whether any of the DISC1 variants have an effect on surface 
expression. COS7 cells were transfected and stained as described above. Cells 
expressing DISC1 again resulted in robust surface expression of NMDA receptors 
(Figure 5.2 A) with strong total staining for total GluN1 (Figure 5.2 C), GluN2B 
(Figure 5.2 B) and DISC1 (Figure 5.2 D). However in cells expressing DISC1 carrying 
the variant L607F (DISC1-607F) the surface expression of NMDA receptors is greatly 
reduced as determined using the t-test (F, p=0.02) with the total staining for the 
proteins remaining similar to that observed with DISC1 (Figure 5.2 G,H,I). The 
variants 704C and 37W did not generate any significant differences in the surface 
expression of NMDA receptors (Figure 5.2 K-T) when compared to DISC1 expressing 
cells. Furthermore quantification of DISC1 signal is similar across all the constructs 
(Figure 5.2 V) indicating a true effect of DISC1-607F rather than an effect of unequal 
expression of the various DISC1 species. 
Notably, the variant forms of DISC1 used in these experiments co-localise with total 




Figure 5.2. DISC1-607F decreases the surface expression of NMDA receptors 
compared to wild-type DISC1.  
COS7 cells expressing GluN1, HA-GluN2B and either DISC1, DISC1-607F, DISC1-704C or 
DISC1-37W were surface stained for NMDA receptors and then stained for total expression 
of transfected protein. DISC1 expressing cells (A-E) show robust surface staining (A) with 
strong total expression of GluN2B (B), GluN1 (C) and DISC1 (D and merge E). DISC1-607F 
expressing cells (F-J) exhibit a decrease in surface expressed NMDA receptors (F) with 
similar amounts of total protein still being expressed (G-I merge J). Quantification of the 
surface-expressed NMDA receptors showed a statistically significant decrease in the 
presence of DISC1-607F in comparison to DISC1 (p=0.02, U). Cells expressing DISC1-704C (K-
O) or DISC1-37W (P-T) showed no difference in surface-expressed NMDA receptors (U). 
Finally, quantification of DISC1 and variant DISC1 showed no significant difference (V). Error 
bars represent SEM, Scale 20 µm, n=3 independent experiments, 20 images per 
experiment, total=60 cells. Statistical analysis of DISC1 vs DISC1-607F was carried out using 




5.3.3 DISC1 and L607F-DISC1 do not affect whole cell NMDA-
induced current in neurons 
I next determined if DISC1 or DISC1-607F transfected neurons exhibit any 
differences in whole cell NMDA-induced currents. Based on the decreased surface 
NMDA receptor expression induced by DISC1-607F in COS7 cells, I wanted to 
determine if there is a functional effect upon NMDA receptors in neurons. Cortical 
neurons were plated on glass coverslips and transfected at DIV 8-9 with GFP (to 
visualise transfected neurons) and either DISC1, DISC1-607F or globin (as a control). 
Whole cell NMDA receptor recordings were made between DIV 10-11. 13 
recordings were made from cultures from 5 different animals (as described in 
(McKay et al., 2012)). The recordings were normalised to the cell capacitance and 
the current density was calculated. There was no significant difference in the 
capacitance of the transfected cells which indicated that the cells which recordings 
were obtained from were of similar size and any differences observed are due to 
differences in NMDA receptor density.  
Globin transfected cells had an average current density of 47.15 pA/pF (Figure 5.3 
A). DISC1 transfected cells gave a similar current density of 40.73 pA/pF (Figure 
5.1Figure 5.3 A), there was no significant difference between globin and DISC1 
transfected cells as determined by t-test. DISC1-607F transfected cells had a similar 
current density of 43.67 pA/PF (Figure 5.3 A) which was not significantly different 
from DISC1. 
Although there is an indication that DISC1 and DISC1-607F do not affect the global 
population of surface expressed NMDA receptors in cortical neuron, more detailed 
investigations will be required for any firm conclusions to be drawn, which is 




Figure 5.3 DISC1 and DISC1-607F have no effect on current density in pyramidal 
neurons 
Cortical neurons were transfected between DIV 8-9 and whole cell NMDA recordings were 
taken DIV 10-11. Neurons were maintained in Mg2+ free recording solution and clamped at 
-70 mV. A whole cell patch was formed and a baseline recording was taken. Cells were then 
washed in NMDA to open NMDA receptors causing a drop in current density. The NMDA 
was washed from the cells by applying the Mg2+ free recording solution. This was repeated 
a further 3 times. An average reading of the baseline when in Mg2+recording solution was 
taken and an average reading of the baseline when NMDA is applied was taken and these 
values were subtracted from each other. These were then divided by the cell capacitance to 
generate the current density. 
Graph A shows the comparison of globin, DISC1 and DISC1-607F whole-cell NMDA currents 
evoked by 300 µm NMDA. B, C and D are example traces used to generate data in A , n=5 







5.3.4 NDE1 and NDE1 phosphomutants modulate the surface 
expression of NMDA receptors 
I next investigated the effect of NDE1 on surface expression of NMDA receptors. 
COS7 cell transfection with GluN1, HA-GluN2B and EV leads to robust surface 
expression of the NMDA receptor (Figure 5.4 A) as well as strong total expression of 
GluN1 and GluN2B, as expected (Figure 5.4 B-C). Cells co-expressing NDE1 generally 
exhibit about the same, or slightly increased, surface expression of NMDA receptors 
as EV-transfected cells (Figure 5.4 E). NDE1 co-expression also does not affect total 
GluN1 and GluN2B expression (Figure 5.4 F-G). Co-transfection with NDE1-131A, 
leads to slightly increased surface NMDA receptor expression (Figure 5.4 J), again 
without affecting total GluN1 or GluN2B total expression (Figure 5.4 K,L). The 
phospho-mimic mutant NDE-131E decreases surface NMDA receptor expression 
(Figure 5.4 O) without affecting total expression levels of GluN1 (Figure 5.4 Q) and 
GluN2B (Figure 5.4 P). Importantly, expression of all three forms of NDE1 was 
similar (Figure 5.4 U). Analysis of the data using one-way ANOVA found an overall 
effect (p=0.047) of NDE1 or phospho-NDE1 on the surface expression of NMDA 
receptors. Post-hoc pairwise Bonferroni testing revealed was due to a significant 
difference between NDE1-131A and NDE1-131E upon NMDA receptor surface 
expression (p<0.05). Individual pairwise Bonferroni testing also revealed a 
significant difference between NDE1 and NDE1-T131E (p<0.05), but this did not 
survive correction for multiple comparisons. 
There was also co-localisation between NDE1 and total GluN1 and total GluN2B 
staining, which indicates that the NMDA receptor and NDE1 might be able to 
associate within COS7 cells. There is some evidence potentially linking NDE1 and 
NMDA receptors as NDE1 has been shown to localise at excitatory synapses 
(Bradshaw et al., 2008).  
Taken together this indicates that NDE1 can modulate the amount of surface 
expressed NMDA receptors in COS7 cells, with phosphorylation at T131 potentially 




Figure 5.4. Effect of NDE1 upon NMDA receptor surface expression.  
COS7 cells co-transfected with GluN1, GluN2B and EV generated robust surface staining (A) 
with strong total staining of GluN2B (B) and GluN1 (C), merged in (D). Cells transfected with 
GluN1, GluN2B and NDE1 showed slightly stronger surface expression of NMDA receptors 
(E) while giving similar total staining of GluN2B (F) and GluN1 (G) as EV-transfected cells, 
and robust NDE1 staining (H merged in I). Similarly, cells exogenously expressing GluN1, 
GluN2B and NDE1-131A exhibited slightly increased NMDA receptor surface expression (J) 
while generating similar GluN2B (K), GluN1 (L) and NDE1-131A (M merged in N) signals, as 
EV or NDE1-transfected cells. Finally cells exogenously expressing GluN1, GluN2B and 
NDE1-131E gave decreased NMDA surface expression (O) whilst still generating similar 
GluN2B (P), GluN1 (Q) and NDE1-131A signal (R merged in S). Quantification of the surface-
expressed NMDA receptors showed a statistically significant decrease in the presence of 
NDE1-131E in comparison to NDE1-131A (p<0.05, T). Finally, quantification of NDE1 and 
phosphomutant NDE1 expression showed no significant difference (U). Error bars represent 
SEM, n=3 independent experiments, 20 images per experiment, total=60 cells Scale 20 µm. 
Statistical analysis of NDE1 and phosphomutant NDE1 was carried out using one-way 
ANOVA with post-hoc pairwise Bonferroni testing. C, G, L and Q were pseudocoloured 




5.3.5 TRAK1 decreases NMDA receptor surface expression 
As reported in Chapter 4 the trafficking molecule TRAK1 co-localises robustly with 
GluN2B so I was interested in using TRAK1, and TRAK1 carrying a putative mutation 
H678R, identified from a patient with schizophrenia (Xu et al., 2011), in the 
trafficking assay. COS7 cells co-expressing GluN1, HA-GluN2B and EV gave robust 
surface staining (Figure 5.5 A) and strong total expression of GluN1 and GluN2B 
(Figure 5.5 B-D). Conversely, COS7 cells co-transfected with GluN1, HA-GluN2B and 
TRAK1 generated very weak NMDA receptor surface staining (Figure 5.5 E-I). 
However as expected, total staining of GluN1 and GluN2B in cells exogenously 
expressing TRAK1 was different to that in EV-transfected cells as the receptor 
subunits appeared to be redistributed to TRAK1-positive aggregations (Figure 5.5 
H), most likely at the mitochondria. TRAK1-678R also decreased the number of 
surface expressed NMDA receptors and caused GluN1 and GluN2B clustering 
(Figure 5.5 J-N). One way ANOVA revealed a significant effect (p=0.009) when 
comparing surface NMDA expression in EV or TRAK1 or TRAK1-678R, which post hoc 
Bonferroni pairwise testing revealed was due to a significant decrease in NMDA 
receptor surface expression in the presence of TRAK1, with no difference between 
TRAK1 and TRAK1-678R (O). Thus the mutation does not have a significant effect on 
TRAK1-induced reduction of NMDA surface expression in COS7 cells. Finally the 
expression of TRAK1 and TRAK1-678R was approximately the same, indicating again 





Figure 5.5. Co-expression of TRAK1 or TRAK1-678R causes a significant decrease in 
surface expressed NMDA receptors. 
COS7 cells expressing GLuN1 GluN2B and EV generated robust surface expression of NMDA 
receptors (A) and strong total gluN2B (B) and GluN1 (C), merged in (D) expression. Cells 
exogenously expressing GluN1, GluN2B and TRAK1 show much reduced NMDA receptor 
surface expression (E) with total staining for both total GLuN2B (F) and GluN1 (G) appearing  
with a similar staining pattern to mitochondria as described in chapter 3, along with TRAK1 
(H), merged in (I). Similarly in cells co-transfected with GluN1, GluN2B and TRAK1-678R 
reduced surface NMDA expression (J) was observed with total staining of GluN2B (K), 
GluN1 (L) and TRAK1-678R (M), merged in (N) having a similar appearance to mitochondrial 
staining as described in chapter 3. Scale 20 µm, n=3 independent experiments, 20 images 
per experiment, total=60 cells.  
Quantification of surface expression (O) using one-way ANOVA shows a statistically 
significant decrease in NMDA receptor surface expression in cells expressing TRAK1 
(P=0.03). Post hoc testing revealed a significant decrease in surface NMDA receptor 
expression in the presence of TRAK1 (p<0.05), but no statistically significant difference 
between TRAK1 and TRAK1-678R expressing cells. Quantification of TRAK1 expression (P) 
shows no significant difference in expression between wild-type and mutant. Error bars 
represent SEM. * p<0.05, 20 cells counted per experiment, 60 in total. C, G and L were 





The precise mechanism of how NMDA receptors are trafficked from the ER to the 
surface is not fully understood. The C-terminal PDZ domain binds and interacts with 
SAP102, mPins and Sec8 and travels along microtubules to the surface membrane 
(Lau and Zukin, 2007, Sans et al., 2003, Sans et al., 2005). However removal of the 
PDZ domain of the GluN2B subunit disrupts SAP102 binding but does not inhibit 
surface expression of GluN2B containing NMDA receptors at the cell surface, which 
indicates another method of intracellular trafficking (Sans et al., 2003). 
The results in this chapter show wild-type DISC1 has no effect on the surface 
expression of the NMDA receptor, at least in COS7 cells. However the DISC1 variant 
607F was found to cause a significant reduction in surface expressed NMDA 
receptors when compared to wild type DISC1. Furthermore neither the 704C nor 
37W variants had any effect on surface expression. As DISC1 is known to bind 
directly to GluN1 (S. Mackie unpublished) and is vital in many different trafficking 
processes (e.g. transport of GRB2, mitochondria and synaptic vesicles and also part 
of the LIS1/NDE1/NDEL1 trafficking complex, (Atkin et al., 2010, Taya et al., 2007, 
Shinoda et al., 2007, Ogawa et al., 2013, Flores Iii et al.), it was surprising to find its 
overexpression doesn’t affect the surface expression of NMDA receptors. However 
because DISC1-607F causes a decrease in surface expression, it is reasonable to 
think DISC1 does play a role in some capacity, which is disrupted by the 607F variant 
form. It has been reported that DISC1-607F fails to rescue mitochondrial trafficking 
deficits induced by DISC1 knock down, whereas both wild type DISC1 and DISC1-
704C can (Atkin et al., 2010), indicating some loss of function of the 607F variant. 
Furthermore DISC1-607F has been associated with lower levels of PCM1 at the 
centrosome (required for correct axonal morphology and embryonic neurogenesis 
(Bradshaw and Porteous, 2012), lower levels of DISC1 in the nucleus and disruption 
of ATF4 mediated transcription (Malavasi et al., 2013), indicating that DISC1-607F 




As DISC1 is largely a brain expressed protein it would be interesting to carry out 
these experiments in neurons. There may be several mechanisms operational in 
neurons which are not present in non-neuronal cell lines which could influence any 
role DISC1 may have in NMDA receptor trafficking. The Millar group has shown that 
the 607F variant affects receptor movement in axons of hippocampal neurons. Time 
lapse imaging showed that in neurons co-transfected with GluN1 and DISC1 the 
607F variant significantly decreases the velocity of movement of GluN1-containing 
vesicles. Although these studies were not directly measuring surface expression 
they further strengthen the evidence for a role of DISC1 in NMDA receptor 
trafficking and for the common variant L607F having an impact on this. 
The other DISC1 variants, 704C and 37W, have been shown to induce disruptions to 
DISC1 function. 704C has also been shown to induce lower levels of PCM1 at the 
centrosome (Eastwood et al., 2010), a mild reduction in DISC1 binding to NDE1 and 
NDEL1, and altered DISC1 oligomeric status (Burdick et al., 2008). 37W has been 
shown to alter the mitochondrial distribution of DISC1 and induce mitochondrial 
morphological abnormalities (Ogawa et al., 2013). Interestingly neither caused any 
disruption to the surface expression of NMDA receptors. One possibility is that the 
607F variant, but not 37W or 704C, disrupts DISC1 binding to the NMDA receptor. 
Structural analysis predicts that 607F is likely to impact on the structure of DISC1 as 
it lies within a leucine zipper and could disrupt the leucine-leucine packing between 
adjacent helices of the zipper, thereby modulating the coiled-coil stability, affecting 
oligomeric state, protein partner selection and the orientation of coiled-coil helices 
(Soares et al., 2011).  The 37W and 704C variants, however, are not predicted to 
alter DISC1 structure, although they do impact on its protein-protein interactions 
(Soares et al., 2011). 
Based on the results showing DISC1-607F decreases the surface expression of 
NMDA receptors in COS7 cells, whole cell recordings of NMDA currents were taken 
from cortical neurons transfected with globin, DISC1 or DISC1-607F. Based on the 
recordings made in Figure 5.3 DISC1 transfected cells showed no significant 
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difference when compared to globin transfected cells. This was to be expected 
based on the data shown in Figure 5.1 which indicates that DISC1 does not cause a 
significant difference in the surface expression of NMDA receptors. However there 
was also no significant difference in current density detected between DISC1 and 
DISC1-607F transfected cells which is not in agreement with the data presented in 
Figure 5.2. This could be due to the differences in model cell used as there is most 
likely additional complexity within the trafficking mechanism of surface expression 
of NMDA receptors in neurons which is not present in COS7 cells. For example 
300nm NMDA was applied to stimulate the neurons, this is a saturating 
concentration of NMDA which stimulated both synaptic and extra-synaptic NMDA 
receptors. DISC1 has been shown to localise to extra-synaptic sites (Paspalas et al., 
2012) and therefore could affect the trafficking of NMDA receptors at either one of 
these sites. This could be investigated by blocking synaptic NMDA receptors and 
measuring the effect of overexpressed DISC1 or DISC1-607F or DISC1 knockdown. 
Furthermore in the COS7 assay the levels of NMDA surface expression is being 
measured at homeostasis i.e. not being stimulated whereas in neurons there is a 
much greater activity of the receptor. For example during synaptic plasticity there 
are rapid changes in surface expressed NMDA receptors, DISC1 could play an 
important role in the transport of the NMDA receptor but this was not captured in 
these experiments. Knockdown of DISC1 and subsequent patch clamping of neurons 
would be the next logical step. 
DISC1-607F has been shown to affect the trafficking of NMDA receptors in axons 
(Malavasi unpublished) and fails to rescue mitochondrial trafficking deficits in axons 
(Atkin et al., 2010). Therefore evidence suggests that DISC1 is involved in NMDA 
receptor trafficking, and that this mechanism may be affected by the 607F variant, 
so measuring the effect of  this variant at a more specific point in the trafficking 
mechanism may be more informative than the whole cell current recordings 
performed here. DISC1 has been shown to interact with dynein and kinesin which 
may link DISC1 to receptor endocytosis as these molecular motors have been shown 
to play a critical role in trafficking of the NMDA receptor to and from the cell 
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surface (Guillaud et al., 2003, Wang et al., 2010a, Setou et al., 2000). Moreover the 
robust association of DISC1 with TRAK1 also suggest a potential role in receptor 
trafficking because TRAK1 is already known to associate with endosomes and 
mediate receptor trafficking (Gilbert et al., 2006, Webber et al., 2008). It would be 
interesting to determine if DISC1 does play a role in receptor endocytosis and if the 
607F variant has an effect on this as well. Furthermore, due to the complexity of 
NMDA receptor signalling it could be that in cells co-expressing DISC1-607F there is 
no overall reduction in current density, but there could still be less receptors 
expressed at the surface, with the ones that are expressed compensating by being 
more active. Alternatively any effect on NMDA receptor trafficking by DISC1-607F 
could be investigated via long term potentiation (LTP) or long term depression (LTD) 
studies as this would measure the influence of DISC1 and DISC1-607F on NMDA 
receptor insertion to synapses over time: if the 607F variant is affecting the 
mechanism of receptor trafficking to or from the cell surface then it may become 
apparent in this kind of study.  
NDE1 binding has been shown to determine correct dynein function (Lam et al., 
McKenney et al.). NDE1 phosphorylation has been shown to decrease its binding to 
dynein, disrupting dynein function and subsequently affecting intracellular 
trafficking (Hirohashi et al., 2006a). My study showed NDE1 and the phospho-null 
mutant NDE1-131A had no effect on surface NMDA receptor expression. However 
the phospho-mimetic NDE1-131E causes a significant decrease in surface expressed 
NMDA receptors when compared to NDE1-131A-expressing cells. This indicates 
NDE1 may be involved in regulating the surface expression of NMDA receptors in 
COS7 cells, but in a phospho-dependent manner. Phosphorylation of NDE1 at T131 
has been shown to disrupt NDE1/LIS1 binding, which could cause deficits in 
trafficking through misregulation of dynein activity (Bradshaw et al., 2011). 
NDE1/LIS1 interaction promotes dynein processivity (McKenney et al., 2010) and 
therefore phosphorylation at T131 may block dynein function resulting in trafficking 
deficits. Blocking dynein function may not explain the reduction in surface 
expressed NMDA receptors as dynein is a retrograde transporter and takes 
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organelles away from the cell periphery. Blocking this function would be predicted 
to result in an increase in cell surface expression (as transport away from the 
surface has been disrupted), therefore there may be another mechanism disrupted 
which results in the reduction of surface expressed NMDA receptors. The 
LIS1/NDE1/NDEL1 complex is also essential for dynein-dependent organelle 
positioning, which includes the Golgi, early endosomes and lysosomes (Lam et al., 
2009). Therefore disruption to this complex may affect Golgi positioning which 
could result in decreased trafficking of NMDA receptors to the surface, or it may be 
that disruption to this complex directly affects the trafficking mechanism of the 
NMDA receptor, resulting in reduced trafficking. 
Interestingly phosphorylation of NDE1 at T131 is controlled by DISC1, therefore 
potentially linking DISC1 and NDE1 in the trafficking of NMDA receptors (Bradshaw 
et al., 2011). DISC1 upregulates phosphorylation of NDE1 at T131 (Bradshaw et al., 
2011), which should result in overexpression of DISC1 causing a reduction in surface 
expression of NMDA receptors, which is not the case (chapter 5.3.1). This may be 
because the levels of phosphorylation of NDE1 are most likely not 100% in the 
presence of overexpressed DISC1, in contrast to overexpression of NDE1-131E 
which should mimic 100% phosphorylation at position 131. Also there could be an 
alternative mechanism which can compensate for any deficit in trafficking resulting 
from increased NDE1 phosphorylation after DISC1 overexpression 
Finally, TRAK1 was found to significantly decrease the surface expression of NMDA 
receptors in COS7 cells. This is most likely due to TRAK1 sequestering the receptors 
at the mitochondria. This was observed as total staining patterns of GluN1 and 
GluN2B revealed a different staining pattern compared to that in EV-transfected 
cells, as they co-localised with overexpressed TRAK1. In 3.4 TRAK1 was found to 
alter GluN2B subcellular distribution by sequestering some of it at the 
mitochondria. Further to this TRAK1 had no effect on GluN1 subcellular distribution 
when expressed without GluN2B, but when the subunits are co-expressed TRAK1 
sequesters both at the mitochondria indicating a strong association with GluN2B 
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and assembled NMDA receptors, which recruits GluN1 to the mitochondria. I 
speculate that this could lead to a decrease in the surface expressed NMDA 
receptors as they are being held at the mitochondria and thereby cannot be 
inserted into the plasma membrane. TRAK1 mutant 678R also had this effect, 
perhaps indicating the mutation has no effect on TRAK1s ability to sequester the 
NMDA receptor at the mitochondria. However, although the effect I observed upon 
NMDA receptor surface expression may be an artefact of TRAK1 overexpression 
there is clearly a robust association between TRAK1 and GLuN2B that is worthy of 
further investigation. 
Although not investigated here it would be interesting to see what effect TRAK1 
knockdown has on NMDA surface expression. As overexpressed TRAK1 is largely 
mitochondrial, endogenous TRAK1 has been shown to be additionally localised to 
early endosomes (Webber et al., 2008) and therefore could be involved in receptor 
recycling. Knock down of TRAK1 could increase surface expression through lack of 
endocytosis of inserted receptors or could cause a decrease in surface expressed 
receptors by blocking recycling of receptors as it does with EGF stimulated EGFR 
degradation (Webber et al., 2008). 
Improvements could have been made to the methods although the script used was 
specifically designed for the analysis of these experiments as a way to determine if 
effects which may be subtle to the eye could be analysed. The quantification of the 
surface intensity of the NMDA receptor provided a numerical value to the level of 
staining at the surface so any observed effect of due to a particular overexpressed 
protein could be determined. This could have been improved by taking a Z-stack of 
the image and quantifying each layer of the cell to build up a 3D image of the cell 
and it surface expression levels. This, however the time taken to acquire all these 
images would have been much greater so to take all the images from each 
experiment on the same day would result in a lower number of replicates and 
ultimately less confidence in the results generated. New super-resolution 
microscopes could improve the image quality and allow for greater clarity of any co-
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localisation and the location within the cell of that co-localisation however I have 
looked at the surface expression rather than the co-localisation of two proteins in 
the results of this chapter so acquiring super-resolution images may not add much 
more information to the image.  
The lab already has data demonstrating that endogenous DISC1, TRAK1 and NDE1 
can be co-immunoprecipitated from brain, thus it is possible that these proteins 
form a complex that regulates NMDA receptor surface expression. This function 
could be influenced by the DISC1 sequence variant 607F: for example altered 
binding efficiencies could lead to decreased trafficking complex formation and 
therefore decreased surface expression. Furthermore the complex could also be 
regulated by phosphorylation events on NDE1 which cause disruption of the 
complex. 
Additionally DISC1, NDE1 and TRAK1 are all expressed in neurons (Bradshaw et al., 
2008, Hayashi-Takagi et al., van Spronsen et al.), so it would be interesting to 
determine if NDE1 or TRAK1 or the DISC1 variants have any effect on NMDA 
receptor surface expression in neurons. I showed here that in COS7 cells they may 
be involved in the trafficking of the NMDA receptor and showed in chapter 4 co-
localisation of; TRAK1, GluN1 and GluN2B; NDE1, GluN1 and GluN2B; and DISC1, 
GluN1 and GluN2B subunits in hippocampal neurons. Therefore it is conceivable 
that they form a complex in neurons and may affect NMDA receptor surface 
expression, however the NMDA receptor is a highly dynamic receptor which is 
constantly inserted and endocytosed from the membrane so additional information 
about how these proteins modulate surface NMDA receptor expression is needed, 
do they alter the trafficking from the ER? Or do they affect the endocytosis when 
the NMDA receptor is internalised? Or can they affect the re-insertion of the 
receptor into the plasma membrane? Some of this will be the focus of the next 
chapter. 
Altogether these results show that wild type DISC1 and the variants 704C and 37W 
do not affect the surface expression of the NMDA receptor. The DISC1 variant 607F 
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significantly decreases surface expression in COS7 cells as do NDE1-131E, TRAK1 
and TRAK1-678R. Thus DISC1 and its binding partners have the ability to modulate 
the surface expression of the NMDA receptor in COS7 cells.  
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6 Investigating a role for DISC1 






To determine if DISC1,DISC1-L607F,NDE1, or NDE1 phosphosite mutants have any 
effect upon surface-labelled NMDA receptor internalisation in COS7 cells. 
6.2 Introduction 
6.2.1 NMDA receptor endocytosis 
Endocytosis is a fundamental mechanism by which cells regulate intracellular 
signalling, cell to cell communication, synaptic strength and synaptic maturation 
(amongst many other things).  In the case of the NMDA receptor, endocytosis 
occurs by the assembly of clathrin coated vesicles and budding of clathrin coated 
vesicles from the plasma membrane. This process is tightly regulated and governed 
by subunit-specific motifs. 
The GluN2B subunit can bind directly to PSD95, via its PDZ domain, which stabilizes 
the NMDA receptors at the surface membrane and suppresses GluN2B mediated 
internalisation. Deletion of the PDZ domain in the GluN2B subunit significantly 
increases internalisation of NMDA receptors. GluN2B contains an internalization 
signal (YEKL) within the distal C-terminus (Roche et al., 2001). This signal is part of a 
well characterised family of tyrosine-based internalisation signals present in the 
membrane proteins (Bonifacino and Dell'Angelica, 1999). This motif acts as a 
recognition motif for the endocytic adaptor protein AP2 linking the NMDA receptor 
to clathrin coated vesicles (Lavezzari et al., 2003, Roche et al., 2001, Carroll and 
Zukin, 2002). Deletion of the YEKL signal in GluN2B inhibits GluN2B internalisation 
(Roche et al., 2001). 
 After internalisation the NMDA receptor localises with transferrin and therefore 
the early endosome. Once the receptor has been internalised, there is a subunit 
specific intracellular trafficking pathway. GluN1/GluN2B homodimers have been 
shown to predominantly follow a recycling pathway as the receptors localise to 
RAB5 before localising to RAB11 (Takahashi et al., 2012). The receptor can then be 
re-inserted into the plasma membrane, which all occurs within 30 minutes 
(Lavezzari et al., 2003, Lavezzari et al., 2004, Tang et al., 2010), and the receptor is 
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thought to be continuously cycled through this pathway. GluN1/GluN2A 
homodimers predominantly follow a degradative pathway as they initially co-
localise with RAB5 before co-localising with RAB7, which is a marker for the late 
endosome (Lavezzari et al., 2003, Lavezzari et al., 2004, Tang et al., 2010), and 
therefore are thought to be predominantly degraded after internalisation. 
 
6.2.2 DISC1, NDE1 and TRAK1 in recycling 
Although not directly investigated yet, DISC1 has been reported to co-localise with 
RAB11 in neurons, opening up a potential role in recycling of receptors (Lepagnol-
Bestel et al., 2013). Furthermore the authors of this paper also found DISC1 not to 
co-localise with RAB7 indicating that DISC1 may not play a role in degradation 
pathways. However, as we shall see later, my more in-depth study has not 
replicated this latter observation. 
Currently NDE1 has not been shown to be directly linked to any RAB proteins, but 
NDE1 is known to regulate the positioning of organelles, with knockdown of NDE1 
causing slight mis-positioning of endocytic compartments and depletion of dynein 
from membranes, both of which could affect the internalisation of cell surface 
proteins (Lam et al., 2009). Also, recently RAB11 (through an interacting protein 
RAB11-FIP3) was shown to link to dynein and mediate transport of material from 
peripheral sorting endosomes to the recycling endosome (Horgan et al., 2010). This 
potentially links NDE1 to RAB11 and recycling pathways as the NDE1/LIS1/NDEL1 
complex is required for dynein function.  
Taken together the literature suggests DISC1 and NDE1 could play a role in receptor 
endocytosis and, as I have previously described, they both associate with the NMDA 
receptor and can alter the surface expression of NMDA receptors in COS7 cells. In 
this chapter I use an internalisation assay to determine the effect of DISC1 or NDE1 
on the endocytosis of NMDA receptors by studying co-localisation of the NMDA 




6.3 Results  
6.3.1 Optimisation of the internalisation assay 
Fluorescent mCherry-tagged RAB5 and RAB7 were used to determine if DISC1 or 
NDE1 play a role in NMDA receptor endocytosis or degradation. In the basic assay 
COS7 cells are transfected with plasmid constructs expressing GluN1, HA-GluN2B 
plus mCherry-RAB5 or mCherry-RAB7. The cells are stained live with an anti-HA 
antibody at 4 °C to label surface-expressed NMDA receptors, fixed, and stained for 
total GluN1. Under these conditions there is little co-localisation between surface 
HA-labelled NMDA receptors and the intracellular fluorescently tagged RAB 
proteins. To examine endocytosis, after surface HA-labelling the cells are incubated 
at 37 °C which allows HA-tagged receptor internalisation. The incubation time is 
critical because a 15 minute incubation leads to surface-labelled receptor/RAB5 co-
localisation, and a 30 minute incubation allows the endocytic pathway to proceed 
further leading to surface-labelled receptor/RAB7 co-localisation (Scott et al., 2004, 
Lavezzari et al., 2004, Tang et al., 2010). These published studies were carried out 
using COS7 cells and are therefore applicable to this assay. For this assay I will use a 
15 minute incubation at 37 °C as I want to determine the effect of DISC1 or NDE1 
upon NMDA receptor internalisation. I will analyse the effect of these proteins on 
the co-localisation between NMDA receptors and the early and late endosomes. 
When expressed individually in COS7 cells RAB5 and RAB7 appear as variably sized 
puncta throughout the cytoplasm and are often highly concentrated in the 
perinuclear region of the cell (Figure 6.1 A, B). When subjected to a 15 minute 
incubation at 37oC the localisation of neither RAB5 nor RAB7 is significantly altered 
(Figure 6.1 C, D) 
Under control conditions (i.e. incubation at 4 °C) COS7 cells co-transfected with 
GluN1, HA-GluN2B and mCherry-RAB5 show no co-localisation between surface-
labelled NMDA receptors and RAB5, and moderate co-localisation between NMDA 
receptors detected post-fixation using the GluN1 antibody (total NMDA receptors) 
and RAB5, as expected (Figure 6.1 E-H). After incubation at 37 °C the NMDA 
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receptors are markedly different, appearing as larger structures whether 
surface/internalised or the total receptor population is detected (Figure 6.1 I). There 
is also clear co-localisation of the HA-labelled NMDA receptors with RAB5 (Figure 
6.1 J-L and see later figures for quantification). This is in agreement with previous 
studies which showed co-localisation between tac-GluN2B chimeras (containing the 
first 20 amino acids of the C-terminal tail) and GFP-RAB5 after incubation at 37 °C 
(Scott et al., 2004).  
In cells transfected with GluN1, GluN2B and mCherry RAB7 there is little co-
localisation between surface-labelled NMDA receptors and RAB7 under control 
conditions (Figure 6.1 M-P), although total NMDA receptor staining as detected 
with the anti-GluN1 antibody post-fixation, exhibits partial co-localisation with the 
RAB7 signal, as would be expected. After incubation, there remains little co-
localisation between the NMDA receptors and RAB7 (Figure 6.1 Q-T), which is in 
accordance with the published literature. 
This optimisation shows that the assay I have developed detects NMDA receptor 
internalisation along the endocytic pathway to early endosomes/sorting endosomes 
where RAB5 is located. I will now examine the effects of DISC1 and DISC1-607F 
upon the co-localisation of RAB5 and RAB7 with NMDA receptors. Because DISC1-
607F causes a decrease in surface-expressed NMDA receptors, I will use this assay 
to try to understand whether the mechanism by which the 607F variant exerts this 
effect involves endocytosis. Additionally the effects of NDE1, NDE1-131A and NDE1-
131E will be studied because NDE1-131E causes decreased NMDA receptor surface 






Figure 6.1 Optimisation of recycling assay  
mCherry-tagged RAB5 (A) and RAB7-expressing (B) constructs were singly transfected into 
COS7 cells. C and D show mCherry-RAB5 or mCherry-RAB7 transfected COS7 cells after a 15 
minute incubation at 37 °C which allows internalisation of the surface NMDA receptors. 
Expression of RAB5 and RAB7 is still detectable after incubation.  
COS7 cells were also co-transfected with GluN1, HA-GluN2B and mCherry-RAB5. GluN2B 
was surface labelled at 4 °C and then cells were either incubated at 4 °C for 15 mins (E-F) or 
at 37 °C (I-L). Incubation at 37 °C caused internalisation of the surface expressed NMDA 
receptors (I) and increase in RAB5 surface NMDA receptor co-localisation (L).  
In addition, COS7 cells were transfected with GluN1, HA-GluN2B and mCherry-RAB7. 
GluN2B was surface labelled at 4 °C and cells were then incubated at either 4 °C for 15 mins 
(M-P) or at 37 °C for 15 mins (Q-T). Again the surface-labelled NMDA receptors became 
internalised (Q) but co-localisation with RAB7 was unchanged following incubation at 37oC. 
Areas of cells encompassed by white boxes are enlarged to the right in the top row and 
below in the next two rows.n=3, Scale bars 20 µm. Images G, K, O and S were 






6.3.2 Quantification of signals 
 
Images of the cells were captured using a Nikon A1R confocal microscope; the same 
settings (laser power, offset, gain and pinhole size) were used when taking all the 
images for each experiment. The images for each experiment were taken at the 
same time to allow for direct comparison between the images. Once the images 
were acquired they were opened in the imaging programme ImageJ and using the 
plugin “co-localisation threshold” the image was analysed and the Pearsons 
coefficient was generated to indicate the level of co-localisation between two of the 
chosen proteins (e.g. RAB5/surface labelled NMDA receptors or RAB5/DISC1). To 
ensure only the co-localisation from the cell of interest was measured, a region of 





6.3.3 DISC1 co-localises with RAB5- and RAB7-positive 
structures  
 
I first investigated whether DISC1 co-localises with components of the endocytic 
pathway, to determine whether any effects upon NMDA receptor endocytosis may 
be due to direct effects upon the endocytic machinery, upon NMDA receptors, or 
both. I began by analysing co-localisation of DISC1 and DISC1-607F with RAB5. An 
association between DISC1 and markers of the early endocytic pathway has not 
previously been demonstrated. However I found that DISC1 shows partial co-
localisation with RAB5 (Figure 6.2 A-C) under control conditions. After incubation at 
37oC the level of co-localisation between DISC1 and RAB5 increases slightly (Figure 
6.2 D-F). DISC1-607F also shows partial co-localisation with RAB5 under control 
conditions (Figure 6.2 G-I).This is unchanged by incubation at 37 oC (Figure 6.2  J-L). 
One-way ANOVA demonstrated that there was no significant effect of incubation, or 
of the variant, upon co-localisation between DISC1 or DISC1-607F and RAB5 (Figure 
6.2 M). Altogether therefore, these data demonstrate that DISC1 co-localises with a 
marker of the early endocytic pathway, and that this association with early 






Figure 6.2 Co-localisation of RAB5 and DISC1 or DISC1-607F is unaffected by 
incubation at 37oC.  
COS7 cells co-transfected with plasmid constructs expressing GluN1, HA-GluN2B, mCherry-
RAB5 and FLAG-DISC1 were labelled live for surface NMDA receptors and then either 
maintained at 4 °C or incubated at 37 °C for 15 minutes to allow for receptor 
internalisation. Cells maintained at 4 °C showed moderate co-localisation between DISC1 
(A) and RAB5 (B merge C). After incubation at 37 °C there was no change in co-localisation 
of DISC1 (D) and RAB5 (E merge F). COS7 cells co-transfected with GluN1, HA-GluN2B, 
mCherry-RAB5 and FLAG-DISC1-607F were treated in the same way. Cells maintained at 4 
°C showed moderate co-localisation between DISC1-607F (G) and RAB5 (H merge I). After 
incubation at 37 °C there was no change in co-localisation of DISC1-607F (J) and RAB5 (K 
merge L). Scale 20  µm 
Histogram (M) represents Pearsons co-localisation coefficient taken from 20 cells per 
condition per experiment from three independent experiments, total=60 cells per 





I also analysed co-localisation between RAB7 and DISC1 or DISC1-607F to determine 
if this occurs and if there is any change after incubation at 37oC. Cells co-expressing 
DISC1 and RAB7 which were not subjected to incubation showed moderate co-
localisation (Figure 6.3 A-C). After incubation there was no change in co-localisation 
between DISC1 and RAB7 (Figure 6.3 D- F). Similarly cells expressing DISC1-607F and 
RAB7 under control conditions showed moderate co-localisation (Figure 6.3 G-I). 
After incubation the level of co-localisation was largely unchanged (Figure 6.3 J-L). 
Furthermore, comparison of DISC1 co-transfected cells and DISC1-607F co-
transfected cells using one-way ANOVA showed no significant difference in RAB7 
co-localisation either before or after incubation (Figure 6.3 M).  
Altogether these data demonstrate that DISC1 co-localises stably with a proportion 
of early and late endosomes, and that this association appears to be unaffected by 





Figure 6.3 RAB7 association with DISC1 and DISC1-L607F 
COS7 cells were transfected with GluN1, HA-GluN2B, mCherry-RAB7 and either FLAG-DISC1 
or FLAG-DISC1-607F. The cells were stained live for surface NMDA receptors and then 
either maintained at 4 °C or incubated at 37 °C for 15 minutes to allow for internalisation of 
the NMDA receptors. Cells were then stained for total GluN1 and DISC1 and imaged. Non-
incubated cells show some co-localisation of DISC1 (A) and RAB7 (B merge C). This was 
unaltered after a 15 minute incubation at 37 °C (D-F). Similarly in non-incubated cells 
DISC1-607F (G) co-localised with RAB7 (H merge I). After incubation DISC1-607F (J) exhibits 
similar co-localisation with RAB7 (K merge L). Scale 20 µm. 
Histogram (M) represents the Pearsons co-efficient of co-localisation between DISC1 and 
RAB7 and DISC1-607F and RAB7 before and after incubation at 37 °C. 20 cells per condition 
from three independent experiments, total=60 cells per condition. Error bars represent 





6.3.4 NDE1 co-localises with RAB5- and RAB7-positive 
structures 
 
Next, co-localisation of RAB5 with NDE1, NDE1-131A or NDE1-131E was measured 
to determine whether 1) NDE1 associates with early endocytic vesicles 2) any co-
localisation with RAB5 is influenced by the phosphosite mutations, and 3) there is 
any effect of incubating the cells at 37 °C. Under basal conditions, NDE1 staining 
appeared as described in chapter 4. It is punctate in appearance and distributed 
throughout the cytoplasm (Figure 6.4 A). RAB5 (Figure 6.4 B) appeared as described 
in 6.3.1 and there is moderate co-localisation between the two proteins (Figure 6.4 
C). After incubation the staining pattern of NDE1 appears largely unchanged (Figure 
6.4 D and E). Similarly, under basal conditions there is moderate co-localisation 
between RAB5 and NDE1-131A (Figure 6.4 G-I) or NDE1-131E (Figure 6.4 M-O). 
After incubation there is a small decrease in the co-localisation between; RAB5 and 
NDE1 (Figure 6.4 D-F), RAB5 and NDE1-131A (Figure 6.4 J-L) and RAB5 and NDE1-





Figure 6.4 RAB5 co-localises with NDE1 
COS7 cells were transfected with GluN1, HA-GluN2B, mCherry-RAB5 and either V5-NDE1, 
V5-NDE1-131A or V5-NDE1-131E. The cells were maintained at 4oC for 15 minutes or 
incubated at 37oC to promote receptor endocytosis. Cells were then fixed and stained for 
total NDE1 or phosphomutant NDE1. NDE1 (A) co-localises with RAB5 (B merge C) and this 
decreases slightly after incubation (D-F). NDE1-131A (G) co-localises with RAB5 (H merge I) 
under basal conditions. Incubation slightly decreases the co-localisation (J-L). Similarly 
NDE1-131E (M) co-localises with RAB5 (N merge O). Incubation slightly decreases this co-
localisation (P-R). Scale 20 µm 
Histogram (S) represents Pearsons co-efficient taken from 20 images per condition per 
experiment from 3 independent experiments, total=60 cells per condition. Error bars 




Co-localisation between RAB7 and NDE1, NDE1-T131A and NDE1-T131E was then 
investigated to determine whether NDE1 may associate with late endocytic vesicles, 
and to find out if there are any effects of the phosphosite mutants, or of incubating 
the cells at 37 °C. Cells co-expressing NDE1, under control conditions gave a robust 
staining pattern for NDE1 (Figure 6.5 A), strong RAB7 staining (Figure 6.5 B) and 
there was moderate co-localisation between the two proteins (Figure 6.5 C). After 
incubation there was no change in the co-localisation of NDE1 and RAB7 (Figure 6.5 
D-E). Similarly in cells co-expressing NDE1-131A there was robust NDE1-131A 
(Figure 6.5 G) and RAB7 signal (Figure 6.5 H) with moderate co-localisation between 
the two proteins (Figure 6.5 I). After incubation there was no change in the amount 
of co-localisation between NDE1-131A and RAB7 (Figure 6.5 J-L). Cells co-expressing 
NDE1-131E under control conditions gave robust staining of NDE1-131E (Figure 6.5 
M) and RAB7 (Figure 6.5 N) with moderate co-localisation (Figure 6.5 O). Analysis of 
NDE1/RAB7 co-localisation using one-way ANOVA found no significant effects of the 
phosphosite mutants, or of incubation at 37oC, thus this association appears to be 
stable. 
As observed for DISC1, it is apparent that NDE1 co-localises with early and late 
endosomes, and that this association is unaffected by internalisation events, or by 





Figure 6.5 NDE1/RAB7 co-localisation 
COS7 cells were transfected with GluN1, HA-GluN2B and mCherry-RAB7, and either empty 
vector (EV), V5-NDE1, V5-NDE1-131A or V5-NDE1-131E. GluN2B was surface-labelled at 4 °C 
and either incubated at 37 °C for 15 minutes to allow for receptor internalisation, or at 4 °C 
for 15 minutes as a control (surface NMDA receptor labelling is shown in Figure 6.1). NDE1 
(A) co-localises with RAB7 (B,C) in control cells and this is unchanged after incubation (D-F). 
NDE1-131A (G) co-localises with RAB7 (H,I) under control conditions and this is unchanged 
after incubation (J-L). NDE1-131E (M) co-localises with RAB7 (N,O) under control conditions 
and this is unchanged after incubation (P-R). Scale 20 µm. 
Histogram (S) shows Pearsons co-efficient of RAB7 and NDE1 or phosphomutant NDE1 co-
localisation. 20 images were taken per condition in 3 independent experiments, total=60 
cells per condition. Error bars represent SEM. Images A, D, G, J, M and P were 




6.3.5 DISC1-607F may inhibit internalisation of surface-
expressed NMDA receptors 
 
I next wanted to investigate whether DISC1 and/or NDE1 influence NMDA receptor 
internalisation, beginning with DISC1. COS7 cells were transfected with plasmid 
constructs expressing GluN1, HA-GluN2B, mCherry-RAB5 and either DISC1, DISC1-
607F or corresponding empty vector (EV). Cells were stained live for surface NMDA 
receptors using the anti-HA antibody, and then incubated for 15 minutes at either 4 
°C or 37oC. In cells co-expressing EV there is little co-localisation between surface-
labelled NMDA receptors and RAB5 (Figure 6.6 A-C). After incubation the surface-
labelled NMDA receptors become internalised and exhibit some co-localisation with 
RAB5 (Figure 6.6 D-F). This was to be expected as it has been found previously that 
upon internalisation NMDA receptors co-localise with RAB5 (Scott et al., 2004). 
DISC1 transfected cells similarly show little co-localisation between surface-labelled 
NMDA receptors and RAB5, compared to that observed in EV-transfected cells 
under basal conditions (Figure 6.6 G-I). After incubation there is an increase in co-
localisation of surface-labelled NMDA receptors and RAB5 (Figure 6.6 J-L). DISC1-
607F expressing cells similarly show limited co-localisation between surface-labelled 
NMDA receptors and RAB5 (Figure 6.6 M-O), equivalent to that of EV or DISC1-
transfected cells under basal conditions. But in this case, following incubation, 
surface-labelled NMDA receptor co-localisation with RAB5 remains approximately 
the same, indicating a possible inhibitory effect of the 607F variant (Figure 6.6 P-R). 
One-way ANOVA indicates a significant effect of incubation at 37oC upon NMDA 
receptor/RAB5 co-localisation (Figure 6.6 S, p=0.02). Post-hoc testing using 
Bonferroni’s Pairwise Comparison Test revealed that this is due to increased 
surface-labelled NMDA receptor/RAB5 co-localisation in EV-transfected cells 
following incubation (p<0.05), an effect that is not seen in cells transfected with 
DISC1-607F. In cells transfected with DISC1, there is increased receptor/RAB5 co-
localisation following incubation, but this does not survive correction for multiple 
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testing (p<0.05 without correction for multiple comparisions, p>0.05 following 
correction). These data therefore indicate that DISC1-607F likely inhibits NMDA 
receptor recruitment to RAB5-positive structures following incubation at 37oC. 
Alternatively, it is possible that in the presence of DISC1-607F, NMDA receptors 
proceed more quickly along the endocytic pathway, with the result that no effect is 






Figure 6.6 DISC1-607F blocks NMDA receptor recruitment to RAB5-positive 
structures following incubation at 37oC.  
COS7 cells were transfected with GluN1, HA-GluN2B and mCherry-RAB5, and either empty 
vector (EV), FLAG-DISC1 or FLAG-DISC1-607F. Cells were surface labelled at 4 °C and either 
incubated at 37 °C for 15 minutes to allow for receptor internalisation or at 4 °C for 15 
minutes as a control. In EV-transfected cells there was a significant increase in co-
localisation after incubation (A-F). DISC1 co-transfected cells showed no change in surface 
NMDA receptor co-localisation with RAB5 (G-L) after incubation at 37oC. DISC1-607F co-
expressing cells also do not exhibit a change in surface NMDA receptor co-localisation with 
RAB5 after incubation at 37oC (M-R). Scale bars 20 µm. 
Histogram (S) represents the Pearsons co-efficient of co-localisation of surface labelled 
NMDA receptors and RAB5. Data represents 20 images per condition from three 




To examine this further, I next determined if DISC1 or DISC1-607F have any effect 
on NMDA receptor co-localisation with RAB7, a marker of late endosomes, where it 
is possible I would detect increased NMDA receptor localisation if their transit along 
the endocytic pathway has been accelerated. COS7 cells were transfected with 
plasmid constructs expressing GluN1, HA-GluN2B, RAB7 and either EV, DISC1 or 
DISC1-607F and treated as described in 6.3.1. EV-transfected cells show little co-
localisation between surface labelled NMDA receptors and RAB7 before incubation 
(Figure 6.7 A-C), or after incubation at 37oC (Figure 6.7 D-F). DISC1-expressing cells 
under control conditions also show limited co-localisation between surface-labelled 
NMDA receptors and RAB7 before (Figure 6.7 G-I) or after incubation (Figure 6.7 J-
L). Similarly, DISC1-607F-expressing cells show limited co-localisation between 
surface-labelled NMDA receptors and RAB7 before (Figure 6.7 M-O) or after 
incubation (Figure 6.7 P-R). 
One-way ANOVA detected no effects of DISC1, the DISC1 607F variant or incubation 
at 37oC (Figure 6.7 S). It therefore appears that the effect of the 607F variant is most 
likely inhibition of NMDA receptor internalisation, rather than promotion of faster 





Figure 6.7 Surface-labelled NMDA receptor non co-localisation with RAB7 is 
unaffected by DISC1. 
COS7 cells were transfected with GluN1, HA-GluN2B and mCherry-RAB7, and either EV, 
FLAG-DISC1 or FLAG-DISC1-607F. The cells were surface labelled at 4 °C and either 
incubated at 37 °C for 15 minutes to allow for receptor internalisation or at 4 °C for 15 
minutes as a control. In EV (A-F), DISC1 (G-L) or DISC1-607F (M-R) transfected cells there 
was no change in surface NMDA receptor co-localisation with RAB7 after incubation. Scale 
bar 20 µm 
Histogram (S) shows Pearsons co-efficient of co-localisation taken from 20 cells per 





6.3.6 DISC1-L607F co-localises more strongly with surface 
NMDA receptors than DISC1, prior to internalisation 
 
I next measured DISC1 and DISC1-607F co-localisation with surface labelled NMDA 
receptors. An association of DISC1 and the GluN1 subunit has been previously 
shown (S.Mackie unpublished) however co-localisation at the surface of the cell had 
not yet been investigated. My studies now show there is co-localisation between 
DISC1 and surface labelled NMDA receptors at 4 °C (Figure 6.8 A-C). After 
incubation at 37 °C there is no change in co-localisation between DISC1 and surface 
labelled NMDA receptors (Figure 6.8 D-F). Similarly, cells co-transfected with DISC1-
607F show no significant difference in co-localisation between DISC1-607F and 
surface labelled NMDA receptors after incubation at 37 °C (Figure 6.8 G-L). There is, 
however, increased NMDA receptor/DISC1 co-localisation at 4oC in the presence of 
the 607F variant. 
One-way ANOVA confirmed a significant effect between the amount of co-
localisation between DISC1 and surface expressed NMDA receptors and DISC1-607F 
and surface expressed NDMA receptors (p=0.02, Figure 6.8 M) and post-hoc 
pairwise Bonferroni testing revealed a significant difference between the levels of 
co-localisation of DISC1/surface labelled NMDA receptors and DISC1-607F/surface 
labelled NMDA receptors at 4 °C (p<0.01). Altogether therefore, these data 
demonstrate that DISC1 co-localises with surface labelled NMDA receptors, and that 
this association appears to be stable following internalisation. Also there appears to 
be a more robust co-localisation between surface labelled NMDA receptors with 





Figure 6.8 The DISC1 607F variant increases DISC1 association with surface NMDA 
receptors  
COS7 cells co-transfected with plasmid constructs expressing GluN1, HA-GluN2B, mCherry-
RAB5 and FLAG-DISC1 were labelled live for surface NMDA receptors and then either 
maintained at 4 °C or incubated at 37 °C for 15 minutes to allow for receptor 
internalisation. Cells maintained at 4 °C showed some co-localisation between DISC1 (A) 
and surface labelled NMDA receptors (B merge C). After incubation at 37 °C there was no 
change in co-localisation of DISC1 (D) and surface labelled NMDA receptors (E merge F). 
COS7 cells co-transfected with GluN1, HA-GluN2B, mCherry-RAB5 and FLAG-DISC1-607F 
were treated in the same way. Cells maintained at 4 °C showed moderate co-localisation 
between DISC1-607F (G) and surface labelled NMDA receptors (H merge I). After incubation 
at 37 °C there was a significant decrease in co-localisation between DISC1-607F (J) and 
surface labelled NMDA receptors (K merge L). Scale 20 µm 
Histogram (M) represents Pearsons co-localisation coefficient taken from 20 cells per 
condition per experiment from three independent experiments, total=60 cells per 
condition.** P<0.01 . Error bars represent SEM. Images B, E, H and K were pseudocolored 




6.3.7 Investigating the effects of NDE1 and NDE1 
phosphositemutants upon NMDA receptor 
internalisation 
COS7 cells were transfected with GluN1, HA-GluN2B, mCherry-RAB5 and either EV, 
NDE1, NDE1-131A or NDE1-131E. In EV-transfected cells, under control conditions, 
there is strong NMDA receptor surface-labelled expression and RAB5 expression but 
with little co-localisation apparent (Figure 6.9A-C). After incubation, the surface-
labelled NMDA receptors become internalised and there is substantial co-
localisation of HA and RAB5 signals as expected (Figure 6.9 D-F). NDE1-transfected 
cells, under control conditions, exhibit strong surface-labelled NMDA receptor 
expression and RAB5 expression (Figure 6.9 G-I), but weak co-localisation between 
surface-labelled NMDA receptors and RAB5, which increases following incubation at 
37oC (Figure 6.9 J-L). NDE1-131A and NDE1-131E co-transfected cells similarly show 
limited co-localisation between surface-labelled NMDA receptors and RAB5 (M-O, 
S-U, respectively) that increases following incubation at 37oC (Figure 6.9 P-R, V-X, 
respectively). Taken together this data shows that the expected increase in surface-
labelled NMDA receptors with RAB5 occurs after incubation at 37 °C. Co-
transfection with NDE1 slightly increases co-localisation of surface labelled NMDA 
receptors with RAB5 under control conditions, but does not greatly affect the 
increase in co-localisation of surface labelled NMDA receptors with RAB5 observed 
after incubation. Phosphomutants NDE1-131A and NDE1-131E have no effect on 
the increase in surface labelled-NMDA receptor co-localisation with RAB5 after 
incubation. 
Analysis of the data using one-way ANOVA indicated an overall significant effect on 
the co-localisation of NMDA receptors and RAB5 after incubation at 37 °C (Figure 
6.9 Y, p=0.0004), which post-hoc Bonferroni pairwise tests revealed to be due to 
increased NMDA receptor/RAB5 co-localisation after incubation at 37oC in the 
presence of EV (p<0.01), NDE1-131A (p<0.01) or NDE1-131E (p<0.05). The same 
trend was apparent in NDE1-transfected cells although this did not reach 
significance (p<0.05 without correction for multiple comparisons, p>0.05 following 
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correction). This is most likely because of the slightly higher baseline co-localisation 
between surface-labelled NMDA receptors and RAB5 in NDE1-expressing cells, 
although this difference is only significant prior to correction for multiple testing 
(co-localisation in EV vs NDE1-transfected cells, p<0.05 without correction for 
multiple comparisons, p>0.05 following correction (Figure 6.9 Y). I therefore 
speculate that NDE1 may weakly promote initial association of NMDA receptors 





Figure 6.9 RAB5 co-localisation with surface NMDA receptors is unaltered by the 
presence of NDE1 or NDE1 phospho-mutants. 
COS7 cells were transfected with GluN1, HA-GluN2B and mCherry-RAB5, and either empty 
vector (EV) (A-F), V5-NDE1 (G-L), V5-NDE1-131A (M-R) or V5-NDE1-131E (S-X). The cells 
were surface-labelled at 4 °C and either incubated at 37 °C for 15 minutes to allow for 
receptor internalisation or at 4 °C for 15 minutes as a control. In all transfected cells there 
was an increase in surface-labelled NMDA receptor co-localisation with RAB5 after 
incubation. Scale bars 20 µm.  
Histogram (Y) represents Pearsons co-efficient for RAB5 surface NMDA receptor co-
localisation. Values were generated from 20 images per condition from three independent 
experiments, total=60 cells per condition. **p<0.01, error bars represent SEM.  
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I next examined whether there is any effect of NDE1 expression upon NMDA 
receptor association with RAB7-positive late endosomes. COS7 cells were 
transfected with GluN1, HA-GluN2B, mCherry-RAB7 and either EV, V5-NDE1, V5-
NDE1-131A or V5-NDE1-131E. There was little co-localisation between surface 
NMDA receptors and RAB7 before or after incubation at 37oC (Figure 6.10 A-F). Co-
expression of V5-NDE1, either wild-type or mutant, slightly increased surface-
labelled NMDA receptor/RAB7 co-localisation (Figure 6.10 G-X) After incubation at 
37oC to allow receptor internalisation there was no change in receptor/RAB7 co-
localisation, and this was unaffected by co-expression of V5-NDE1, either wild-type 
or mutant (Figure 6.10 Y). 
Analysis using one-way ANOVA found that there is no significant effect of NDE1 or 
the phosphosite mutants upon surface-labelled NMDA receptor non co-localisation 





Figure 6.10 RAB7 co-localisation with surface-labelled NMDA receptors is not 
changed by the presence of NDE1 or phosphosite mutants 
COS7 cells were transfected with GluN1, HA-GluN2B and mCherry-RAB7, and either empty 
vector (EV) (A-F), NDE1 (G-L), NDE1-131A (M-R)  or NDE1-131E (S-X). The cells were surface 
labelled at 4 °C and either incubated at 37 °C for 15 minutes to allow for receptor 
internalisation or at 4 °C for 15 minutes as a control. Scale bar 20 µm.  
Histogram (Y) represents Pearsons co-efficient for co-localisation between surface NMDA 
receptor and RAB7. 20 images per condition in three independent experiments, total=60 




6.3.8 NDE1 and surface labelled NMDA receptors 
 
In addition to the measurement of NDE1 co-localisation with RAB5, I measured co-
localisation between surface labelled NMDA receptors and NDE1 or NDE1-131A or 
NDE1-131E. There was co-localisation between NDE1 and surface labelled NMDA 
receptors (Figure 6.11 A-C) when incubated at 4 °C. After incubation at 37 °C to 
allow receptor internalisation, there was a decrease in co-localisation between 
NDE1 and surface labelled NMDA receptors (Figure 6.11 D-F). Cells co-transfected 
with NDE1-131A and NDE1-131E had similar levels of co-localisation to NDE1 
transfected cells when incubated at 4oC (Figure 6.11 G-I and M-O respectively).  
Similarly after incubation at 37oC there was a decrease in co-localisation between 
NDE1-131A and surface labelled NMDA receptors Figure 6.11 J-L) and NDE1-131E 
and surface labelled NMDA receptors (Figure 6.11 P-R). 
One way ANOVA revealed a significant effect of incubation at 37oC upon 
receptor/NDE1 co-localisation (p=0.007). Post-hoc pairwise Bonferroni testing 
revealed this effect is due to a significant decrease in NMDA receptor/NDE1 and 
NMDA receptor/NDE1-131A co-localisation following internalisation (p<0.05 for 
both comparisons). The decrease in NMDA receptor/NDE1-131E co-localisation did 
not survive correction for multiple testing (p<0.05 prior to multiple comparisons 
test, p>0.05 following the test), but the trend is the same. 
This decrease in NMDA receptor/NDE1 co-localisation following receptor 
internalisation is consistent with my earlier suggestion that NDE1 may promote 
receptor association with the endocytic machinery prior to onset of internalisation; 
if NDE1 promotes the association with the endocytic machinery, it may then 
dissociate from the receptor once internalisation has taken place, although we 
might expect that the association would be maintained in order to promote dynein-




Figure 6.11 Incubation at 37oC decreases surface-labelled NMDA receptor and 
NDE1 co-localisation 
COS7 cells were transfected with GluN1, HA-GluN2B and mCherry-RAB5, and either V5-
NDE1 (A-F), V5-NDE1-131A (G-L) or V5-NDE1-131E (M-R). The cells were surface-labelled at 
4 °C and either incubated at 37 °C for 15 minutes to allow for receptor internalisation or at 
4 °C for 15 minutes as a control. In all transfected cells there was a decrease in surface-
labelled NMDA receptor co-localisation with V5-NDE1, V5-NDE1-131A  and V5-NDE1-131E 
after incubation. Scale bars 20 µm.  
Histogram (S) represents Pearsons co-efficient for V5-NDE1 surface NMDA receptor co-
localisation. Values were generated from 20 images per condition from three independent 
experiments, total=60 cells per condition. *p<0.05, error bars represents SEM. Images B, E, 







NMDA receptor endocytosis is a highly regulated process, the exact mechanisms of 
which are still unknown. The results from this chapter suggest an involvement for 
both DISC1 and NDE1, potentially shining light on new areas of the mechanism. 
I analysed co-localisation between DISC1 or DISC1-607F and RAB5 or RAB7, markers 
of endocytic vesicles/early endosomes and late endosomes, respectively. A 
proportion of DISC1 and RAB5 co-localise under control conditions, suggesting that 
DISC1 co-localises with endocytic vesicles/early endosomes, although additional 
work is required before firm conclusions can be made about this. Such work could 
include subcellular fractionation to isolate endosomes, additional co-localisation 
work in other cell types including neurons, and higher resolution microscopy. 
DISC1/RAB5 co-localisation is little changed following incubation at 37 °C, likely 
indicating a consistent level of association of DISC1 with early endosomes. The 607F 
variant has little effect upon DISC1 co-localisation with RAB5, suggesting it does not 
affect the association of DISC1 with early endosomes. Further to this, analysis of co-
localisation between RAB7 and DISC1 showed a moderate association of DISC1 with 
late endosomes, which is also unchanged after incubation at 37oC. With DISC1-607F 
there is similar moderate co-localisation between the two proteins under control 
conditions and after incubation at 37oC. DISC1 may therefore either be a stable 
component of endocytic vesicles/early endosomes and late endosomes and directly 
involved in the endocytic pathway, perhaps via regulation of membrane trafficking, 
or it may be associated with internalised species that pass through the early and 
late endosomes, or both. Either way, the association of DISC1 with endosomes is 
apparently not affected by the 607F variant.  
DISC1/RAB7 interaction was previously studied by Lepagnol-Bastel et al but the 
group found no co-localisation between the two proteins, which is at odds with the 
data presented here (Lepagnol-Bestel et al., 2013). There may be several reasons 
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for this, first of all the studies performed by Lepagnol-Bastel et al used a DISC1 
antibody characterised in an earlier study (Koike et al., 2006) which was shown by 
western blotting to be specific for the long isoform of DISC1 (~100KD). The 
specificity of the antibody for immunofluorescent detection of DISC1 has, however, 
not been demonstrated, and indeed on western blots the antibody nonspecifically 
detects other proteins, suggesting that any immunofluorescence data generated 
using this antibody should be interpreted with caution. Moreover, I detected co-
localisation of only a small proportion of DISC1 with RAB7-positive endosomes, thus 
the association may be difficult to detect unless specifically examined at high 
magnification, which was not the case in the Lepagnol-Bastel study. 
Because DISC1 co-localises with endocytic vesicles/early endosomes and late 
endosomes I determined whether its interactor NDE1 also co-localises with these 
vesicles. All forms of NDE1 were found to display moderate co-localisation with 
RAB5 under control conditions. NDE1, NDE1-131A and NDE1-131E were all found to 
also exhibit moderate co-localisation with RAB7. Like its interactor DISC1, NDE1 
therefore co-localises with early and late endosomes. Following incubation at 37oC 
to allow endocytosis to occur, all forms of NDE1 exhibit reduced association with 
RAB5. However the association of NDE1 with late endosomes is not substantially 
altered by internalisation. Like DISC1, NDE1 may therefore be a stable component 
of late endosomes, but it’s association with endocytic vesicles/early endosomes 
appears to be dynamically regulated. This association with the endocytic machinery 
is unaffected by the T131 phosphorylation site. 
I have shown that DISC1 and NDE1 are within close proximity to components of the 
NMDA recycling pathway so could potentially modulate NMDA receptor cell surface 
expression via regulation of endocytosis. At present nothing is known about an 
endocytic role for DISC1, and little is known about a role for NDE1 in endocytosis, 
although one study identified a potential role. This study reported that NDE1 is 
essential for dynein binding to membranes, consistent with its role in regulating 
dynein activity via LIS1 (Lam et al., 2009). The study also showed NDE1 to be 
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essential for the correct positioning of organelles such as early endosomes (Lam et 
al., 2009). Altogether then, NDE1 may recruit active dynein molecules to 
endosomes for their correct/efficient retrograde transit along the endocytic 
pathway. Although the T131 phosphosite apparently does not regulate NDE1 
association with endosomes, it may, for example, affect its ability to activate 
dynein, although I detected no effect of the T131 site upon receptor transit along 
the endocytic pathway. The role of DISC1 may be modulation of trafficking, as has 
already been observed for synaptic vesicles and mitochondria (Atkin et al., 2010, 
Ogawa et al., 2013, Mead et al., 2010). 
In addition to these published observations I noted a weak effect of NDE1 upon 
NMDA receptor association with early endosomes under basal conditions that 
suggests NDE1 may promote receptor association with the endocytic machinery 
prior to internalisation, but this effect was not robust. Consistent with this I 
detected dissociation of NDE1 from NMDA receptor complexes following 
internalisation, which again suggests a role in the early stages of the internalisation 
process. I did not, however, observe any effect of the NDE1 phosphosite mutants, 
despite my previous finding in chapter 5 that the NDE1-131E phosphomimic 
decreases overall NMDA receptor surface expression in comparison to the NDE1-
131A phosphonull mutant. The NDE1-131E mutant therefore likely exerts its effects 
at a different stage of the NMDA receptor trafficking pathway to the endocytic 
stages examined here. 
On the other hand, I did find effects of the DISC1 607F variant, but not of DISC1 
itself, upon NMDA receptor internalisation, which is somewhat consistent with the 
data obtained in chapter 5; In the presence of DISC1-607F I observed no increase in 
NMDA receptor/RAB5 co-localisation following internalisation, which should 
normally happen. Thus the variant form of DISC1 either slows down receptor 
internalisation, or alternatively, speeds it up so that at the time point measured 
there is no apparent abnormality, although the lack of effect upon NMDA 
receptor/RAB7 co-localisation suggests that the former is more likely. The results 
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from chapter 5 show that the 607F variant causes a decrease in surface-expressed 
NMDA receptors when compared to DISC1 (Figure 5.3). This was thought to be most 
likely due to either decreased receptor forward trafficking to the cell surface, or to 
increased internalisation. However my data from chapter 6 suggest that NMDA 
receptor internalisation is in fact retarded in the presence of DISC1-607F. It is 
therefore possible that DISC1-607F acts at more than one step in the NMDA 
receptor trafficking pathway; perhaps inhibiting both forward trafficking and 
internalisation. Consistent with this speculation, from separate work we now know 
that the 607F variant reduces net anterograde NMDA receptor movement in 
neurons (J.K. Millar and E. Malavasi, personal communication). Therefore by 
inference, DISC1-607F may inhibit transit of NMDA receptors to the cell surface in 
COS7 cells as well. 
I also noted that, unlike NDE1, DISC1 apparently remains stably associated with 
NMDA receptors during internalisation. It will therefore be interesting to discover 
what role DISC1 is carrying out. My studies have unfortunately shed little 
mechanistic light on this, but by showing that DISC1 may affect the rate of forward 
trafficking and of endocytosis, I have paved the way for such studies in the future.  
Next, it would be interesting to determine the effect of the DISC1 species upon 
surface-labelled NMDA receptor co-localisation with RAB11, a marker of recycling 
endosomes, and determine if they influence receptor re-insertion into the surface 
membrane. It would also be interesting to determine if there is any effect of TRAK1 
on NMDA receptors endocytosis; this was not studied here due to the 
overexpression of TRAK1 causing NMDA receptors to aggregate at the 
mitochondria. TRAK1 knock down and subsequent co-localisation analysis of surface 
NMDA/RAB5 or RAB11 would one possible way to explore its role.  
To follow up the observations made in this chapter it is important to determine if 
DISC1 or NDE1 co-localise with RAB5 and RAB7 in neurons and if they have similar 
effects on co-localisation with these proteins after incubation in neurons. 
Furthermore it would be interesting to determine the effect on receptor membrane 
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insertion in neurons. A paper by Tang et al devised a novel way to label both 
recycled and newly inserted NMDA receptors at the surface after incubation. The 
authors labelled surface receptors at room temperature, and incubated the neurons 
at 37 °C to internalise the receptors. Excess surface labelled receptors were blocked 
and the cells were incubated again at 37 °C to allow for recycling of receptors. Cells 
were then fixed and the surface receptors were labelled with a secondary antibody. 
Finally the cells were permeabilised and incubated with a secondary antibody to 
lable receptors which hadn’t recycled back to the surface. The co-localisation 
between DISC1, NDE1 or TRAK1, and recycled or newly inserted receptors could be 
determined and therefore shed light on any potential role DISC1, NDE1 or TRAK1 
might have in the re-insertion of NDMA receptors into the surface membrane (Tang 
et al., 2010). As discussed in 5.4 the image quality could have been improved by 
acquiring super-resolution images. These images have a much finer resolution and 
can take much more detailed images so any co-localisation which occurs could be 
assessed in a much greater detail. 
While the data in this chapter do not provide a mechanistic explanation of the 
effects of DISC1-607F or NDE1-131E upon surface expression of NMDA receptors in 
COS7 cells, I have made the novel discovery that DISC1 and NDE1 associate with 
early and late endosomes, and demonstrated that DISC1 apparently influences the 
rate of NMDA receptor endocytosis, at least in COS7 cells.
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The biological function of DISC1 is still largely unknown. DISC1 plays a critical role in 
many different developmental processes; however the exact mechanism of how it 
exerts its function is still poorly understood in many cases. In this thesis I have 
provided evidence for DISC1 and its pathway partners NDE1 and TRAK1 having an 
involvement in the trafficking and surface expression of the NMDA receptor. 
Furthermore I have also shown that polymorphisms within DISC1 and the 
phosphorylation status of NDE1 can affect this. 
DISC1 is a multifunctional multicompartmentalised protein and is well placed to 
modulate the trafficking of the NMDA receptor (Figure 7.1-1). However the exact 
points at which DISC1 may modulate NMDA receptor trafficking need to be 
elucidated. I have provided some evidence for a potential association between 
DISC1 and the NMDA receptor within the ER. DISC1 has not been previously shown 
to be present in the ER but co-transfection with GluN1 and GluN2B subunits and co-
staining with an ER marker shows co-localisation between DISC1, the ER and GluN1 
and GluN2B subunits. Although this needs to be further verified by other 
experimental methods DISC1 could be well placed to regulate NMDA receptor 
release from the ER. Both subunits are needed to form a receptor and it is not until 
the NMDA receptor is fully formed that it is released from the ER (Standley et al., 
2000, Scott et al., 2001, Xia et al., 2001). Retention signals and phosphosites 
regulate the release of the GluN1 subunit from the ER. DISC1 is known to regulate 
the activity of PKA via its interaction with PDE4 and regulation of cAMP, and specific 
PKA and PKC sites on the C-terminal tail of the GluN1 subunit are thought to 
contribute to ER retention/release. Therefore if DISC1 is present within the ER it 
may play a role in the regulation of the release of the NMDA receptor from the ER 
via regulation of receptor phosphorylation. 
I provided evidence for the 607F variant of DISC1 reducing the expression of surface 
expressed NMDA receptors in COS-7 cells (Figure 7.1-2). Although I did not find any 
evidence for wild-type DISC1 modulating the surface expression of the NMDA 
receptor it is reasonable to think DISC1 does plays a role in the expression of the 
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NDMA receptor and that DISC1-607F disrupts this. DISC1 is known to link to dynein 
(Kamiya et al., 2005) and kinesin (Taya et al., 2007) to regulate their transport 
within the cell and is therefore well placed to modulate the trafficking of the NMDA 
receptor. Indeed the lab already has data indicating a role for DISC1 in regulating 
neuronal NMDA receptor trafficking, a role that is compromised by the 607F variant 
(E. Malavasi & K. Millar, unpublished). Based on all these observations it would be 
interesting to determine if DISC1 has an effect on NMDA receptor surface 
expression in neurons.  
Finally I showed evidence for the modulation of the internalisation of NMDA 
receptors (Figure 7.1-3). When co-expressed with DISC1 the levels of internalised 
NMDA receptor is reduced, indicating DISC1 may play a role in the internalisation of 
the receptor. I also provided evidence for an association of DISC1 and RAB5- and 
RAB7-positive endocytic vesicles. This needs to be investigated in more detail but 
potentially opens new areas for DISC1 research; not only could DISC1 be involved in 
the trafficking to the surface of the cell it could also be involved in the recycling 
and/or degradation of the receptor, potentially influencing the trafficking of the 





Figure 7.1 The cycle of the NMDA receptor and potential sites of modulation by 
DISC1 
1. NMDA receptors are assembled within the ER from individual subunitsDISC1 may be 
located near the ER and could affect NDMA receptor release via its regulation of PKA via 
cAMP through its interaction with PDE4. 
2. Assembled receptors are trafficked to the surface of the cell. DISC1 is a known trafficking 
molecule and, via its association with TRAK1 and NDE1, could be involved in the trafficking 
of the NMDA receptor. Results presented in this thesis show that the common DISC1 
variant 607F can modulate the surface expression of the NMDA receptor Furthermore 
NDE1 and TRAK1 may also be involved in this process as NDE1 also modulates the surface 
expression of NMDA receptors, while TRAK1 is robustly associated with the GluN2B 
subunit. 
3. Receptors are internalised and either recycled back to the surface, or removed and 
degraded. DISC1 and NDE1 both may associate (directly or indirectly) with early and late 
endocytic vesicles and may therefore be involved in the process of receptor endocytosis 
and subsequent steps. The DISC1 607-F variant appears to inhibit NMDA receptor 

























NDE1 is a known trafficking molecule critical for the correct positioning of 
organelles, membrane transport and cell signalling. I showed that NDE1 can 
modulate the surface expression of the NMDA receptor and the phosphorylation 
status of T131 may play an important role in regulating this (chapter 4). I also 
studied whether NDE1 may affect the internalisation of the NMDA receptor but it 
was found to have no effect. NDE1 did however dissociate from the RAB5 following 
incubation which, as discussed in chapter 6 could link NDE1 to endocytosis, and via 
its interaction with dynein could play a role in receptor degradation by trafficking 
the receptor away from the surface. NDE1 CNVs have been linked to mental illness 
as well as other disorders of the brain (Hennah et al., 2007, Tomppo et al., 2009). 
These copy number variants could lead to alterations in NDE1 structure, function or 
activity. As results in chapters 5 and 6 have shown phosphorylation of NDE1 can 
affect its function therefore more work is needed to determine if NDE1 may be 
involved in NMDA trafficking, Knockdown of NDE1 and observing any effect on 
NMDA receptor trafficking could provide insight into any role NDE1 may have. 
Finally I studied the effect of TRAK1 upon NMDA receptor surface expression. I 
determined that TRAK1 robustly co-localises with the GluN2B subunit of the NDMA 
receptor which was confirmed by additional experiments performed in the Millar 
lab. Further to this TRAK1 decreased the level of surface expressed NDMA receptors 
when co-expressed in COS-7 cells. As discussed in chapter 5 this was largely due to 
the sequestering of the NMDA receptor at the mitochondria where TRAK1 is known 
to accumulate when overexpressed. TRAK1 is known to be involved in endocytosis 
and interacts with EEA1 (Webber et al., 2008) and therefore may also be involved in 
the recycling of NMDA receptors from the surface of the cell. This could not be 
studied in the assays performed in chapter 6 due to the sequestering of the NDMA 
receptor but KD studies could be one way of studying the role of TRAK1 in NMDA 
receptor endocytosis. TRAK1 specifically co-localises with the GluN2B subunit of the 
NMDA receptor, and coupled with its known role in trafficking and in endocytosis it 
is well placed to play a role in the modulation of NMDA receptor trafficking. 
Knockdown studies of TRAK1 would be the next logical step to study as 
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overexpression of TRAK1 leads to the mitochondrial clustering of TRAK1 (Brickley et 
al., 2005) thereby making it difficult to assess any novel effect of TRAK1. It would be 
interesting to determine if TRAK1 also co-localises with the GluN2A subunit of the 
NMDA receptor, GluN2B containing NDMA receptors are predominantly expressed 
in the developing brain before an upregulation of GluN2A containing NMDA 
receptors in adulthood. If it is a subunit specific interaction this could open up a 
novel area of research of TRAK1 and NMDA receptors in the developing brain and 
coupled with the interaction between DISC1, GluN1 and TRAK1 could thereby 
implicate DISC1. However further research is required to uncover any role TRAK1 
may play in NMDA receptor trafficking. 
Based on the data presented here DISC1 may form a complex with TRAK1, NDE1 
and the NMDA receptor (Figure 7.2). DISC1 is known to associate with both NDE1 
and TRAK1 (Millar et al., 2003, Brandon et al., 2004, Burdick et al., 2008, Bradshaw 
et al., 2008, Bradshaw et al., 2009, Ogawa et al., 2013) and unpublished data shows 
an interaction between GluN1 and DISC1 (S.Mackie and K.Millar unpublished). 
Furthermore I have provided evidence for (and further experiments from the Millar 
lab have confirmed) an association between TRAK1 and the GluN2B subunit of the 
NDMA receptor, providing further evidence for the formation of a complex. Finally I 
showed evidence of a potential association between the NMDA receptor and NDE1, 
although more experiments are needed to confirm this. DISC1, NDE1 and TRAK1 are 
all known trafficking molecules. Via their association with dynein and kinesin they 
can modulate intracellular trafficking and organelle positioning. With their 
individual associations with subunits of the NMDA receptor and their known 
associations with each other there is evidence for the formation of a 
DISC1/NDE1/TRAK1/NMDA receptor complex which may regulate the forward 
trafficking of the NMDA receptor.  
Looking at the wider area of DISC1 research and the implication of the data 
presented in this thesis. The DISC1 family and carriers of the t(1;11) translocation 
are predicted to produce a C-terminally truncated DISC1 protein (DISC1 1-597). This 
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predicted protein is truncated before the L607 which has been the focus of study in 
this chapter, it is reasonable to think that a truncated protein may result in similar 
decreases in surface NDMA receptor expression as observed in COS7 cells co-
expressing L607F-DISC1. Although not replicated by the patch clamping experiments 
performed in 5.3.2 an effect on NMDA receptor endocytosis was observed in both 
DISC1 and 607F-DISC1 expressing cells which indicates DISC1 may still play a role in 
NMDA receptor trafficking via regulation of endocytosis. Disruptions to NMDA 
trafficking could lead to lower expression of the NDMA receptor which may result in 
hypofunction of NMDA receptors which is a major theory of mental illness as NMDA 
antagonists modelled both the positive and negative symptoms of schizophrenia 
and bipolar disorder (Moghaddam and Krystal, 2012, Krystal et al., 1994). Disruption 
to DISC1 could also result in alterations in neuronal signalling as the NDMA receptor 
is the major excitatory receptor in the mammalian brain and is thought to be 





Figure 7.2 Potential complex formation between DISC1, TRAK1, NDE1 and the 
NMDA receptor 
DISC1 has previously been shown to interact with TRAK1 and NDE1 and the NMDA 
receptor. TRAK1 and DISC1 are known interactors as are kinesin and DISC1, NDE1 and 
dynein and TRAK1 and dynein. DISC1 and TRAK1 have also been shown to bind to the 
NMDA receptor and therefore could form a complex which affects the trafficking and 
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